,drug_name,section_name,gpt_output
0,IMPAVIDO,adverse reactions,"nausea, vomiting, diarrhea, headache, decreased appetite, dizziness, abdominal pain, pruritus, somnolence, elevated transaminases, elevated creatinine, death, Stevens-Johnson syndrome, melena, thrombocytopenia, arthritis, skin rash, CTCAE Grade 4 diarrhea, CTCAE Grade 4 hyperbilirubinemia, asthenia, motion sickness, malaise, pyrexia, lymphangitis, agranulocytosis, generalized edema, peripheral edema, jaundice, seizure, scrotal pain, decreased ejaculate volume, absent ejaculation, epistaxis, anemia, lymphadenopathy, abdominal distension, constipation, dysphagia, flatulence, fatigue, abscess, cellulitis, ecthyma, paresthesia, testicular pain, testicular swelling, urticaria, rash, pyoderma"
1,IMPAVIDO,boxed warnings,"EMBRYO-FETAL TOXICITY, fetal harm, fetal death <death>, teratogenicity"
2,IMPAVIDO,warnings and precautions,"Embryo-Fetal Toxicity, Reproductive effects, testicular atrophy, impaired fertility, Renal Effects, serum creatinine increase, Hepatic Effects, transaminases increase, bilirubin increase, Gastrointestinal Effects, fluid intake, Thrombocytopenia, platelet count decrease, Absorption of Oral Contraceptives, vomiting, diarrhea, Stevens-Johnson syndrome, death, reversible follicular atresia, diestrus, reduced viable sperm counts, Scrotal pain, decreased ejaculation, <negated> absent ejaculation, volume depletion"
3,LIVALO,adverse reactions,"rhabdomyolysis, myoglobinuria, acute renal failure, myopathy, myositis, liver enzyme abnormalities, myalgia, back pain, diarrhea, constipation, pain in extremity, arthralgia, headache, influenza, nasopharyngitis, elevated creatine phosphokinase, transaminases, alkaline phosphatase, bilirubin, glucose, hypersensitivity reactions, rash, pruritus, urticaria, abdominal discomfort, abdominal pain, dyspepsia, nausea, asthenia, fatigue, malaise, hepatitis, jaundice, hepatic failure, dizziness, hypoesthesia, insomnia, depression, interstitial lung disease, erectile dysfunction, muscle spasms, cognitive impairment, memory loss, forgetfulness, amnesia, memory impairment, confusion, immune-mediated necrotizing myopathy, death"
4,LIVALO,warnings and precautions,"myopathy, rhabdomyolysis, acute renal failure secondary to myoglobinuria, liver enzyme abnormalities, persistent elevations in hepatic transaminases, immune-mediated necrotizing myopathy (IMNM), proximal muscle weakness, elevated serum creatine kinase, muscle biopsy showing necrotizing myopathy without significant inflammation, markedly elevated creatine kinase (CK) levels, unexplained muscle pain, tenderness, weakness, malaise, fever, increases in serum transaminases (aspartate aminotransferase [AST]/serum glutamic-oxaloacetic transaminase, alanine aminotransferase [ALT]/serum glutamic-pyruvic transaminase), fatal and non-fatal hepatic failure, serious liver injury with clinical symptoms and/or hyperbilirubinemia or jaundice, increases in HbA1c, fasting serum glucose levels, death"
5,XENAZINE,adverse reactions,"Depression, suicidality, akathisia, restlessness, agitation, parkinsonism, dysphagia, sedation, somnolence, fatigue, insomnia, anxiety, nausea, irritability, decreased appetite, obsessive reaction, balance difficulty, bradykinesia, dizziness, dysarthria, unsteady gait, headache, vomiting, fall, laceration (head), ecchymosis, upper respiratory tract infection, shortness of breath, bronchitis, dysuria, diarrhea, tremor, confusion, worsening aggression, pneumonia, hyperhidrosis, skin rash"
6,XENAZINE,boxed warnings,"depression, suicidal thoughts, suicidality, worsening of depression, unusual changes in behavior, prior suicide attempts, prior suicide ideation, untreated depression, inadequately treated depression"
7,XENAZINE,warnings and precautions,"worsening mood, cognition, rigidity, functional capacity, Neuroleptic Malignant Syndrome (NMS), restlessness, agitation, akathisia, parkinsonism, Dysphagia, aspiration pneumonia, Sedation/Somnolence, QTc prolongation, depression, cognitive decline, disability, suicidal ideation, suicidality, death, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure changes, tachycardia, diaphoresis, cardiac dysrhythmia, elevated creatinine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, bradykinesia, hypertonia, esophageal dysmotility, torsade de pointes-type ventricular tachycardia, postural dizziness, syncope, orthostatic hypotension, Hyperprolactinemia, amenorrhea, galactorrhea, gynecomastia, impotence, osteoporosis, Tardive Dyskinesia (TD), vacuous chewing, involuntary dyskinetic movements, melanin-containing tissues toxicity."
8,LINZESS,adverse reactions,"diarrhea, abdominal pain, flatulence, abdominal distension, viral gastroenteritis, headache, fecal incontinence, dehydration, gastroesophageal reflux disease, vomiting, fatigue, upper respiratory tract infection, sinusitis, dyspepsia, rectal hemorrhage, hematochezia <negated>, melena <negated>, allergic reactions <negated>, urticaria <negated>, hives <negated>"
9,LINZESS,boxed warnings,"deaths due to dehydration, death"
10,LINZESS,warnings and precautions,"severe diarrhea, mortality due to dehydration, death"
11,OPSUMIT,adverse reactions,"Embryo-fetal Toxicity, Hepatotoxicity, Decrease in Hemoglobin, anemia, nasopharyngitis, pharyngitis, bronchitis, headache, influenza, urinary tract infection, hypersensitivity reactions, angioedema, pruritus, rash, nasal congestion"
12,OPSUMIT,boxed warnings,"EMBRYO-FETAL TOXICITY, fetal harm"
13,OPSUMIT,warnings and precautions,"hepatotoxicity, liver failure, decreases in hemoglobin, pulmonary edema, decreases in sperm count, embryo-fetal toxicity, elevations of aminotransferases, nausea <negated>, vomiting <negated>, right upper quadrant pain <negated>, fatigue <negated>, anorexia <negated>, jaundice <negated>, dark urine <negated>, fever <negated>, itching <negated>, hemoglobin decrease, hematocrit decrease, anemia <negated>, pulmonary edema with pulmonary veno-occlusive disease (PVOD), adverse effects on spermatogenesis"
14,ASCLERA,adverse reactions,"Injection site hematoma, Injection site irritation, Injection site discoloration, Injection site pain, Injection site pruritus, Injection site warmth, Neovascularisation, Injection site thrombosis, Anaphylactic shock, Angioedema, Urticaria generalized, Asthma, Cerebrovascular accident, Migraine, Paresthesia (local), Loss of consciousness, Confusional state, Dizziness, Cardiac arrest, Palpitations, Deep vein thrombosis, Pulmonary embolism, Syncope vasovagal, Circulatory collapse, Vasculitis, Dyspnea, Skin hyperpigmentation, Dermatitis allergic, Hypertrichosis (in the area of sclerotherapy), Injection site necrosis, Pyrexia, Hot flush, Nerve injury, death"
15,ASCLERA,warnings and precautions,"anaphylaxis, severe allergic reactions, death, tissue necrosis, extravasation, severe necrosis, ischemia, gangrene, inadvertent perivascular injection, pain"
16,KYNAMRO,adverse reactions,"hepatotoxicity, injection site reactions, flu-like symptoms, nausea, headache, elevations in serum transaminases, ALT increased, alanine aminotransferase increased, aspartate aminotransferase increased, liver function test abnormal, angina pectoris, palpitations, vomiting, abdominal pain, fatigue, influenza like illness, pyrexia, chills, edema peripheral, hepatic steatosis, pain in extremity, musculoskeletal pain, insomnia, hypertension, hypersensitivity reaction, angioedema, glomerular nephritis, thrombocytopenic purpura, death (if a fatal event is listed, which it is not in this text)"
17,KYNAMRO,boxed warnings,"hepatotoxicity, elevations in transaminases, elevation in alanine aminotransferase (ALT) >= 3x upper limit of normal (ULN), hepatic fat increase, hepatic steatosis, steatohepatitis, cirrhosis, clinically significant liver toxicity, death"
18,KYNAMRO,warnings and precautions,"erythema, pain, tenderness, pruritus, local swelling, influenza-like illness, pyrexia, chills, myalgia, arthralgia, malaise, fatigue, hepatotoxicity, elevations in transaminases, hepatic steatosis, steatohepatitis <negated>, cirrhosis <negated>, nausea <negated>, vomiting <negated>, abdominal pain <negated>, fever <negated>, jaundice <negated>, lethargy <negated>, alcohol-induced liver injury <negated>, hepatotoxicity from other medications <negated>"
19,XARELTO,adverse reactions,"Increased risk of stroke, bleeding risk, spinal/epidural hematoma, bleeding, hemorrhage, major bleeding, bleeding into a critical organ, fatal bleeding <death>, gastrointestinal bleeding, non-fatal critical organ bleeding, intracranial bleeding, retroperitoneal bleeding, intraocular bleeding, intra-articular bleeding <negated>, non-fatal non-critical organ bleeding, decrease in Hb >= 2g/dL, transfusion of >=2 units of whole blood or packed red blood cells, clinically relevant non-major bleeding, any bleeding, menorrhagia, abdominal pain upper, dyspepsia, toothache, fatigue, sinusitis, urinary tract infection, back pain, osteoarthritis, oropharyngeal pain, wound secretion, pain in extremity, muscle spasm, syncope, pruritus, blister, pulmonary hemorrhage, pulmonary hemorrhage with bronchiectasis, agranulocytosis, thrombocytopenia, retroperitoneal hemorrhage, jaundice, cholestasis, hepatitis, hepatocellular injury, hypersensitivity, anaphylactic reaction, anaphylactic shock, angioedema, cerebral hemorrhage, subdural hematoma, epidural hematoma, hemiparesis, Stevens-Johnson syndrome"
20,XARELTO,boxed warnings,"thrombotic events, spinal/epidural hematoma, pathological bleeding, long-term paralysis, permanent paralysis, neurological impairment, death"
21,XARELTO,warnings and precautions,"bleeding, serious bleeding, fatal bleeding, death, obstetric hemorrhage, thrombotic events, stroke, blood loss, pathological hemorrhage, active pathological hemorrhage <negated>, epidural hematoma, spinal hematoma, paralysis, neurological impairment, midline back pain, sensory deficits, motor deficits, numbness, tingling, weakness in lower limbs, bowel dysfunction, bladder dysfunction, acute renal failure, pregnancy-related hemorrhage, fetal distress"
22,CAPRELSA,adverse reactions,"QT Prolongation, Torsades de Pointes, Skin Reactions, Stevens-Johnson Syndrome, Interstitial Lung Disease, Ischemic Cerebrovascular Events, Hemorrhage, Heart Failure, Diarrhea, Hypothyroidism, Hypertension, Reversible Posterior Leukoencephalopathy Syndrome, Embryofetal Toxicity, rash, acneiform dermatitis, nausea, headache, upper respiratory tract infections, decreased appetite, abdominal pain, asthenia, fatigue, pyrexia, elevated creatinine, Gastrointestinal Disorders, Diarrhea/Colitis, Nausea, Abdominal Pain, Vomiting, Dyspepsia, Dry Mouth, Skin and Cutaneous Disorders, Rash, Dermatitis Acneiform/Acne, Dry Skin, Photosensitivity Reaction, Pruritus, Nail abnormalities, Alopecia, Vascular Disorders, Hypertension/Hypertensive Crisis/Accelerated Hypertension, Nervous System Disorders, Headache, Dysgeusia, General Disorders, Fatigue, Infections, Upper Respiratory Tract Infections, Metabolic and Nutritional Disorders, Decreased Appetite, Hypocalcemia, Investigations, ECG QT Prolonged, Eye Disorders, Corneal Abnormalities, Blurred Vision, Renal Disorders, Proteinuria, Psychiatric Disorders, Depression, Endocrine Disorders, Hypothyroidism, Musculoskeletal Disorders, Muscle Spasms, pancreatitis <negated>, heart failure, intestinal perforation, bleeding events, Laboratory Abnormalities, Hypocalcemia, ALT Increased, Hypoglycemia, Creatinine Increased, Hypomagnesemia, Hematologic, Neutropenia, Thrombocytopenia, death (due to the mention of fatal events, although not explicitly stated, it is implied by the context of serious adverse reactions)."
23,CAPRELSA,boxed warnings,"QT prolongation, Torsades de Pointes, sudden death, death"
24,CAPRELSA,warnings and precautions,"Prolonged QT Interval, Torsades de pointes, sudden death, death, Severe skin reactions, Stevens-Johnson syndrome, Interstitial lung disease (ILD), fatalities, Ischemic cerebrovascular events, hemorrhage, heart failure, diarrhea, hypertension, reversible posterior leukoencephalopathy syndrome (RPLS), Embryofetal toxicity, Photosensitivity reactions, pneumonitis, Serious hemorrhagic events, Hypothyroidism, hypertensive crisis, seizures, headache, visual disturbances, confusion, altered mental function, embryotoxic, fetotoxic, teratogenic, adverse effects on female fertility, embryofetal development, postnatal development of pups"
25,KADCYLA,adverse reactions,"Hepatotoxicity, Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Pulmonary Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions, Hemorrhage, Thrombocytopenia, Neurotoxicity, fatigue, nausea, musculoskeletal pain, headache, increased transaminases, constipation, epistaxis, Neutropenia, Anemia, Lacrimation increased, Dry eye, Vision blurred, Conjunctivitis, Dyspepsia, Stomatitis, Dry Mouth, Abdominal pain, Vomiting, Diarrhea, Peripheral edema, Chills, Pyrexia, Asthenia, Nodular regenerative hyperplasia, Portal hypertension, Drug hypersensitivity, Infusion-related reaction, Urinary tract infection, Blood alkaline phosphatase increased, Hypokalemia, Myalgia, Arthralgia, Dysgeusia, Dizziness, Peripheral neuropathy, Insomnia, Pneumonitis, Dyspnea, Cough, Pruritus, Rash, Hypertension, Increased bilirubin, Increased AST, Increased ALT, Decreased platelet count, Decreased hemoglobin, Decreased neutrophils, Decreased potassium, Hepatic failure"
26,KADCYLA,boxed warnings,"hepatotoxicity, liver failure, death, reductions in left ventricular ejection fraction, embryo-fetal death, birth defects"
27,KADCYLA,warnings and precautions,"pulmonary toxicity, interstitial lung disease, pneumonitis, infusion-related reactions, hypersensitivity reactions, hemorrhage, thrombocytopenia, neurotoxicity, hepatotoxicity, severe drug-induced liver injury, hepatic encephalopathy, death, nodular regenerative hyperplasia, non-cirrhotic portal hypertension, left ventricular dysfunction, embryo-fetal toxicity, oligohydramnios, pulmonary hypoplasia, skeletal abnormalities, neonatal death, acute respiratory distress syndrome, dyspnea, cough, fatigue, pulmonary infiltrates, flushing, chills, pyrexia, hypotension, wheezing, bronchospasm, tachycardia, allergic reaction, anaphylactic-like reaction, central nervous system hemorrhage, respiratory hemorrhage, gastrointestinal hemorrhage, peripheral neuropathy, extravasation, erythema, tenderness, skin irritation, pain, swelling at the infusion site"
28,RELISTOR,adverse reactions,"Gastrointestinal perforation, Severe or persistent diarrhea, Opioid withdrawal, Abdominal pain, Nausea, Diarrhea, Hyperhidrosis, Hot flush, Tremor, Chills, Flatulence, Dizziness, Vomiting, Feeling of body temperature change, Piloerection, Myocardial infarctions, Stroke, Cardiac arrest, Sudden death, Cramping, Diaphoresis, Flushing, Malaise, Pain, death"
29,RELISTOR,warnings and precautions,"Gastrointestinal perforation, severe abdominal pain, worsening abdominal pain, severe diarrhea, persistent diarrhea, opioid withdrawal, hyperhidrosis, chills, abdominal pain, anxiety, yawning, death"
30,JUXTAPID,adverse reactions,"hepatotoxicity, reduced absorption of fat-soluble vitamins, reduced serum fatty acids, gastrointestinal adverse reactions, diarrhea, nausea, vomiting, dyspepsia, abdominal pain, abdominal discomfort, abdominal distension, constipation, flatulence, increased ALT, chest pain, influenza, nasopharyngitis, fatigue, decreased weight, fever, back pain, headache, dizziness, pharyngolaryngeal pain, nasal congestion, angina pectoris, palpitations, gastroesophageal reflux disease, defecation urgency, rectal tenesmus, gastroenteritis, transaminase elevations, hepatic steatosis, death"
31,JUXTAPID,boxed warnings,"hepatotoxicity, elevations in transaminases, elevation in alanine aminotransferase (ALT), elevation in aspartate aminotransferase (AST), hepatic fat increase, hepatic steatosis, steatohepatitis, cirrhosis, liver disease, clinically significant liver toxicity, death"
32,JUXTAPID,warnings and precautions,"Embryo-Fetal Toxicity, Gastrointestinal adverse reactions, Hepatotoxicity, Elevation of Transaminases, Hepatic Steatosis, Reduced Absorption of Fat-Soluble Vitamins and Serum Fatty Acids, Diarrhea, Nausea, Dyspepsia, Vomiting, Abdominal pain, Abdominal discomfort, Abdominal distension, Constipation, Flatulence, Myopathy, Rhabdomyolysis <negated>, Supratherapeutic anticoagulation, Subtherapeutic anticoagulation, Malabsorption"
33,SAVELLA,adverse reactions,"nausea, headache, constipation, dizziness, insomnia, hot flush, hyperhidrosis, vomiting, palpitations, heart rate increased, dry mouth, hypertension, tachycardia, vision blurred, abdominal pain, chest pain, chills, chest discomfort, upper respiratory tract infection, blood pressure increased, decreased appetite, migraine, paresthesia, tremor, hypoesthesia, tension headache, anxiety, dyspnea, rash, pruritus, flushing, weight loss, dysuria, ejaculation disorder, erectile dysfunction, ejaculation failure, libido decreased, prostatitis, scrotal pain, testicular pain, testicular swelling, urinary hesitation, urinary retention, urethral pain, urine flow decreased, diarrhea, dyspepsia, gastroesophageal reflux disease, flatulence, abdominal distension, fatigue, peripheral edema, irritability, pyrexia, urinary tract infection, cystitis, contusion, fall, hypercholesterolemia, somnolence, dysgeusia, depression, stress, night sweats, leukopenia, neutropenia, thrombocytopenia, supraventricular tachycardia, accommodation disorder, hyperprolactinemia, hepatitis, anorexia, hyponatremia, rhabdomyolysis, convulsions, loss of consciousness, Parkinsonism, aggression, anger, delirium, hallucination, homicidal ideation, acute renal failure, galactorrhea, erythema multiforme, Stevens Johnson syndrome, hypertensive crisis, death"
34,SAVELLA,boxed warnings,"suicidal thinking, suicidality, behavior changes, clinical worsening, unusual changes in behavior, increased risk of suicidal ideation"
35,SAVELLA,warnings and precautions,"suicidality, suicide risk, Serotonin Syndrome, elevated blood pressure, heart rate elevations, Seizures, Hepatotoxicity, ALT elevations, AST elevations, fulminant hepatitis, Withdrawal symptoms, Abnormal Bleeding, genitourinary adverse events, dysuria, urinary retention, testicular pain, ejaculation disorders, Angle Closure Glaucoma, elevated transaminases, hyponatremia, mental status changes, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, gastrointestinal symptoms, nausea, vomiting, diarrhea, anxiety, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania, emotional lability, lethargy, tinnitus, seizures, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, falls, hallucination, syncope, respiratory arrest, death, ecchymoses, hematomas, epistaxis, petechiae, hemorrhages, activation of mania, hypomania, Angle Closure Glaucoma, <negated>suicidal ideation (0% in patients treated with Savella 100 mg/day), <negated>suicides (no suicides occurred in the short-term or longer-term fibromyalgia trials)."
36,SAMSCA,adverse reactions,"thirst, dry mouth, asthenia, constipation, pollakiuria, polyuria, hyperglycemia, death, nausea, pyrexia, anorexia, gastrointestinal bleeding, disseminated intravascular coagulation, intracardiac thrombus, ventricular fibrillation, prothrombin time prolonged, ischemic colitis, diabetic ketoacidosis, rhabdomyolysis, cerebrovascular accident, urethral hemorrhage, vaginal hemorrhage, pulmonary embolism, respiratory failure, deep vein thrombosis, osmotic demyelination syndrome, hypernatremia, hypersensitivity reactions, anaphylactic shock, rash generalized"
37,SAMSCA,boxed warnings,"osmotic demyelination, dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma, death"
38,SAMSCA,warnings and precautions,"Liver injury, Dehydration, Hypovolemia, Osmotic demyelination syndrome, Dysarthria, Mutism, Dysphagia, Lethargy, Affective changes, Spastic quadriparesis, Seizures, Coma, Death, Fatigue, Anorexia, Right upper abdominal discomfort, Dark urine, Jaundice, Hyperkalemia"
39,JETREA,adverse reactions,"Decreased Vision, Intravitreal Injection Procedure Associated Effects, Potential for Lens Subluxation, Retinal Breaks, vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, retinal edema, macular edema, increased intraocular pressure, anterior chamber cell, photophobia, vitreous detachment, ocular discomfort, iritis, cataract, dry eye, metamorphopsia, conjunctival hyperemia, retinal degeneration, dyschromatopsia"
40,JETREA,warnings and precautions,"decreased vision, progression of the condition with traction, surgical intervention, intraocular inflammation, intraocular infection, intraocular hemorrhage, increased intraocular pressure (IOP), lens subluxation, retinal detachment, retinal tear, dyschromatopsia, yellowish vision, electroretinographic (ERG) changes, a-wave amplitude decrease, b-wave amplitude decrease"
41,OPDIVO,adverse reactions,"Immune-Mediated Pneumonitis, Immune-Mediated Colitis, Immune-Mediated Hepatitis, Immune-Mediated Nephritis, Renal Dysfunction, Immune-Mediated Hypothyroidism, Hyperthyroidism, Other Immune-Mediated Adverse Reactions, rash, fatigue, dyspnea, musculoskeletal pain, decreased appetite, cough, nausea, constipation, abdominal pain, hyponatremia, increased aspartate aminotransferase, increased lipase, pruritus, upper respiratory tract infection, peripheral edema, ventricular arrhythmia, iridocyclitis, infusion-related reactions, increased amylase, dizziness, peripheral neuropathy, sensory neuropathy, exfoliative dermatitis, erythema multiforme, vitiligo, psoriasis, increased alkaline phosphatase, hyperkalemia, increased ALT, asthenia, edema, pyrexia, chest pain, pain, arthralgia, vomiting, diarrhea, decreased weight, pneumonia, stomatitis, peripheral neuropathy, bronchitis, increased creatinine, hypercalcemia, hypokalemia, hypomagnesemia, hypocalcemia, lymphopenia, anemia, thrombocytopenia, death"
42,OPDIVO,warnings and precautions,"immune-mediated pneumonitis, moderate pneumonitis, severe pneumonitis, life-threatening pneumonitis, death, immune-mediated colitis, moderate colitis, severe colitis, life-threatening colitis, immune-mediated hepatitis, liver function changes, transaminase elevation, total bilirubin elevation, immune-mediated nephritis, renal dysfunction, serum creatinine elevation, immune-mediated hypothyroidism, hyperthyroidism, embryofetal toxicity, fetal harm, adrenal insufficiency, uveitis, pancreatitis, facial nerve paresis, abducens nerve paresis, demyelination, autoimmune neuropathy, motor dysfunction, vasculitis, hypophysitis, diabetic ketoacidosis, hypopituitarism, Guillain-Barre syndrome, myasthenic syndrome, diarrhea, colitis, liver test abnormalities, AST increase, alkaline phosphatase increase, ALT increase, total bilirubin increase, elevated creatinine, thyroid function changes, hypothyroidism, hyperthyroidism, abortion, premature infant death"
43,VICTOZA,adverse reactions,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Renal Impairment, Hypersensitivity Reactions, headache, nausea, diarrhea, anti-liraglutide antibody formation, Immunogenicity-related events, urticaria, vomiting, dyspepsia, constipation, injection site reactions, papillary thyroid carcinoma, increased serum bilirubin, elevated serum calcitonin, increased heart rate, Medullary thyroid carcinoma, Dehydration, Increased serum creatinine, acute renal failure, worsening of chronic renal failure, Angioedema, anaphylactic reactions, Allergic reactions, rash, pruritus, Acute pancreatitis, hemorrhagic pancreatitis, necrotizing pancreatitis, death"
44,VICTOZA,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), mass in the neck <negated>, dysphagia <negated>, dyspnea <negated>, persistent hoarseness <negated>"
45,VICTOZA,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, fatal hemorrhagic pancreatitis, non-fatal hemorrhagic pancreatitis, necrotizing pancreatitis, death, Serious Hypoglycemia, Renal Impairment, acute renal failure, worsening of chronic renal failure, Hypersensitivity, serious hypersensitivity reactions, anaphylactic reactions, angioedema, Macrovascular Outcomes <negated>."
46,EFFIENT,adverse reactions,"Bleeding, life-threatening bleeding, fatal bleeding, death, Thrombotic thrombocytopenic purpura, TIMI Major bleeding, TIMI Minor bleeding, Symptomatic intracranial hemorrhage (ICH), Requiring inotropes, Requiring surgical intervention, Requiring transfusion (>=4 units), Bleeding Unrelated to CABG Surgery, Bleeding Related to CABG, Reoperation, Transfusion of >=5 units, Intracranial hemorrhage, Hemorrhagic events, epistaxis, gastrointestinal hemorrhage, hemoptysis, subcutaneous hematoma, post-procedural hemorrhage, retroperitoneal hemorrhage, pericardial effusion/hemorrhage/tamponade, retinal hemorrhage, Malignancies, severe thrombocytopenia, anemia, abnormal hepatic function, allergic reactions, angioedema, Hypertension, Hypercholesterolemia/Hyperlipidemia, Headache, Back pain, Dyspnea, Nausea, Dizziness, Cough, Hypotension, Fatigue, Non-cardiac chest pain, Atrial fibrillation, Bradycardia, Leukopenia (<4 x 10^9 WBC/L), Rash, Pyrexia, Peripheral edema, Pain in extremity, Diarrhea, Thrombocytopenia, Hypersensitivity reactions, anaphylaxis."
47,EFFIENT,boxed warnings,"significant bleeding, fatal bleeding, death, active pathological bleeding <negated>, transient ischemic attack <negated>, stroke <negated>, intracranial bleeding, hypotensive, cardiovascular events"
48,EFFIENT,warnings and precautions,"CABG-related bleeding, stent thrombosis, myocardial infarction, death, Thrombotic thrombocytopenic purpura (TTP), Hypersensitivity, angioedema, bleeding, TIMI Major bleeding, TIMI Minor bleeding, intracranial hemorrhage, hypotension, active bleeding <negated>, TIA <negated>, stroke <negated>, fatal bleeding, gastrointestinal (GI) bleeding, active peptic ulcer disease, severe hepatic impairment, moderate to severe renal impairment, thrombocytopenia, microangiopathic hemolytic anemia, neurological findings, renal dysfunction, fever"
49,ENTYVIO,adverse reactions,"Infusion-Related Reactions, Hypersensitivity Reactions, Infections, Progressive Multifocal Leukoencephalopathy, Liver Injury, nasopharyngitis, headache, arthralgia, nausea, pyrexia, upper respiratory tract infection, fatigue, cough, bronchitis, influenza, back pain, rash, pruritus, sinusitis, oropharyngeal pain, pain in extremities, anaphylaxis, dyspnea, bronchospasm, urticaria, flushing, increased blood pressure, heart rate, dizziness, vomiting, anal abscess, sepsis, tuberculosis, salmonella sepsis, Listeria meningitis, giardiasis, cytomegaloviral colitis, hepatitis, malignancies, colon cancer, transitional cell carcinoma, breast cancer, carcinoid tumor, squamous cell carcinoma, B-cell lymphoma, malignant hepatic neoplasm, malignant lung neoplasm, malignant melanoma, lung cancer, renal cancer, death"
50,ENTYVIO,warnings and precautions,"hypersensitivity reactions, anaphylaxis, infections, severe infections, progressive multifocal leukoencephalopathy (PML), death, dyspnea, bronchospasm, urticaria, flushing, rash, increased blood pressure, increased heart rate, nasopharyngitis, upper respiratory tract infection, anal abscess, sepsis, tuberculosis, salmonella sepsis, Listeria meningitis, giardiasis, cytomegaloviral colitis, liver injury, jaundice, severe liver injury, neurological signs or symptoms, progressive weakness, clumsiness of limbs, disturbance of vision, changes in thinking, memory issues, confusion, personality changes, elevations of transaminase, elevations of bilirubin, severe disability."
51,ADEMPAS,adverse reactions,"Embryo-Fetal Toxicity, Hypotension, Bleeding, Headache, Dyspepsia, Gastritis, Dizziness, Nausea, Diarrhea, Vomiting, Anemia, Gastroesophageal Reflux, Constipation, Palpitations, Nasal Congestion, Epistaxis, Dysphagia, Abdominal Distension, Peripheral Edema"
52,ADEMPAS,boxed warnings,embryo-fetal toxicity
53,ADEMPAS,warnings and precautions,"symptomatic hypotension, bleeding, pulmonary edema, fetal harm, hypovolemia, severe left ventricular outflow obstruction, resting hypotension, autonomic dysfunction, ischemia, serious bleeding, hemoptysis, death, vaginal hemorrhage, catheter site hemorrhage, subdural hematoma, hematemesis, intra-abdominal hemorrhage, pulmonary veno-occlusive disease (PVOD)"
54,MOVANTIK,adverse reactions,"Gastrointestinal perforation, Opioid withdrawal, abdominal pain, diarrhea, nausea, flatulence, vomiting, headache, hyperhidrosis, chills, anxiety, irritability, yawning"
55,MOVANTIK,warnings and precautions,"Gastrointestinal perforation, severe abdominal pain, persistent abdominal pain, worsening abdominal pain, opioid withdrawal, hyperhidrosis, chills, diarrhea, abdominal pain, anxiety, irritability, yawning, gastrointestinal adverse reactions, reduced analgesia"
56,STIVARGA,adverse reactions,"hepatotoxicity, hemorrhage, dermatological toxicity, hypertension, cardiac ischemia and infarction, reversible posterior leukoencephalopathy syndrome (RPLS), gastrointestinal perforation or fistula, asthenia/fatigue, hand-foot skin reaction (HFSR), diarrhea, decreased appetite/food intake, mucositis, dysphonia, infection, pain (not otherwise specified), decreased weight, gastrointestinal and abdominal pain, rash, fever, nausea, anemia, thrombocytopenia, neutropenia, lymphopenia, hypocalcemia, hypokalemia, hyponatremia, hypophosphatemia, hyperbilirubinemia, increased AST, increased ALT, proteinuria, increased INR, increased lipase, increased amylase, alopecia, hypothyroidism, headache, musculoskeletal stiffness, hypersensitivity reaction, death <negated>"
57,STIVARGA,boxed warnings,"hepatotoxicity, severe hepatotoxicity, fatal hepatotoxicity <death>, elevated liver function tests, hepatocellular necrosis"
58,STIVARGA,warnings and precautions,"hemorrhage, dermatological toxicity, hypertension, cardiac ischemia, infarction, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), gastrointestinal perforation, fistulae, wound healing complications, embryofetal toxicity, hepatotoxicity, liver injury, hepatocyte necrosis, lymphocyte infiltration, hepatic failure, metastatic disease in the liver, increased incidence of hemorrhage, fatal hemorrhage, respiratory tract hemorrhage, gastrointestinal tract hemorrhage, genitourinary tract hemorrhage, skin and subcutaneous tissue reactions, hand-foot skin reaction (HFSR), palmar-plantar erythrodysesthesia (PPE), severe rash, erythema multiforme, Stevens Johnson Syndrome, toxic epidermal necrolysis, hypertensive crisis, myocardial ischemia, myocardial infarction, subcortical vasogenic edema, seizures, headache, visual disturbances, confusion, altered mental function, gastrointestinal fistula, wound dehiscence, embryolethal, teratogenic, cardiovascular malformations, genitourinary malformations, skeletal malformations, death"
59,ANORO,adverse reactions,"asthma-related death, paradoxical bronchospasm, cardiovascular effects, worsening of narrow-angle glaucoma, worsening of urinary retention, pharyngitis, sinusitis, lower respiratory tract infection, constipation, diarrhea, pain in extremity, muscle spasms, neck pain, chest pain, productive cough <negated>, dry mouth <negated>, dyspepsia <negated>, abdominal pain, gastroesophageal reflux disease <negated>, vomiting <negated>, musculoskeletal chest pain <negated>, chest discomfort <negated>, asthenia <negated>, atrial fibrillation <negated>, ventricular extrasystoles <negated>, supraventricular extrasystoles <negated>, myocardial infarction <negated>, pruritus <negated>, rash <negated>, conjunctivitis <negated>, headache, back pain, cough, urinary tract infection, arthralgia, nausea, vertigo, pleuritic pain, viral respiratory tract infection, toothache, diabetes mellitus, death"
60,ANORO,boxed warnings,"asthma-related death, death"
61,ANORO,warnings and precautions,"asthma-related death, paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, hypokalemia, hyperglycemia, cardiovascular effects, fatalities, hypersensitivity reactions, anaphylactic reactions, increases in pulse rate, systolic blood pressure increase, diastolic blood pressure increase, electrocardiographic changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, coronary insufficiency, cardiac arrhythmias, hypertension, convulsive disorders, thyrotoxicosis, diabetes mellitus aggravation, ketoacidosis aggravation, eye pain, discomfort, blurred vision, visual halos, colored images, red eyes from conjunctival congestion, corneal edema, difficulty passing urine, painful urination, death"
62,VIMPAT,adverse reactions,"Suicidal Behavior and Ideation, Dizziness, Ataxia, Cardiac Rhythm and Conduction Abnormalities, Syncope, Multiorgan Hypersensitivity Reactions, diplopia, headache, nausea, insomnia, somnolence, fatigue, vomiting, blurred vision, vertigo, diarrhea, gait disturbance, asthenia, contusion, skin laceration, tremor, nystagmus, balance disorder, memory impairment, depression, pruritus, neutropenia, anemia, palpitations, tinnitus, constipation, dyspepsia, dry mouth, oral hypoaesthesia, irritability, pyrexia, feeling drunk, fall, muscle spasms, paresthesia, cognitive disorder, hypoaesthesia, dysarthria, disturbance in attention, cerebellar syndrome, confusional state, mood altered, depressed mood, injection site pain, injection site discomfort, injection site irritation, injection site erythema, profound bradycardia, oral paresthesia, chest pain, abnormal coordination, hyperhidrosis, agranulocytosis, aggression, agitation, hallucination, psychotic disorder, angioedema, rash, urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis, death"
63,VIMPAT,warnings and precautions,"suicidal behavior, suicidal ideation, dizziness, ataxia, syncope, cardiac rhythm abnormalities, conduction abnormalities, PR interval prolongation, first-degree atrioventricular block, second-degree atrioventricular block, complete AV block, bradycardia, atrial fibrillation, atrial flutter, increased seizure frequency <negated>, multiorgan hypersensitivity reactions, symptomatic hepatitis, nephritis, rash, elevated liver enzymes, myocarditis, phenylketonuria"
64,BANZEL,adverse reactions,"Suicidal Behavior and Ideation, Central Nervous System Reactions, QT Shortening, Multi-Organ Hypersensitivity, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Leukopenia, headache, dizziness, fatigue, somnolence, nausea, vomiting, influenza, nasopharyngitis, decreased appetite, rash, ataxia, diplopia, bronchitis, sinusitis, psychomotor hyperactivity, upper abdominal pain, aggression, ear infection, disturbance in attention, pruritis, tremor, nystagmus, blurred vision, anxiety, constipation, dyspepsia, back pain, gait disturbance, vertigo, convulsion, anemia, lymphadenopathy, neutropenia, iron deficiency anemia, thrombocytopenia, bundle branch block right, atrioventricular block first degree, pollakiuria, urinary incontinence, dysuria, hematuria, nephrolithiasis, polyuria, enuresis, nocturia, incontinence, Stevens-Johnson syndrome, death"
65,BANZEL,warnings and precautions,"new or worsening depression, suicidal thoughts/behavior, unusual changes in mood or behavior, Central nervous system reactions, QT interval shortening, multi-organ hypersensitivity reaction, precipitating seizures, seizure exacerbation, status epilepticus, somnolence, fatigue, coordination abnormalities, dizziness, gait disturbances, ataxia, sudden death <negated>, ventricular arrhythmias <negated>, ventricular fibrillation <negated>, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, leukopenia, death"
66,XELJANZ,adverse reactions,"upper respiratory tract infections, headache, diarrhea, nasopharyngitis, serious infections, pneumonia, cellulitis, herpes zoster, urinary tract infections, tuberculosis <negated>, disseminated tuberculosis, opportunistic infections <negated>, malignancies excluding NMSC, lymphoma, lung cancer, breast cancer, gastric cancer, colorectal cancer, renal cell cancer, prostate cancer, malignant melanoma, lymphopenia, neutropenia, liver enzyme elevations, drug-induced liver injury, lipid elevations, serum creatinine elevations, anemia, diverticulitis, dehydration, insomnia, paresthesia, dyspnea, cough, sinus congestion, abdominal pain, dyspepsia, vomiting, gastritis, nausea, hepatic steatosis, rash, erythema, pruritus, musculoskeletal pain, arthralgia, tendonitis, joint swelling, non-melanoma skin cancers, pyrexia, fatigue, peripheral edema"
67,XELJANZ,boxed warnings,"serious infections, death, tuberculosis, bacterial infections, invasive fungal infections, viral infections, opportunistic infections, hospitalization, lymphoma, malignancies, Epstein Barr Virus-associated post-transplant lymphoproliferative disorder, cryptococcosis, pneumocystosis"
68,XELJANZ,warnings and precautions,"serious infection, localized infections, gastrointestinal perforations, lymphocyte abnormalities, neutropenia, anemia, liver enzyme elevations, lipid elevations, tuberculosis, mycobacterial infections, cryptococcosis, esophageal candidiasis, pneumocystosis, multidermatomal herpes zoster, cytomegalovirus, BK virus, pneumonia, cellulitis, herpes zoster, urinary tract infection, diverticulitis, histoplasmosis, coccidioidomycosis, listeriosis, malignancy, lymphoproliferative disorders, non-melanoma skin cancer, viral reactivation, Epstein Barr Virus-associated post-transplant lymphoproliferative disorder, death"
69,GATTEX,adverse reactions,"abdominal pain, injection site reactions, nausea, headaches, abdominal distension, upper respiratory tract infection, vomiting, fluid overload, flatulence, hypersensitivity, appetite disorders, sleep disturbances, cough, skin hemorrhage, gastrointestinal stoma complication, malignancy, colorectal polyps, gastrointestinal obstruction, gallbladder disease, biliary disease, pancreatic disease, congestive heart failure, cognition and attention disturbances, immunogenicity, anti-GATTEX antibodies, neutralizing antibodies."
70,GATTEX,warnings and precautions,"neoplastic growth, acceleration of neoplastic growth, intestinal obstruction, biliary disease, pancreatic disease, fluid overload, colorectal polyps, small bowel neoplasia, colorectal cancer <negated>, small bowel cancer <negated>, cholecystitis, cholangitis, cholelithiasis, pancreatitis, congestive heart failure, altered mental status"
71,XOFIGO,adverse reactions,"Bone Marrow Suppression, nausea, diarrhea, vomiting, peripheral edema, anemia, lymphocytopenia, leukopenia, thrombocytopenia, neutropenia, pancytopenia, renal failure and impairment, dehydration, erythema, pain, edema, secondary malignant neoplasms, osteosarcoma"
72,XOFIGO,warnings and precautions,"Bone Marrow Suppression, bone marrow failure, ongoing pancytopenia, death, blood transfusions, bone marrow suppression <negated>, vascular hemorrhage, myelosuppression, infection-related deaths, serious infections, febrile neutropenia, thrombocytopenia, neutropenia, pancytopenia, leukopenia, additive myelosuppression"
73,SYNRIBO,adverse reactions,"myelosuppression, bleeding, hyperglycemia, thrombocytopenia, anemia, neutropenia, diarrhea, nausea, fatigue, asthenia, injection site reaction, pyrexia, infection, lymphopenia, pancytopenia, increased alanine aminotransferase, bone marrow failure, febrile neutropenia, constipation, abdominal pain, upper abdominal pain, vomiting, edema peripheral, anorexia, arthralgia, pain in extremity, back pain, myalgia, headache, insomnia, cough, epistaxis, alopecia, rash, leukocytosis, chills, dyspnea, death, hemoglobin decreased, leukocytes decreased, neutrophils decreased, platelets decreased, alanine aminotransferase increased, bilirubin increased, creatinine increased, glucose increased, uric acid increased, glucose decreased, tachycardia, palpitations, acute coronary syndrome, angina pectoris, arrhythmia, bradycardia, ventricular extrasystoles, ear pain, ear hemorrhage, tinnitus, cataract, vision blurred, conjunctival hemorrhage, dry eye, lacrimation increased, conjunctivitis, diplopia, eye pain, eyelid edema, stomatitis, mouth ulceration, abdominal distension, dyspepsia, gastroesophageal reflux disease, gingival bleeding, aphthous stomatitis, dry mouth, hemorrhoids, gastritis, gastrointestinal hemorrhage, melena, mouth hemorrhage, oral pain, anal fissure, dysphagia, gingival pain, gingivitis, mucosal inflammation, pain, chest pain, hyperthermia, influenza-like illness, catheter site pain, general edema, malaise, hypersensitivity, contusion, transfusion reaction, decreased appetite, diabetes mellitus, gout, dehydration, bone pain, muscular weakness, muscle spasms, musculoskeletal chest pain, musculoskeletal pain, musculoskeletal stiffness, musculoskeletal discomfort, dizziness, cerebral hemorrhage, paresthesia, convulsion, hypoesthesia, lethargy, sciatica, burning sensation, dysgeusia, tremor, anxiety, depression, agitation, confusional state, mental status change, dysuria, pharyngolaryngeal pain, nasal congestion, dysphonia, productive cough, rales, rhinorrhea, hemoptysis, sinus congestion, erythema, pruritus, dry skin, petechiae, hyperhidrosis, night sweats, ecchymosis, purpura, skin lesion, skin ulcer, rash erythematous, rash papular, skin exfoliation, skin hyperpigmentation, hematoma, hypertension, hot flush, hypotension"
74,SYNRIBO,warnings and precautions,"severe thrombocytopenia, neutropenia, anemia, increased risk of hemorrhage, fatal cerebral hemorrhage, severe non-fatal gastrointestinal hemorrhage, glucose intolerance, hyperglycemia, hyperosmolar non-ketotic hyperglycemia, embryo-fetal toxicity, fetal harm, death"
75,ICLUSIG,adverse reactions,"Vascular Occlusion, Heart Failure, Hepatotoxicity, Hypertension, Pancreatitis, Neuropathy, Ocular Toxicity, Hemorrhage, Fluid Retention, Cardiac Arrhythmias, Myelosuppression, Arterial ischemia, Abdominal pain, Constipation, Nausea, Diarrhea, Vomiting, Oral mucositis, GI hemorrhage, Febrile neutropenia, Sepsis, Pneumonia, Urinary tract infection, Upper respiratory tract infection, Nasopharyngitis, Cellulitis, Headache, Peripheral neuropathy, Dizziness, Pleural effusion, Cough, Dyspnea, Rash and related conditions, Dry skin, Arthralgia, Myalgia, Pain in extremity, Back pain, Muscle spasms, Bone pain, Fatigue or asthenia, Pyrexia, Edema, peripheral, Pain, Chills, Decreased appetite, Weight decreased, Insomnia, Arterial ischemic event, Cardiovascular, Cerebrovascular, Peripheral vascular, CNS hemorrhage, Gastrointestinal hemorrhage, Cardiac failure, Effusions, Atrial fibrillation, Venous thromboembolism, Thrombocytopenia, Anemia, Neutropenia, Leukopenia, Lymphopenia, ALT increased, AST increased, Alkaline phosphatase increased, Albumin decreased, Bilirubin increased, Lipase increased, Amylase increased, Glucose increased, Phosphorus decreased, Calcium decreased, Sodium decreased, Glucose decreased, Potassium decreased, Potassium increased, Sodium increased, Bicarbonate decreased, Creatinine increased, Calcium increased, Triglycerides increased"
76,ICLUSIG,boxed warnings,"vascular occlusion, arterial thrombosis, venous thrombosis, myocardial infarction, stroke, stenosis of large arterial vessels of the brain, severe peripheral vascular disease, urgent revascularization procedures, heart failure, hepatotoxicity, liver failure, death"
77,ICLUSIG,warnings and precautions,"hypertension, high blood pressure, pancreatitis, neuropathy, peripheral neuropathy, cranial neuropathy, ocular toxicity, blindness, blurred vision, retinal toxicities, macular edema, retinal vein occlusion, retinal hemorrhage, conjunctival irritation, corneal irritation, dry eye, eye pain, visual blurring, cataracts, glaucoma, iritis, iridocyclitis, ulcerative keratitis, hemorrhage, serious bleeding events, cerebral hemorrhage, gastrointestinal hemorrhage, fluid retention, brain edema <negated>, pericardial effusion, pleural effusion, ascites, peripheral edema, cardiac arrhythmias, bradyarrhythmias, complete heart block, sick sinus syndrome, atrial fibrillation, supraventricular tachyarrhythmias, atrial flutter, supraventricular tachycardia, atrial tachycardia, myelosuppression, thrombocytopenia, neutropenia, anemia, tumor lysis syndrome, hyperuricemia, compromised wound healing, gastrointestinal perforation, embryo-fetal toxicity, death"
78,SABRIL,adverse reactions,"Vision Loss, Magnetic Resonance Imaging (MRI) Abnormalities in Infants, Neurotoxicity, Suicidal Behavior and Ideation, Withdrawal of Antiepileptic Drugs (AEDs), Anemia, Somnolence, Fatigue, Peripheral Neuropathy, Weight Gain, Edema, permanent vision loss, nystagmus, vision blurred, memory impairment, arthralgia, abnormal coordination, confusional state, increased weight, upper respiratory tract infection, aggression, diplopia, bronchitis, ear infection, otitis media acute, headache, dizziness, convulsion, nasopharyngitis, visual field defect, depression, tremor, nausea, diarrhea, insomnia, irritability, coordination abnormal, vomiting, influenza, pyrexia, rash, tinnitus, vertigo, asthenopia, eye pain, diarrhoea, abdominal pain upper, dyspepsia, stomach discomfort, abdominal pain, toothache, abdominal distension, gait disturbance, asthenia, oedema peripheral, fever, chest pain, thirst, malaise, contusion, joint sprain, muscle strain, wound secretion, increased appetite, back pain, pain in extremity, myalgia, muscle twitching, muscle spasms, somnolence, dizziness, nystagmus, tremor, memory impairment, coordination abnormal, disturbance in attention, sensory disturbance, hyporeflexia, paraesthesia, lethargy, hyperreflexia, hypoaesthesia, sedation, status epilepticus, dysarthria, postictal state, sensory loss, irritability, depression, confusional state, anxiety, depressed mood, thinking abnormal, abnormal behaviour, expressive language disorder, nervousness, abnormal dreams, dysmenorrhoea, erectile dysfunction, pharyngolaryngeal pain, cough, pulmonary congestion, sinus headache, rash, psychomotor hyperactivity, disorientation, acne, strabismus, conjunctivitis, vomiting, constipation, diarrhea, fever, viral infection, pneumonia, candidiasis, ear infection, gastroenteritis viral, sinusitis, urinary tract infection, croup infectious, decreased appetite, sedation, somnolence, status epilepticus, lethargy, convulsion, hypotonia, irritability, insomnia, nasal congestion, cough, rash, Congenital cardiac defects, congenital external ear anomaly, congenital hemangioma, congenital hydronephrosis, congenital male genital malformation, congenital oral malformation, congenital vesicoureteric reflux, dentofacial anomaly, dysmorphism, fetal anticonvulsant syndrome, hamartomas, hip dysplasia, limb malformation, limb reduction defect, low set ears, renal aplasia, retinitis pigmentosa, supernumerary nipple, talipes, Deafness, Delayed puberty, Gastrointestinal hemorrhage, esophagitis, Developmental delay, facial edema, malignant hyperthermia, multi-organ failure, Cholestasis, Dystonia, encephalopathy, hypertonia, hypotonia, muscle spasticity, myoclonus, optic neuritis, dyskinesia, Acute psychosis, apathy, delirium, hypomania, neonatal agitation, psychotic disorder, Laryngeal edema, pulmonary embolism, respiratory failure, stridor, Angioedema, maculo-papular rash, pruritus, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), death"
79,SABRIL,boxed warnings,"permanent bilateral concentric visual field constriction, vision loss, tunnel vision, decrease in visual acuity, severe vision loss, retinopathy <negated>, glaucoma <negated>, progressive visual field constriction, worsening vision loss, death"
80,SABRIL,warnings and precautions,"Permanent vision loss, Abnormal MRI signal changes, Suicidal behavior and ideation, Withdrawal seizures <negated>, Anemia, Somnolence and fatigue, Neurotoxicity, Intramyelinic edema (IME), Vacuolation, Convulsions, Neuromotor impairment, Learning deficits, Apoptotic neurodegeneration, Peripheral Neuropathy, Weight Gain, Edema"
81,VPRIV,adverse reactions,"hypersensitivity reactions, headache, dizziness, abdominal pain, nausea, back pain, joint pain, prolonged activated PTT, fatigue/asthenia, pyrexia, bone pain, tachycardia, rash, urticaria, flushing, hypertension, hypotension"
82,VPRIV,warnings and precautions,"hypersensitivity reactions, anaphylaxis, headache, dizziness, hypotension, hypertension, nausea, fatigue, asthenia, pyrexia, body temperature increased, chest discomfort, dyspnea, pruritus"
83,DALIRESP,adverse reactions,"Psychiatric Events Including Suicidality, Weight Decrease, Diarrhea, Nausea, Headache, Back Pain, Influenza, Insomnia, Dizziness, Decreased Appetite, Atrial Fibrillation, Lung Cancer, Prostate Cancer, Acute Pancreatitis, Acute Renal Failure, Abdominal Pain, Dyspepsia, Gastritis, Vomiting, Rhinitis, Sinusitis, Urinary Tract Infection, Muscle Spasms, Tremor, Anxiety, Depression, Hypersensitivity Reactions, Angioedema, Urticaria, Rash"
84,DALIRESP,warnings and precautions,"acute bronchospasm, psychiatric events, suicidality, insomnia, anxiety, depression, suicidal thoughts, mood changes, weight decrease, weight loss, moderate weight loss, severe weight loss, drug interactions, suicidal ideation, suicide attempts, completed suicide <negated>, death"
85,SYLVANT,adverse reactions,"severe infections, infusion-related reactions, hypersensitivity, pruritus, increased weight, rash, hyperuricemia, upper respiratory tract infection, rash generalized, rash maculo-papular, rash popular, rash pruritic, skin hyperpigmentation, eczema, psoriasis, dry skin, lower respiratory tract infection, thrombocytopenia, edema, constipation, hypertriglyceridemia, hypercholesterolemia, oropharyngeal pain, renal impairment, headache, hypotension, abdominal pain, abdominal distension, decreased appetite, dehydration, peripheral edema, diarrhea, pain in extremities, arthralgia, fatigue, anaphylaxis, back pain, chest pain, nausea, vomiting, flushing, erythema, palpitations, death"
86,SYLVANT,warnings and precautions,"severe infections, infections, live vaccines <negated>, Infusion Related Reactions, anaphylaxis, mild to moderate infusion reaction, Gastrointestinal (GI) perforation, death"
87,LASTACAFT,adverse reactions,"eye irritation, burning and/or stinging on instillation, eye redness, eye pruritus, nasopharyngitis, headache, eye discharge, eye swelling, erythema of eyelid, eyelid edema, hypersensitivity, somnolence"
88,LASTACAFT,warnings and precautions,"eye injury, contamination, contact lens-related irritation <negated>, death"
89,GAZYVA,adverse reactions,"Hepatitis B reactivation, Progressive multifocal leukoencephalopathy, Infusion reactions, Tumor lysis syndrome, Infections, Neutropenia, Thrombocytopenia, Anemia, Pyrexia, Cough, Nausea, Diarrhea, Leukopenia, Urinary tract infection, Back pain, Nasopharyngitis, Constipation, Lymphopenia, Hypocalcemia, Hyperkalemia, Hyponatremia, AST (SGOT increased), Creatinine increased, ALT (SGPT increased), Hypoalbuminemia, Alkaline phosphatase increased, Hypokalemia, Musculoskeletal disorders, Liver enzyme elevations, Immunogenicity, Worsening of Pre-existing Cardiac Conditions, death"
90,GAZYVA,boxed warnings,"Hepatitis B Virus reactivation, fulminant hepatitis, hepatic failure, death, Progressive Multifocal Leukoencephalopathy"
91,GAZYVA,warnings and precautions,"infusion reactions, tumor lysis syndrome, neutropenia, thrombocytopenia, hepatitis B virus reactivation, fulminant hepatitis, hepatic failure, death, progressive multifocal leukoencephalopathy (PML), hypotension, tachycardia, dyspnea, respiratory symptoms, bronchospasm, larynx and throat irritation, wheezing, laryngeal edema, nausea, vomiting, diarrhea, hypertension, flushing, headache, pyrexia, chills, anaphylaxis, acute life-threatening respiratory symptoms, other life-threatening infusion reaction, acute renal failure, hyperkalemia, hypocalcemia, hyperuricemia, hyperphosphatemia, serious bacterial infections, serious fungal infections, new or reactivated viral infections, fatal infections, hemorrhagic events, fatal hemorrhagic events, bleeding, infection, live virus vaccines <negated>."
92,ONGLYZA,adverse reactions,"upper respiratory tract infection, urinary tract infection, headache, peripheral edema, lymphopenia, rash, blood creatinine increased, blood creatine phosphokinase increased, sinusitis, abdominal pain, gastroenteritis, vomiting, fractures, thrombocytopenia, hypoglycemia, hypersensitivity reactions, urticaria, facial edema, tuberculosis, salmonella sepsis, death, anaphylaxis <negated>, angioedema <negated>, exfoliative skin conditions <negated>, acute pancreatitis <negated>, severe and disabling arthralgia <negated>"
93,ONGLYZA,warnings and precautions,"acute pancreatitis, hypoglycemia, hypersensitivity-related events, urticaria, facial edema, anaphylaxis, angioedema, exfoliative skin conditions, arthralgia, severe joint pain, <negated>macrovascular risk reduction"
94,SIVEXTRO,adverse reactions,"nausea, headache, diarrhea, vomiting, dizziness, anemia, palpitations, tachycardia, asthenopia, vision blurred, visual impairment, vitreous floaters, infusion-related reactions, drug hypersensitivity, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, white blood cell count decreased, hypoesthesia, paresthesia, VIIth nerve paralysis, insomnia, pruritus, urticaria, dermatitis, flushing, hypertension, myelosuppression, peripheral neuropathy, optic neuropathy"
95,SIVEXTRO,warnings and precautions,"neutropenia, Clostridium difficile-associated diarrhea, mild diarrhea, fatal colitis <death>, CDAD, morbidity, mortality, drug-resistant bacteria"
96,PREPOPIK,adverse reactions,"nausea, headache, vomiting, abdominal bloating <negated>, distension <negated>, pain/cramping <negated>, watery diarrhea <negated>, electrolyte abnormalities, potassium (low), sodium (low), chloride (low), magnesium (high), calcium (low), creatinine (high), eGFR (low), allergic reactions, rash, urticaria, purpura, hypokalemia, hyponatremia, hypermagnesemia, abdominal pain, diarrhea, fecal incontinence, proctalgia, reversible aphthoid ileal ulcers, ischemic colitis, generalized tonic-clonic seizures"
97,PREPOPIK,warnings and precautions,"fluid and electrolyte abnormalities, arrhythmia, seizures, renal impairment, mucosal ulcerations, GI obstruction <negated>, GI perforation <negated>, aspiration, nausea, vomiting, dehydration, orthostatic hypotension, orthostatic changes, cardiac arrhythmias, generalized tonic-clonic seizures, renal injury, serious arrhythmias, colonic mucosal aphthous ulcerations, ischemic colitis, ulcerative colitis, impaired gag reflex, regurgitation."
98,OFEV,adverse reactions,"Liver Enzyme and Bilirubin Elevations, Gastrointestinal Disorders, Embryofetal Toxicity, Arterial Thromboembolic Events, Risk of Bleeding, Gastrointestinal Perforation, diarrhea, nausea, abdominal pain, vomiting, liver enzyme elevation, decreased appetite, headache, weight decreased, hypertension, bronchitis, myocardial infarction, pneumonia, lung neoplasm malignant, death, hypothyroidism"
99,OFEV,warnings and precautions,"elevated liver enzymes, ALT elevations, AST elevations, bilirubin elevations, gastrointestinal disorders, diarrhea, nausea, vomiting, embryofetal toxicity, arterial thromboembolic events, bleeding events, gastrointestinal perforation, liver enzyme increases, ALT and/or AST elevations, bilirubin elevations, myocardial infarction, bleeding, gastrointestinal perforation"
100,ZONTIVITY,adverse reactions,"Bleeding, life-threatening bleeding, fatal bleeding, death, GUSTO severe bleeding, intracranial bleeding, bleeding with hemodynamic compromise requiring intervention, GUSTO moderate bleeding, bleeding requiring transfusion, GUSTO Bleeding Categories, Severe bleeding, Moderate or Severe bleeding, Any GUSTO Bleeding, Fatal Bleeding, Intracranial Hemorrhage (ICH), Clinically Significant Bleeding, Gastrointestinal Bleeding, Anemia, Depression, Rashes, Eruptions, Exanthemas, iron deficiency, retinopathy, retinal disorder, diplopia, oculomotor disturbances."
101,ZONTIVITY,boxed warnings,"bleeding, stroke <negated>, transient ischemic attack <negated>, intracranial hemorrhage, active pathological bleeding <negated>, fatal bleeding, death"
102,ZONTIVITY,warnings and precautions,"bleeding, ICH, fatal bleeding <death>, hypotensive"
103,BELVIQ,adverse reactions,"Serotonin Syndrome, NMS-like Reactions, Valvular Heart Disease, Cognitive Impairment, Psychiatric Disorders, Hypoglycemia, Heart Rate Decreases, Hematological Changes, Prolactin Elevation, headache, dizziness, fatigue, nausea, dry mouth, constipation, back pain, cough, diarrhea, vomiting, upper respiratory tract infection, nasopharyngitis, urinary tract infection, musculoskeletal pain, rash, toothache, peripheral edema, seasonal allergy, gastroenteritis, worsening of diabetes mellitus, decreased appetite, muscle spasms, anxiety, insomnia, stress, depression, hypertension, euphoria, lymphocyte count decrease, neutrophil count decrease, hemoglobin decrease, eye disorders, blurred vision, dry eye, visual impairment, visual disorders, conjunctival infections, ocular sensation disorders, cataract conditions, valvular regurgitation"
104,BELVIQ,warnings and precautions,"Serotonin Syndrome, Neuroleptic Malignant Syndrome (NMS)-like Reactions, Valvular heart disease, Cognitive Impairment, disturbances in attention, memory impairment, Psychiatric Disorders, euphoria, dissociation, depression <negated>, suicidal thoughts <negated>, hypoglycemia, Priapism, painful erections, Heart Rate Decreases, bradycardia, Hematological Changes, decreases in white blood cell count, leukopenia, lymphopenia, neutropenia, decreases in red blood cell count, anemia, decreases in hemoglobin, decreases in hematocrit, Prolactin Elevation, galactorrhea, gynecomastia, prolactinoma, Pulmonary Hypertension, death"
105,STELARA,adverse reactions,"Infections, Malignancies, Reversible Posterior Leukoencephalopathy Syndrome, Nasopharyngitis, Upper respiratory tract infection, Headache, Fatigue, Diarrhea, Back pain, Dizziness, Pharyngolaryngeal pain, Pruritus, Injection site erythema, Myalgia, Depression, Cellulitis, Herpes zoster, Diverticulitis, Injection site reactions (pain, swelling, pruritus, induration, hemorrhage, bruising, irritation), Arthralgia, Nausea, Dental infections, Serious hypersensitivity reactions (including anaphylaxis and angioedema), Other hypersensitivity reactions (including rash and urticaria), Pustular psoriasis, Erythrodermic psoriasis, <negated>Death"
106,STELARA,warnings and precautions,"serious infections, infections, mycobacteria infections, salmonella infections, Bacillus Calmette-Guerin (BCG) vaccinations infections, tuberculosis (TB), malignancies, anaphylaxis, hypersensitivity reactions, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), diverticulitis, cellulitis, pneumonia, appendicitis, cholecystitis, sepsis, osteomyelitis, viral infections, gastroenteritis, urinary tract infections, disseminated infections, fatal outcomes <negated>, death, angioedema, headache, seizures, confusion, visual disturbances, preeclampsia, eclampsia, acute hypertension, cytotoxic agents, immunosuppressive therapy, non-live vaccinations insufficient immune response <negated>, live vaccines <negated>, BCG vaccines <negated>, Ultraviolet-induced skin cancers"
107,NATROBA,adverse reactions,"application site erythema, ocular erythema, application site irritation, application site dryness, application site exfoliation, alopecia, dry skin"
108,NATROBA,warnings and precautions,"Benzyl alcohol toxicity, serious adverse reactions, death"
109,ELELYSO,adverse reactions,"pruritus, flushing, headache, arthralgia, pain in extremity, abdominal pain, vomiting, fatigue, back pain, dizziness, nausea, rash, urticaria, hypersensitivity reactions, severe vomiting, gastrointestinal inflammation, mild throat irritation, chest discomfort, anaphylaxis, immune-mediated fixed drug eruption, Type III immune-mediated fixed drug eruption, death"
110,ELELYSO,warnings and precautions,"hypersensitivity reactions, anaphylaxis, urticaria, hypotension, flushing, wheezing, chest tightness, nausea, vomiting, dizziness, pruritus, angioedema, erythema, rash, cough, throat irritation"
111,STRIVERDI,adverse reactions,"asthma-related death, nasopharyngitis, upper respiratory tract infection, bronchitis, urinary tract infection, cough, dizziness, rash, diarrhea, back pain, arthralgia, COPD exacerbation, pneumonia, atrial fibrillation, constipation, pyrexia, lung cancer, death"
112,STRIVERDI,boxed warnings,"asthma-related death, death"
113,STRIVERDI,warnings and precautions,"clinically significant cardiovascular effects, fatal <death>, life-threatening paradoxical bronchospasm, asthma-related death, deterioration of disease, acute episodes of bronchospasm, excessive use of STRIVERDI RESPIMAT, paradoxical bronchospasm, increases in pulse rate, systolic blood pressure increase, diastolic blood pressure increase, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, aggravation of pre-existing diabetes mellitus, aggravation of ketoacidosis, significant hypokalemia, increases in plasma glucose, cardiac arrhythmias, angioedema"
114,BELSOMRA,adverse reactions,"CNS depressant effects, daytime impairment, abnormal thinking, behavioral changes, worsening of depression, suicidal ideation, sleep paralysis, hypnagogic hallucinations, hypnopompic hallucinations, cataplexy-like symptoms, somnolence, diarrhea, dry mouth, upper respiratory tract infection, headache, dizziness, abnormal dreams, cough, increase in serum cholesterol"
115,BELSOMRA,warnings and precautions,"daytime somnolence, impaired alertness, motor coordination impairment, impaired driving, insomnia, nighttime ""sleep-driving"", complex behaviors while not fully awake, depression, worsening of depression, suicidal thinking, compromised respiratory function, sleep paralysis, hypnagogic/hypnopompic hallucinations, cataplexy-like symptoms, CNS depressant effects, daytime impairment, somnolence, risk of falling asleep while driving, CNS depression, amnesia, anxiety, hallucinations, neuro-psychiatric symptoms, suicidal ideation, suicidal thoughts, suicidal actions, death (if suicidal actions include completed suicides), leg weakness"
116,NPLATE,adverse reactions,"arthralgia, dizziness, insomnia, myalgia, pain in extremity, abdominal pain, shoulder pain, dyspepsia, paresthesia, headache, bone marrow reticulin deposition, worsening thrombocytopenia <negated>, erythromelalgia, hypersensitivity, angioedema"
117,NPLATE,warnings and precautions,"increased blast cell counts, progression to acute myelogenous leukemia, thrombotic/thromboembolic complications, portal vein thrombosis, worsened thrombocytopenia, formation of neutralizing antibodies, bone marrow reticulin formation, bone marrow fibrosis, lack or loss of response to Nplate, death"
118,ORBACTIV,adverse reactions,"Hypersensitivity Reactions, Infusion related reactions, Clostridium difficile-associated diarrhea, Osteomyelitis, headache, nausea, vomiting, limb and subcutaneous abscesses, diarrhea, cellulitis, dizziness, infusion site phlebitis, infusion site reaction, abscess (limb and subcutaneous), Alanine aminotransferase increased, Aspartate aminotransferase increased, tachycardia, anemia, eosinophilia, infusion site erythema, extravasation, induration, pruritis, rash, edema peripheral, hypersensitivity <negated>, osteomyelitis <negated>, total bilirubin increased, hyperuricemia, hypoglycemia, tenosynovitis, myalgia, bronchospasm, wheezing, urticaria, angioedema, erythema multiforme, pruritis, leucocytoclastic vasculitis, rash."
119,ORBACTIV,warnings and precautions,"bleeding, aPTT prolongation, PT prolongation, INR prolongation, hypersensitivity reactions, infusion-related reactions, pruritus, urticaria, flushing, Clostridium difficile-associated diarrhea, CDAD, colitis, diarrhea, osteomyelitis, death (due to fatal colitis)"
120,MEKINIST,adverse reactions,"New Primary Malignancies, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Interstitial Lung Disease, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, rash, diarrhea, lymphedema, pyrexia, chills, fatigue, nausea, vomiting, abdominal pain, peripheral edema, cough, headache, arthralgia, night sweats, decreased appetite, constipation, myalgia, stomatitis, hypertension, dermatitis acneiform, dry skin, pruritus, paronychia, lymphedema, hemorrhage, bradycardia, xerostomia, folliculitis, rash pustular, cellulitis, rhabdomyolysis, dizziness, dysgeusia, vision blurred, dry eye, increased aspartate aminotransferase (AST), increased alanine aminotransferase (ALT), hypoalbuminemia, anemia, increased alkaline phosphatase, edema peripheral, erythema, oropharyngeal pain, back pain, muscle spasms, pain in extremity, dehydration, insomnia, urinary tract infection, renal failure, transient blindness, pancreatitis, asthenia, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperkeratosis, hyperhidrosis, leukopenia, lymphopenia, neutropenia, thrombocytopenia, hyperbilirubinemia, hyperglycemia, increased gamma-glutamyltransferase (GGT), hyponatremia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QTcF prolongation."
121,MEKINIST,warnings and precautions,"Tumor promotion, Hemolytic anemia, New primary malignancies, Hemorrhage, Major hemorrhagic events, Venous Thromboembolism, Deep vein thrombosis, Pulmonary embolism, Cardiomyopathy, Ocular Toxicities, Retinal Vein Occlusion (RVO), Interstitial Lung Disease (ILD), Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Embryofetal Toxicity, Basal cell carcinoma, Cutaneous squamous cell carcinomas (SCC), Keratoacanthoma, New primary melanoma <negated>, Non-Cutaneous Malignancies, Pancreatic adenocarcinoma, Colorectal carcinoma, Head and neck carcinoma, Glioblastoma, Intracranial hemorrhage, Gastric hemorrhage, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, Pneumonitis, Pyrexia, Rash, Dermatitis acneiform rash, Palmar-plantar erythrodysesthesia syndrome, Erythema, Secondary infections of the skin, death"
122,CYRAMZA,adverse reactions,"Hemorrhage, Arterial Thromboembolic Events, Hypertension, Infusion-Related Reactions, Gastrointestinal Perforation, Impaired Wound Healing, Reversible Posterior Leukoencephalopathy Syndrome, Proteinuria, Nephrotic Syndrome, Thyroid Dysfunction, diarrhea, fatigue, neutropenia, epistaxis, decreased appetite, stomatitis, anemia, intestinal obstruction, red blood cell transfusions, Hyponatremia, Headache, rash, febrile neutropenia, granulocyte colony-stimulating factors, Gastrointestinal hemorrhage events, Fatigue/Asthenia, Peripheral edema, Hypoalbuminemia, sepsis, Lacrimation increased, Palmar-plantar erythrodysesthesia syndrome, death"
123,CYRAMZA,boxed warnings,"hemorrhage, gastrointestinal hemorrhage, severe hemorrhagic events, death, gastrointestinal perforation, impaired wound healing"
124,CYRAMZA,warnings and precautions,"arterial thromboembolic events, myocardial infarction, cardiac arrest, cerebrovascular accident, cerebral ischemia, death, hypertension, infusion-related reactions, rigors/tremors, back pain/spasms, chest pain, chills, flushing, dyspnea, wheezing, hypoxia, paresthesia, bronchospasm, supraventricular tachycardia, hypotension, gastrointestinal perforation, impaired wound healing, encephalopathy, ascites, hepatorenal syndrome, reversible posterior leukoencephalopathy syndrome, proteinuria, nephrotic syndrome, thyroid dysfunction, hypothyroidism, embryofetal toxicity"
125,RAXIBACUMAB,adverse reactions,"rash, pain in extremity, pruritus, somnolence, urticaria, clonus, dyspnea, anemia, leukopenia, lymphadenopathy, palpitations, vertigo, fatigue, infusion site pain, peripheral edema, blood amylase increased, blood creatine phosphokinase increased, prothrombin time prolonged, back pain, muscle spasms, syncope vasovagal, insomnia, flushing, hypertension"
126,RAXIBACUMAB,warnings and precautions,"infusion reactions, rash, urticaria, pruritus"
127,ARCALYST,adverse reactions,"Mycobacterium intracellulare infection, gastrointestinal bleeding, colitis, sinusitis, bronchitis, Streptococcus pneumoniae meningitis, death, injection-site reaction (ISR), upper respiratory infection, nausea, diarrhea, abdominal pain upper <negated>, cough, hypoesthesia, stomach discomfort, urinary tract infection, erythema, swelling, pruritis, mass, bruising, inflammation, pain, edema, dermatitis, discomfort, urticaria, vesicles, warmth, hemorrhage, neutropenia <negated>, transient neutropenia."
128,ARCALYST,warnings and precautions,"serious infections, life-threatening infections, hypersensitivity reactions, severe bronchitis, bacterial meningitis, death, increased risk of serious infections, increased risk of reactivation of latent tuberculosis, TB, atypical infections, opportunistic infections, increased risk of malignancies, changes in lipid profiles, <negated> efficacy of live vaccines, <negated> risks of secondary transmission of infection by live vaccines, <negated> effectiveness of vaccination with inactivated antigens"
129,RAPIVAB,adverse reactions,"serious skin reactions, hypersensitivity reactions, neuropsychiatric events, diarrhea, death, Alanine Aminotransferase increased, Serum Glucose increased, Creatine Phosphokinase increased, Neutrophils decreased, constipation, insomnia, AST increased, hypertension, Stevens-Johnson Syndrome, exfoliative dermatitis, rash, abnormal behavior, hallucination"
130,RAPIVAB,warnings and precautions,"Stevens-Johnson syndrome, erythema multiforme, hallucinations, delirium, abnormal behavior, death, serious skin reactions, neurologic and behavioral symptoms, encephalitis <negated>, encephalopathy <negated>, bacterial infections, secondary bacterial infections"
131,FOLOTYN,adverse reactions,"Bone Marrow Suppression, Mucositis, Dermatologic Reactions, Tumor Lysis Syndrome, Hepatic Toxicity, thrombocytopenia, nausea, fatigue, pyrexia, sepsis, febrile neutropenia, dehydration, dyspnea, anemia, constipation, edema, cough, epistaxis, vomiting, neutropenia, diarrhea, anorexia, hypokalemia, rash, pruritus, pharyngolaryngeal pain, liver function test abnormal, abdominal pain, pain in extremity, back pain, leukopenia, night sweats, asthenia, tachycardia, upper respiratory tract infection, cardiopulmonary arrest, pancytopenia, toxic epidermal necrolysis, death"
132,FOLOTYN,warnings and precautions,"thrombocytopenia, neutropenia, anemia, mucositis, dermatologic reactions, death, tumor lysis syndrome, hepatic toxicity, toxic epidermal necrolysis (TEN), skin exfoliation, ulceration, embryo-fetal toxicity"
133,KRYSTEXXA,adverse reactions,"anaphylaxis, infusion reactions, gout flares, nausea, contusion, ecchymosis, nasopharyngitis, constipation, chest pain, vomiting, congestive heart failure exacerbation, urticaria, dyspnea, erythema, pruritus, anti-pegloticase antibodies, anti-PEG antibodies"
134,KRYSTEXXA,boxed warnings,"anaphylaxis, infusion reactions, delayed-type hypersensitivity reactions"
135,KRYSTEXXA,warnings and precautions,"Anaphylaxis, Infusion Reactions, Gout Flares, Congestive Heart Failure Exacerbation, Wheezing, Peri-oral Edema, Lingual Edema, Hemodynamic Instability, Rash, Urticaria, Delayed Type Hypersensitivity Reactions, Death"
136,NUCYNTA,adverse reactions,"Respiratory Depression, Interaction with Alcohol, Chronic Pulmonary Disease, Hypotensive Effects, Interactions with Other CNS Depressants, Drug abuse, addiction, dependence, Gastrointestinal Effects, Seizures, Serotonin Syndrome, nausea, dizziness, vomiting, somnolence, headache, Constipation, Dry mouth, Dyspepsia, Fatigue, Feeling hot, Nasopharyngitis, Upper respiratory tract infection, Urinary tract infection, Decreased appetite, Tremor, Lethargy, Insomnia, Confusional state, Abnormal dreams, Anxiety, Pruritus, Hyperhidrosis, Pruritus generalized, Rash, Hot flush, heart rate increased, heart rate decreased, visual disturbance, abdominal discomfort, impaired gastric emptying, irritability, edema, drug withdrawal syndrome, feeling drunk, hypersensitivity, gamma-glutamyltransferase increased, alanine aminotransferase increased, aspartate aminotransferase increased, involuntary muscle contractions, sensation of heaviness, hypoesthesia, paresthesia, disturbance in attention, sedation, dysarthria, depressed level of consciousness, memory impairment, ataxia, presyncope, syncope, coordination abnormal, seizure, euphoric mood, disorientation, restlessness, agitation, nervousness, thinking abnormal, urinary hesitation, pollakiuria, oxygen saturation decreased, cough, dyspnea, respiratory depression, urticaria, blood pressure decreased, diarrhea, headache, hallucination, suicidal ideation, panic attack, palpitations, Anaphylaxis, angioedema, anaphylactic shock, death"
137,NUCYNTA,warnings and precautions,"misuse, abuse, addiction, overdose, death, respiratory depression, hypotension, sedation, respiratory arrest, sighing pattern of breathing, carbon dioxide (CO2) retention, respiratory drive decrease, apnea, accidental ingestion, fatal overdose, central nervous system depression, profound sedation, coma, vasodilation, cardiac output reduction, blood pressure reduction, circulatory shock, intracranial pressure increase, brain tumors, impaired consciousness <negated>, coma <negated>, convulsions, seizure disorders, seizures, serotonin syndrome, mental-status changes, autonomic instability, tachycardia, labile blood pressure, hyperthermia, neuromuscular aberrations, hyperreflexia, incoordination, gastrointestinal symptoms, nausea, vomiting, diarrhea, GI obstruction, paralytic ileus, sphincter of Oddi spasm, biliary tract disease, acute pancreatitis, withdrawal symptoms, anxiety, sweating, insomnia, rigors, pain, tremors, upper respiratory symptoms, piloerection, hallucinations, impaired mental abilities, impaired physical abilities, hepatic impairment, renal impairment, elevated metabolite."
138,ACTEMRA,adverse reactions,"upper respiratory tract infections, nasopharyngitis, headache, hypertension, increased ALT, injection site reactions, serious infections, pneumonia, urinary tract infection, cellulitis, herpes zoster, gastroenteritis, diverticulitis, sepsis, bacterial arthritis, opportunistic infections, gastrointestinal perforation, purulent peritonitis, lower GI perforation, fistula, abscess, infusion reactions, rash, pruritus, urticaria, anaphylaxis, neutropenia, thrombocytopenia, elevated liver enzymes, liver enzyme abnormalities, lipids, hyperlipidemia, increased LDL, increased HDL, increased LDL/HDL ratio, increased ApoB/ApoA1 ratio, immunogenicity, anti-tocilizumab antibodies, malignancies, dizziness, bronchitis, mouth ulceration, abdominal pain upper, gastritis, transaminase increased, oral herpes simplex, stomatitis, gastric ulcer, weight increased, total bilirubin increased, leukopenia, edema peripheral, dyspnea, cough, conjunctivitis, nephrolithiasis, hypothyroidism, injection site reactions (erythema, pain, hematoma), macrophage activation syndrome (MAS), angioedema, Stevens-Johnson Syndrome, death"
139,ACTEMRA,boxed warnings,"serious infections, hospitalization, death, active tuberculosis, pulmonary disease, extrapulmonary disease, latent tuberculosis, invasive fungal infections, candidiasis, aspergillosis, pneumocystis, bacterial infections, viral infections, opportunistic pathogens, tuberculosis (TB)"
140,ACTEMRA,warnings and precautions,"serious infections, gastrointestinal perforation, neutropenia, thrombocytopenia, elevated liver enzymes, lipid abnormalities, immunosuppression, hypersensitivity reactions, anaphylaxis, death, viral reactivation, herpes zoster, hepatitis B <negated>, malignancies, demyelinating disorders, active hepatic disease, hepatic impairment, pneumonia, urinary tract infection, cellulitis, herpes zoster, gastroenteritis, diverticulitis, sepsis, bacterial arthritis, tuberculosis, cryptococcus, aspergillosis, candidiasis, pneumocystosis, histoplasmosis, coccidioidomycosis, listeriosis, transaminase elevations, total cholesterol increase, triglycerides increase, LDL cholesterol increase, HDL cholesterol increase, multiple sclerosis <negated>, chronic inflammatory demyelinating polyneuropathy <negated>"
141,VIIBRYD,adverse reactions,"Suicidal Thoughts and Behaviors, Serotonin Syndrome, Increased Risk of Bleeding, Activation of Mania or Hypomania, Discontinuation Syndrome, Seizures, Angle-Closure Glaucoma, Hyponatremia, diarrhea, nausea, vomiting, insomnia, abdominal pain, dyspepsia, flatulence, gastroenteritis, abdominal distension, headache, dizziness, somnolence, paresthesia, abnormal dreams, restlessness, fatigue, palpitations, increased appetite, arthralgia, increased weight, abnormal orgasm, erectile dysfunction, libido decreased, ejaculation disorder, ventricular extrasystoles, dry eye, vision blurred, cataracts, sedation, tremor, migraine, panic attack, hyperhidrosis, night sweats, irritability, hallucinations, suicide attempt <negated>, suicidal ideation <negated>, rash, generalized rash, urticaria, drug eruption, death"
142,VIIBRYD,boxed warnings,"suicidal thoughts and behaviors, clinical worsening, <negated> safety and efficacy of VIIBRYD have not been established in pediatric patients"
143,VIIBRYD,warnings and precautions,"Serotonin Syndrome, Increased Risk of Bleeding, Activation of Mania/Hypomania, Seizures, Angle Closure Glaucoma, Suicidal Thoughts and Behavior, mental status changes, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, gastrointestinal symptoms, nausea, vomiting, diarrhea, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, Discontinuation Syndrome, dysphoric mood, irritability, anxiety, confusion, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, Hyponatremia, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death"
144,LUZU,adverse reactions,"application site reactions, contact dermatitis, cellulitis, death"
145,LUMASON,adverse reactions,"severe cardiopulmonary reactions, hypersensitivity reactions, headache, nausea, hypersensitivity-type rash, near syncope symptoms, anaphylactic shock, dysgeusia, injection site pain, chest discomfort, feeling hot, chest pain, injection site warmth, fatalities <death>, anaphylactoid reactions <synonym for hypersensitivity reactions>, arrhythmias, hypertensive episodes"
146,LUMASON,boxed warnings,"serious cardiopulmonary reactions, fatalities <death>, death"
147,LUMASON,warnings and precautions,"cardiopulmonary reactions, death, anaphylactoid reactions, fatal cardiac arrest, respiratory arrest, shock, syncope, symptomatic arrhythmias, atrial fibrillation, tachycardia, bradycardia, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia, hypertension, hypotension, dyspnea, hypoxia, chest pain, respiratory distress, stridor, wheezing, loss of consciousness, convulsions, skin erythema, rash, urticaria, flushing, throat tightness, anaphylactic shock, systemic embolization, tissue ischemia, ventricular arrhythmias"
148,LYNPARZA,adverse reactions,"Myelodysplastic syndrome, Acute Myeloid Leukemia, Pneumonitis, Anemia, Nausea, Fatigue, Asthenia, Vomiting, Diarrhea, Dysgeusia, Dyspepsia, Headache, Decreased appetite, Nasopharyngitis, Pharyngitis, URI, Cough, Arthralgia, Musculoskeletal pain, Myalgia, Back pain, Dermatitis, Rash, Abdominal pain, Discomfort, Increase in creatinine, Mean corpuscular volume elevation, Decrease in hemoglobin, Decrease in lymphocytes, Decrease in absolute neutrophil count, Decrease in platelets, COPD <negated>, Cerebrovascular accident <negated>, Intestinal perforation <negated>, Pulmonary embolism <negated>, Sepsis <negated>, Suture rupture <negated>, Death, Constipation, Peripheral edema, Dizziness, Urinary tract infection, Dyspnea, Leukopenia, Stomatitis, Peripheral neuropathy, Pyrexia, Hypomagnesemia, Hyperglycemia, Anxiety, Depression, Insomnia, Dysuria, Urinary incontinence, Vulvovaginal disorder, Dry skin, Eczema, Pruritis, Hypertension, Venous thrombosis, Hot flush."
149,LYNPARZA,warnings and precautions,"Myelodysplastic syndrome/Acute Myeloid Leukemia (MDS/AML), death, Pneumonitis, death, Embryo-Fetal toxicity, hematological toxicity, dyspnea, fever, cough, wheezing, teratogenic, embryo-fetal toxicity"
150,EGRIFTA,adverse reactions,"hypersensitivity, rash, urticaria, arthralgia, extremity pain, peripheral edema, hyperglycemia, carpal tunnel syndrome, injection site reactions, injection site erythema, pruritus, pain, injection site irritation, swelling, hemorrhage, myalgia, paresthesia, hypoesthesia, nausea, vomiting, dyspepsia, abdominal pain upper, palpitations, depression, night sweats, hypertension, muscle strain, blood creatine phosphokinase increased, neuropathy peripheral, insomnia, hot flush"
151,EGRIFTA,warnings and precautions,"neoplasms, elevated IGF-1, fluid retention, edema, arthralgia, carpal tunnel syndrome, glucose intolerance, hypersensitivity reactions, rash, urticaria, injection site reactions, acute critical illness, death, pruritus, erythema, flushing, pain, irritation, bruising, increased mortality <negated>"
152,ELLA,adverse reactions,"headache, abdominal pain, nausea, dysmenorrhea, fatigue, dizziness, upper abdominal pain, acne, death"
153,ELLA,warnings and precautions,"ectopic pregnancy, lower abdominal pain, altered menstrual cycle, delayed menses, <negated>termination of an existing pregnancy, decreased plasma concentration, rapid return of fertility, reduced contraceptive action, earlier menses, later menses, increased cycle length, intermenstrual bleeding, <negated>protection against STI/HIV, <negated>protection against HIV infection (AIDS), <negated>protection against other sexually transmitted infections (STIs)"
154,ZALTRAP,adverse reactions,"Hemorrhage, Gastrointestinal Perforation, Compromised Wound Healing, Fistula Formation, Hypertension, Arterial Thromboembolic Events, Proteinuria, Neutropenia, Neutropenic Complications, Diarrhea, Dehydration, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), leukopenia, AST increased, stomatitis, fatigue, thrombocytopenia, ALT increased, weight decreased, decreased appetite, epistaxis, abdominal pain, dysphonia, serum creatinine increased, headache, asthenia, Urinary Tract Infection, Dyspnea, Oropharyngeal Pain, Rhinorrhea, Abdominal Pain Upper, Hemorrhoids, Rectal Hemorrhage, Proctalgia, Palmar-Plantar Erythrodysesthesia Syndrome, Skin Hyperpigmentation, venous thromboembolic events, severe hypersensitivity reactions, deep venous thrombosis, pulmonary embolism, infections, nasopharyngitis, upper respiratory tract infection, pneumonia, catheter site infection, tooth infection"
155,ZALTRAP,boxed warnings,"HEMORRHAGE, GASTROINTESTINAL PERFORATION, COMPROMISED WOUND HEALING, GI hemorrhage, fatal hemorrhage, severe bleeding, GI bleeding, fatal GI perforation, death"
156,ZALTRAP,warnings and precautions,"Fistula Formation, Hypertension, Arterial Thromboembolic Events, Proteinuria, Neutropenia, Neutropenic Complications, Diarrhea, Dehydration, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Hemorrhage, Gastrointestinal Hemorrhage, Hematuria, Post-procedural Hemorrhage, Intracranial Hemorrhage, Pulmonary Hemorrhage/Hemoptysis, Gastrointestinal Perforation, Compromised Wound Healing, Transient Ischemic Attacks, Cerebrovascular Accident, Angina Pectoris, Nephrotic Syndrome, Thrombotic Microangiopathy (TMA), Febrile Neutropenia, Neutropenic Infection/Sepsis, death"
157,MYRBETRIQ,adverse reactions,"hypertension, nasopharyngitis, urinary tract infection, headache, nausea, diarrhea, constipation, dizziness, tachycardia, atrial fibrillation, prostate cancer, upper respiratory tract infection, arthralgia, abdominal pain, fatigue, palpitations, blood pressure increased, glaucoma, dyspepsia, gastritis, abdominal distension, sinusitis, rhinitis, GGT increased, AST increased, ALT increased, LDH increased, nephrolithiasis, bladder pain, vulvovaginal pruritus, vaginal infection, urticaria, leukocytoclastic vasculitis, rash, pruritus, purpura, lip edema, back pain, dry mouth, influenza, cystitis, dry eyes, vision blurred, cerebrovascular accident, osteoarthritis, neoplasm, breast cancer, lung neoplasm malignant, Stevens-Johnson syndrome, angioedema, urinary retention"
158,MYRBETRIQ,warnings and precautions,"Increases in Blood Pressure, Urinary Retention, Angioedema, death <negated>, Worsening of pre-existing hypertension, Upper airway swelling <negated>"
159,EDURANT,adverse reactions,"Skin and Hypersensitivity Reactions, Depressive Disorders, Hepatotoxicity, headache, insomnia, rash, abdominal pain, nausea, vomiting, fatigue, dizziness, abnormal dreams, diarrhea, abdominal discomfort, cholecystitis, cholelithiasis, decreased appetite, somnolence, sleep disorders, anxiety, glomerulonephritis membranous, glomerulonephritis mesangioproliferative, nephrolithiasis, nephrotic syndrome, Severe skin and hypersensitivity reactions, DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)"
160,EDURANT,warnings and precautions,"Torsade de Pointes, Severe skin and hypersensitivity reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), rash with systemic symptoms, elevations in hepatic serum biochemistries, Severe depressive disorders, depressed mood, depression, dysphoria, major depression, mood altered, negative thoughts, suicide attempt, suicidal ideation, Hepatotoxicity, hepatic adverse events, hepatitis B or C co-infection, elevated baseline transaminases, hepatotoxicity with no pre-existing hepatic disease, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, Immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia, tuberculosis, Autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, QTc interval prolongation <negated>, Grade 4 rash <negated>, death"
161,HARVONI,adverse reactions,"Fatigue, Headache, Nausea, Diarrhea <negated>, Insomnia <negated>, Bilirubin Elevations, Lipase Elevations, Creatine Kinase <negated>, Serious symptomatic bradycardia, death"
162,HARVONI,warnings and precautions,"serious symptomatic bradycardia, fatal cardiac arrest, death, pacemaker intervention, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pains, confusion, memory problems"
163,OSPHENA,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, hot flush, vaginal discharge, muscle spasms, genital discharge, hyperhidrosis, thromboembolic stroke, hemorrhagic stroke, deep vein thrombosis (DVT), allergic conditions, hypersensitivity, angioedema, rash, rash erythematous, rash generalized, pruritus, urticaria"
164,OSPHENA,boxed warnings,"endometrial cancer, cardiovascular disorders, stroke, deep vein thrombosis (DVT), thromboembolic stroke, hemorrhagic stroke, endometrial hyperplasia <negated>"
165,OSPHENA,warnings and precautions,"Venous Thromboembolism, DVT, pulmonary embolism, breast cancer <negated>, Severe Hepatic Impairment, cardiovascular disorders, arterial vascular disease, hypertension, diabetes mellitus, tobacco use, hypercholesterolemia, obesity, systemic lupus erythematosus, stroke, hemorrhagic stroke, Coronary Heart Disease, nonfatal MI, silent MI, CHD death, Endometrial Cancer, simple hyperplasia without atypia, endometrial thickening, proliferative endometrium, uterine polyps, breast cancer <negated>, severe hepatic impairment"
166,ERIVEDGE,adverse reactions,"muscle spasms, alopecia, dysgeusia, weight loss, fatigue, nausea, diarrhea, decreased appetite, constipation, arthralgias, vomiting, ageusia, amenorrhea, hyponatremia, hypokalemia, azotemia"
167,ERIVEDGE,boxed warnings,"embryo-fetal death, severe birth defects, embryotoxic, fetotoxic, teratogenic, severe midline defects, missing digits, irreversible malformations, death"
168,ERIVEDGE,warnings and precautions,"embryo-fetal death, severe birth defects, embryotoxic, fetotoxic, teratogenic, death"
169,LATUDA,adverse reactions,"Increased Mortality in Elderly Patients with Dementia-Related Psychosis, Suicidal Thoughts and Behaviors, Cerebrovascular Adverse Reactions, Stroke, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Hyperglycemia, Diabetes Mellitus, Dyslipidemia, Weight Gain, Hyperprolactinemia, Leukopenia, Neutropenia, Agranulocytosis, Orthostatic Hypotension, Syncope, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Dysregulation, Suicide, Activation of Mania/Hypomania, Dysphagia, Neurological Adverse Reactions in Patients with Parkinson's Disease, Dementia with Lewy Bodies, somnolence, akathisia, extrapyramidal symptoms, nausea, vomiting, diarrhea, anxiety, salivary hypersecretion, back pain, dizziness, insomnia, agitation, restlessness, dry mouth, nasopharyngitis, influenza, urinary tract infection, fatigue, increased appetite, weight increased, dystonia, parkinsonism, abnormal dreams, panic attack, sleep disorder, dysuria, renal failure, amenorrhea, dysmenorrhea, breast enlargement, breast pain, galactorrhea, erectile dysfunction, rash, pruritus, angioedema, hypertension, sudden death <negated>, anemia, tachycardia, AV block 1st degree, angina pectoris, bradycardia, vertigo, blurred vision, abdominal pain, gastritis, CPK increased, decreased appetite, rhabdomyolysis, cerebrovascular accident, dysarthria, death"
170,LATUDA,boxed warnings,"increased mortality,death,dementia-related psychosis,suicidal thoughts,suicidal behaviors,increased risk of suicidal thoughts and behavior in children,increased risk of suicidal thoughts and behavior in adolescents,increased risk of suicidal thoughts and behavior in young adults,<negated> increased risk of suicidal thoughts and behavior in patients over age 24,<negated> suicidal thoughts and behavior in patients aged 65 and older,worsening of depression,emergence of suicidal thoughts,emergence of suicidal behaviors"
171,LATUDA,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Hyperglycemia, Diabetes Mellitus, polydipsia, polyuria, polyphagia, weakness, Dyslipidemia, Weight Gain, Hyperprolactinemia, Leukopenia, Neutropenia, Agranulocytosis, Orthostatic Hypotension, Syncope, dizziness, tachycardia, bradycardia, death, suicidal thoughts, suicidal behaviors, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania, seizures, cognitive impairment, motor impairment, body temperature dysregulation, activation of mania/hypomania, Dysphagia, confusion, obtundation, postural instability, falls, extrapyramidal symptoms, neuroleptic malignant syndrome."
172,LEXISCAN,adverse reactions,"Myocardial Ischemia, Sinoatrial Nodal Block, Atrioventricular Nodal Block, Atrial Fibrillation, Atrial Flutter, Hypersensitivity, Anaphylaxis, Hypotension, Hypertension, Bronchoconstriction, Seizure, Cerebrovascular Accident, Stroke, Dyspnea, Headache, Flushing, Chest Discomfort, Dizziness, Angina Pectoris, Chest Pain, Nausea, Abdominal Discomfort, Dysgeusia, Feeling Hot, ECG Abnormalities, Rhythm Abnormalities, PACs, PVCs, First-degree AV Block, Second-degree AV Block, AV Conduction Abnormalities, Ventricular Conduction Abnormalities, Respiratory Abnormalities, Wheezing, FEV1 Reduction, Renal Impairment, Myocardial Infarction, Cardiac Arrest, Ventricular Arrhythmias, Supraventricular Tachyarrhythmias, Heart Block, Asystole, Marked Hypertension, Symptomatic Hypotension, Transient Ischemic Attack, QTc Prolongation, Tremor, Transient Ischemic Attack, Intracranial Hemorrhage, Abdominal Pain, Vomiting, Myalgias, Diarrhea, Fecal Incontinence, Angioedema, Cardiac Arrest, Respiratory Arrest, Respiratory Distress, Decreased Oxygen Saturation, Throat Tightness, Urticaria, Rashes, Musculoskeletal Pain, Dyspnea Exertional, Tachypnea, Obstructive Airway Disorder."
173,LEXISCAN,warnings and precautions,"Myocardial Ischemia, death, unstable angina, cardiovascular instability, Sinoatrial (SA) Nodal Block, Atrioventricular (AV) Nodal Block, first-degree AV block, second-degree AV block, third-degree AV block, sinus bradycardia, Atrial Fibrillation, Atrial Flutter, Hypersensitivity, Anaphylaxis, angioedema, cardiac arrest, respiratory arrest, respiratory distress, decreased oxygen saturation, hypotension, throat tightness, urticaria, rashes, Hypertension, Bronchoconstriction, dyspnea, respiratory compromise, Seizure, convulsive seizures, Cerebrovascular Accident, Stroke, Hemorrhagic stroke, ischemic stroke, ventricular arrhythmias, syncope, transient ischemic attacks."
174,BRILINTA,adverse reactions,"Bleeding, Dyspnea, Dizziness, Nausea, Intracranial hemorrhage, Major bleed, Fatal/Life-threatening bleed, Fatal <negated> (as it is part of the description of types of bleeding but not reported as an adverse reaction), Intrapericardial with cardiac tamponade, Hypovolemic shock, Severe hypotension requiring intervention, Significantly disabling, Intraocular with permanent vision loss, Decrease in Hb of at least 3 g/dL, Fall in hematocrit (Hct) of at least 9%, Transfusion of 2 or more units, Decrease in Hb of more than 5 g/dL, Fall in hematocrit (Hct) of at least 15%, Transfusion of 4 or more units, Death (as fatal events are mentioned), Diarrhea, Bradycardia, Syncope, Pre-syncope, Loss of consciousness, Gout, Serum Uric Acid increase, Serum Creatinine increase, Acute renal failure <negated>, Chronic renal failure <negated>, Toxic nephropathy <negated>, Oliguria <negated>."
175,BRILINTA,boxed warnings,"bleeding, fatal bleeding, death, active pathological bleeding, intracranial hemorrhage<negated>, urgent coronary artery bypass graft surgery<negated>"
176,BRILINTA,warnings and precautions,"Dyspnea, Severe Hepatic Impairment, General Risk of Bleeding, Myocardial Infarction <negated>, Stroke <negated>, Death <negated>"
177,KERYDIN,adverse reactions,"application site exfoliation, ingrown toenail, application site erythema, application site dermatitis, skin irritation, contact sensitization <negated>"
178,ZELBORAF,adverse reactions,"New Primary Malignancies, Hypersensitivity Reactions, Dermatologic Reactions, QT Prolongation, Hepatotoxicity, Photosensitivity, Ophthalmologic Reactions, Radiation Sensitization, Radiation Recall, arthralgia, rash, alopecia, fatigue, photosensitivity reaction, nausea, pruritus, skin papilloma, cuSCC, hyperkeratosis, rash maculo-papular, actinic keratosis, dry skin, rash papular, erythema, myalgia, pain in extremity, musculoskeletal pain, back pain, edema peripheral, pyrexia, asthenia, diarrhea, vomiting, constipation, headache, dysgeusia, cutaneous SCC, seborrheic keratosis, gamma-glutamyltransferase increased, decreased appetite, cough, sunburn, palmar-plantar erythrodysesthesia syndrome, keratosis pilaris, panniculitis, erythema nodosum, Stevens-Johnson syndrome, toxic epidermal necrolysis, arthritis, neuropathy peripheral, VIIth nerve paralysis, basal cell carcinoma, oropharyngeal squamous cell carcinoma, folliculitis, retinal vein occlusion, vasculitis, atrial fibrillation, GGT increase, AST increase, ALT increase, alkaline phosphatase increase, bilirubin increase, Progression of pre-existing chronic myelomonocytic leukemia, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), Neutropenia, Pancreatitis, death (due to fatal events being listed)."
179,ZELBORAF,warnings and precautions,"Cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, non-cutaneous squamous cell carcinoma, other malignancies, tumor promotion in BRAF wild-type melanoma, serious hypersensitivity reactions, anaphylaxis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), severe dermatologic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, QT prolongation, hepatotoxicity, photosensitivity, serious ophthalmologic reactions, uveitis, embryo-fetal toxicity, radiation sensitization, radiation recall"
180,FYCOMPA,adverse reactions,"Serious Psychiatric and Behavioral Reactions, Suicidal Behavior and Ideation, Dizziness, Gait Disturbance, Somnolence, Fatigue, Falls, Nausea, Weight Gain, Vertigo, Ataxia, Headache, Vomiting, Contusion, Abdominal Pain, Anxiety, Aggression, Anger, Blurred Vision, Irritability, Dysarthria, Back Pain, Cough, Upper Respiratory Tract Infection, Hypersomnia, Balance Disorder, Diplopia, Head Injury, Hypoaesthesia, Pain in Extremity, Constipation, Myalgia, Coordination Abnormal, Euphoric Mood, Confusional State, Hyponatremia, Limb Injury, Mood Altered, Arthralgia, Asthenia, Memory Impairment, Musculoskeletal Pain, Oropharyngeal Pain, Paraesthesia, Peripheral Edema, Skin Laceration, Urinary Tract Infection, Ligament Sprain, Rash, Elevated Triglycerides, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)"
181,FYCOMPA,boxed warnings,"aggression, hostility, irritability, anger, homicidal ideation and threats, changes in mood, behavior, personality changes, death"
182,FYCOMPA,warnings and precautions,"suicidal thoughts, suicidal behavior, dizziness, gait disturbance, somnolence, fatigue, falls, increase in seizure frequency, hostility, aggression, hostility- and aggression-related adverse reactions, irritability, anger, anxiety, belligerence, affect lability, agitation, physical assault, homicidal ideation, homicidal threat, paranoia, euphoric mood, mental status changes, disorientation, confusional state, disorientation, delusion, vertigo, ataxia, balance disorder, abnormal coordination, asthenia, lethargy, head injuries, bone fracture, death"
183,ISTODAX,adverse reactions,"Myelosuppression, Infection, Electrocardiographic Changes, Tumor Lysis Syndrome, Neutropenia, Lymphopenia, Thrombocytopenia, Nausea, Fatigue, Vomiting, Anorexia, Anemia, ECG T-wave changes, Asthenia, Hypomagnesemia, Diarrhea, Pyrexia, Dysgeusia, Constipation, Hypotension, Pruritus, Hypokalemia, Dermatitis, Exfoliative dermatitis, Hypocalcemia, Leukopenia, Alanine aminotransferase increased, Aspartate aminotransferase increased, Hypoalbuminemia, Electrocardiogram ST-T wave changes, Hyperglycemia, Hyponatremia, Hypermagnesemia, Hypophosphatemia, Hyperuricemia, Sepsis, Supraventricular arrhythmia, Central line infection, Edema, Ventricular arrhythmia, Dehydration, Catheter related infection, Dyspnea, QT prolongation, Gastrointestinal disorders, Abdominal pain, Stomatitis, General disorders and administration site conditions, Chills, Edema peripheral, Blood and lymphatic system disorders, Metabolism and nutrition disorders, Nervous system disorders, Headache, Respiratory, thoracic and mediastinal disorders, Cough, Investigations, Weight decreased, Cardiac disorders, Tachycardia, Pneumonia, Cellulitis, Deep vein thrombosis, Febrile neutropenia, Chest pain, Pulmonary embolism, Hyperbilirubinemia, Hypoxia, Hypersensitivity, Packed red blood cell transfusion, Platelet transfusion, Reactivation of hepatitis B virus infection, Multi-organ failure, Septic shock, Candida sepsis, Sepsis/cardiogenic shock, Epstein Barr virus reactivation, death."
184,ISTODAX,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infections, death, pneumonia, sepsis, viral reactivation, Epstein Barr virus reactivation, hepatitis B virus reactivation, liver failure, electrocardiographic changes, T-wave changes, ST-segment changes, tumor lysis syndrome, embryo-fetal toxicity"
185,ZIOPTAN,adverse reactions,"conjunctival hyperemia, ocular stinging/irritation, ocular pruritus, allergic conjunctivitis, cataract, dry eye, ocular pain, eyelash darkening, growth of eyelashes, vision blurred, headache, common cold, cough, urinary tract infection, exacerbation of asthma, dyspnea, iritis/uveitis, periorbital changes, lid changes, deepening of the eyelid sulcus"
186,ZIOPTAN,warnings and precautions,"iris pigmentation, periorbital tissue pigmentation, eyelash pigmentation, increased length of eyelashes, increased thickness of eyelashes, increased number of eyelashes, iris color change, increased eyelash color, increased eyelash thickness, increased eyelash shape, increased number of lashes, intraocular inflammation, iritis <negated>, uveitis <negated>, macular edema, cystoid macular edema"
187,SIGNIFOR,adverse reactions,"Hypocortisolism, Hyperglycemia, Diabetes, Bradycardia, QT prolongation, Liver Test Elevations, Cholelithiasis, Pituitary Hormone Deficiency, Diarrhea, Nausea, Hyperglycemia, Cholelithiasis, Headache, Abdominal pain, Fatigue, Diabetes mellitus, Injection site reactions, Nasopharyngitis, Alopecia, Asthenia, Glycosylated hemoglobin increased, Alanine aminotransferase increased, Gamma-glutamyl transferase increased, Edema peripheral, Abdominal pain upper, Decreased appetite, Hypercholesterolemia, Hypertension, Dizziness, Hypoglycemia, Type 2 diabetes mellitus, Anxiety, Influenza, Insomnia, Myalgia, Arthralgia, Pruritus, Lipase increased, Constipation, Hypotension, Vomiting, Back pain, Dry skin, Electrocardiogram QT prolonged, Hypokalemia, Pain in extremity, Sinus bradycardia, Vertigo, Abdominal distension, Adrenal insufficiency, Aspartate aminotransferase increased, Blood glucose increased, Anemia <negated>, Blood amylase increased <negated>, Prothrombin time prolonged <negated>, Pancreatitis <negated>"
188,SIGNIFOR,warnings and precautions,"hypocortisolism, biochemical hypocortisolism, clinical hypocortisolism, Hyperglycemia, Diabetes, Bradycardia, QT Prolongation, Liver Test Elevations, Cholelithiasis, weakness, fatigue, anorexia, nausea, vomiting, hypotension, hyponatremia, hypoglycemia, severe hyperglycemia, ketoacidosis, high-grade heart block, ALT elevation, AST elevation, bilirubin elevation, hypokalemia, hypomagnesemia, deficiency of pituitary hormones"
189,SOVALDI,adverse reactions,"Serious Symptomatic Bradycardia, fatigue, headache, nausea, insomnia, anemia, pruritus, asthenia, rash, decreased appetite, chills, influenza like illness, pyrexia, diarrhea, neutropenia, myalgia, irritability, pancytopenia <negated>, severe depression <negated>, suicidal ideation <negated>, suicide <negated>, hematologic effects <negated>, psychiatric disorders <negated>, laboratory abnormalities <negated>, bilirubin elevations <negated>, creatine kinase elevations <negated>, lipase elevations <negated>, elevated total bilirubin <negated>, cardiac disorders <negated>, death"
190,SOVALDI,warnings and precautions,"serious symptomatic bradycardia, pacemaker intervention, fatal cardiac arrest, death, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pains, confusion, memory problems, reduced therapeutic effect <negated>, rifampin <negated>, St. John's wort <negated>"
191,OLYSIO,adverse reactions,"Serious Symptomatic Bradycardia, Hepatic Decompensation, Hepatic Failure, Photosensitivity, Rash, Pruritus, Nausea, Fatigue, Headache, Myalgia, Dyspnea, Alkaline phosphatase elevation, Hyperbilirubinemia, Insomnia, Dizziness, Diarrhea, Cardiac Disorders <negated>, Hepatobiliary Disorders <negated>"
192,OLYSIO,warnings and precautions,"serious symptomatic bradycardia, death, hepatic decompensation, hepatic failure, photosensitivity reactions, rash, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pain, confusion, memory problems, elevated bilirubin levels, fatigue, lack of appetite, nausea and vomiting, jaundice, discolored feces, burning, erythema, exudation, blistering, edema, severe rash, mucosal signs, conjunctivitis, systemic symptoms"
193,PLEGRIDY,adverse reactions,"Hepatic Injury, Depression, Suicide, Seizures, Anaphylaxis, Allergic Reactions, Injection Site Reactions, Congestive Heart Failure, Decreased Peripheral Blood Counts, Autoimmune Disorders, injection site erythema, influenza-like illness, pyrexia, headache, myalgia, chills, injection site pain, asthenia, injection site pruritus, arthralgia, Nausea, Vomiting, Hyperthermia, Pain, Injection site edema, Injection site warmth, Injection site hematoma, Injection site rash, Body temperature increased, Alanine aminotransferase increased, Aspartate aminotransferase increased, Gamma-glutamyl-transferase increased, Pruritus"
194,PLEGRIDY,warnings and precautions,"hepatic injury, hepatitis, autoimmune hepatitis, severe hepatic failure, asymptomatic elevation of hepatic transaminases, elevation of hepatic enzymes, elevations in hepatic transaminases, elevations of alanine aminotransferase, elevations of aspartate aminotransferase, elevated bilirubin, depression, suicidal ideation, suicide, seizures, anaphylaxis, allergic reactions, angioedema, urticaria, injection site reactions, injection site necrosis, injection site erythema, injection site pain, injection site pruritus, injection site edema, congestive heart failure, cardiomyopathy, decreased peripheral blood counts, pancytopenia, severe thrombocytopenia, decreases in white blood cell counts, clinically significant decreases in lymphocyte counts, neutrophil counts, platelet counts, severe neutropenia, infections, bleeding, symptoms of anemia, autoimmune disorders, idiopathic thrombocytopenia, hyperthyroidism, hypothyroidism"
195,VIBATIV,adverse reactions,"Nephrotoxicity, Infusion-related reactions, Clostridium difficile-associated diarrhea, diarrhea, taste disturbance, nausea, vomiting, foamy urine, death, rigors, decreased appetite, renal failure acute, renal impairment, renal insufficiency, renal failure, increased serum creatinine, serious hypersensitivity reactions, anaphylactic reactions, rash<negated>, pruritus<negated>, acute renal failure, electrocardiogram QTc interval prolonged, septic shock<negated>, multi-organ failure<negated>."
196,VIBATIV,boxed warnings,"increased mortality, nephrotoxicity, new onset renal impairment, worsening renal impairment, adverse developmental outcomes, death"
197,VIBATIV,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, infusion-related reactions, Clostridium difficile-associated disease, mild diarrhea, fatal colitis <negated>, coagulation test interference, QTc prolongation, nephrotoxicity, increased mortality, decreased clinical response, renal adverse events, renal dysfunction, renal impairment, drug-resistant bacteria, superinfection, death"
198,KIT,adverse reactions,"injection site irritation, pain, death"
199,KIT,warnings and precautions,"hypersensitivity, hypersensitivity reactions, serious hypersensitivity reactions, cancer, excessive radiation exposure"
200,HETLIOZ,adverse reactions,"headache, increased alanine aminotransferase, nightmares, unusual dreams, upper respiratory tract infection, urinary tract infection"
201,HETLIOZ,warnings and precautions,somnolence
202,VOTRIENT,adverse reactions,"diarrhea, hypertension, hair color changes, depigmentation, nausea, anorexia, vomiting, fatigue, decreased weight, decreased appetite, tumor pain, dysgeusia, headache, musculoskeletal pain, myalgia, gastrointestinal pain, dyspnea, hepatotoxicity, QT prolongation, torsades de pointes, cardiac dysfunction, hemorrhagic events, arterial thromboembolic events, venous thromboembolic events, thrombotic microangiopathy, gastrointestinal perforation, fistula, interstitial lung disease, pneumonitis, reversible posterior leukoencephalopathy syndrome, infection, increased toxicity with other cancer therapies, asthenia, abdominal pain, alopecia, chest pain, dysphonia, facial edema, palmar-plantar erythrodysesthesia, hand-foot syndrome, proteinuria, rash, skin depigmentation, weight decreased, arthralgia, muscle spasms, leukopenia, neutropenia, thrombocytopenia, lymphocytopenia, ALT increased, AST increased, glucose increased, total bilirubin increased, phosphorus decreased, sodium decreased, magnesium decreased, glucose decreased, exfoliative rash, cough, peripheral edema, mucositis, dizziness, skin disorder, stomatitis, insomnia, hypothyroidism, epistaxis, left ventricular dysfunction, dry skin, chills, vision blurred, nail disorder, lipase elevations, pneumothorax, bradycardia, retinal detachment, tear, pancreatitis, death"
203,VOTRIENT,boxed warnings,"hepatotoxicity, severe hepatotoxicity, fatal hepatotoxicity <death>"
204,VOTRIENT,warnings and precautions,"Increases in serum transaminase levels, bilirubin, severe hepatotoxicity, fatal hepatotoxicity, prolonged QT intervals, torsades de pointes, cardiac dysfunction, congestive heart failure, decreased left ventricular ejection fraction (LVEF), fatal hemorrhagic events, arterial thromboembolic events, fatal arterial thromboembolic events, venous thromboembolic events (VTE), fatal pulmonary emboli (PE), thrombotic microangiopathy (TMA), thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), gastrointestinal perforation, fistula, fatal gastrointestinal perforation, interstitial lung disease (ILD), pneumonitis, fatal ILD/pneumonitis, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), fatal RPLS, hypertension, hypertensive crisis, hypothyroidism, proteinuria, serious infections, fatal infections, death"
205,JAKAFI,adverse reactions,"Thrombocytopenia, Anemia, Neutropenia, Risk of Infection, Symptom Exacerbation Following Interruption or Discontinuation of Treatment, Non-Melanoma Skin Cancer, Bruising, Dizziness, Headache, Urinary Tract Infections, Weight Gain, Flatulence, Herpes Zoster, Abdominal Pain, Diarrhea, Fatigue, Pruritus, Dyspnea, Muscle Spasms, Nasopharyngitis, Constipation, Cough, Edema, Arthralgia, Asthenia, Epistaxis, Nausea, Hypertension, Hypercholesterolemia, Elevated ALT, Elevated AST, Hypertriglyceridemia"
206,JAKAFI,warnings and precautions,"Thrombocytopenia, Anemia, Neutropenia, Risk of Infection, Serious bacterial infections, Mycobacterial infections, Fungal infections, Viral infections, Tuberculosis, Progressive multifocal leukoencephalopathy (PML), Herpes Zoster, Symptom Exacerbation, Fever, Respiratory distress, Hypotension, Disseminated intravascular coagulation (DIC) <negated>, Multi-organ failure, Non-Melanoma Skin Cancer, Basal cell carcinoma, Squamous cell carcinoma, Merkel cell carcinoma, death"
207,AKYNZEO,adverse reactions,"headache, asthenia, dyspepsia, fatigue, constipation, erythema, death"
208,AKYNZEO,warnings and precautions,"hypersensitivity reactions, anaphylaxis, serotonin syndrome, mental status changes, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms, nausea, vomiting, diarrhea, death"
209,VIEKIRA,adverse reactions,"fatigue, nausea, pruritus, skin reactions, insomnia, asthenia, serious adverse event (SAE), rash, erythema, eczema, rash maculo-papular, rash macular, dermatitis, rash papular, skin exfoliation, rash pruritic, rash erythematous, rash generalized, dermatitis allergic, dermatitis contact, exfoliative rash, photosensitivity reaction, psoriasis, skin reaction, ulcer, urticaria, dyspnea, serum ALT elevations, serum bilirubin elevations, anemia/decreased hemoglobin, headache, cough, irritability, ocular icterus, jaundice, hyperbilirubinemia, muscle spasms, hypersensitivity reactions, angioedema, death (due to mention of fatal events)"
210,VIEKIRA,warnings and precautions,"ALT elevations, fatigue, weakness, lack of appetite, nausea and vomiting, jaundice, discolored feces, liver inflammation, increased conjugated bilirubin, increased alkaline phosphatase, increased INR, loss of therapeutic effect of VIEKIRA PAK, development of resistance, clinically significant adverse reactions, HIV-1 protease inhibitor drug resistance"
211,PERJETA,adverse reactions,"Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions, Anaphylaxis, Diarrhea, Alopecia, Neutropenia, Nausea, Fatigue, Rash, Peripheral Neuropathy, Vomiting, Thrombocytopenia, Anemia, Asthenia, Edema Peripheral, Mucosal Inflammation, Pyrexia, Nail Disorder, Pruritus, Dry Skin, Constipation, Stomatitis, Febrile Neutropenia, Leukopenia, Headache, Dysgeusia, Dizziness, Myalgia, Arthralgia, Upper Respiratory Tract Infection, Nasopharyngitis, Dyspnea, Decreased Appetite, Lacrimation Increased, Insomnia, Paronychia, Pleural Effusion, Cardiac Disorders, Immune System Disorders, Peripheral Sensory Neuropathy, Metabolism and Nutrition Disorders, Psychiatric Disorders, Cough, Epistaxis, Oropharyngeal Pain, ALT Increased, Palmar-Plantar Erythrodysaesthesia Syndrome, Dyspepsia, Hypokalemia, Death"
212,PERJETA,boxed warnings,"left ventricular dysfunction, CHF, decreased LVEF, embryo-fetal death, birth defects, oligohydramnios, delayed renal development, death"
213,PERJETA,warnings and precautions,"Left Ventricular Dysfunction, LVEF declines, Symptomatic left ventricular systolic dysfunction, congestive heart failure, Embryo-fetal toxicity, Fetal harm, oligohydramnios, delayed fetal kidney development, embryo-fetal death, Infusion-Related Reactions, Hypersensitivity Reactions, Anaphylaxis, pyrexia, chills, fatigue, headache, asthenia, hypersensitivity, vomiting, dysgeusia, myalgia, death"
214,KEYTRUDA,adverse reactions,"Immune-mediated pneumonitis, Immune-mediated colitis, Immune-mediated hepatitis, Immune-mediated endocrinopathies, Renal failure, Immune-mediated nephritis, Other immune-mediated adverse reactions, Infusion-related reactions, Fatigue, Cough, Nausea, Pruritus, Rash, Decreased appetite, Constipation, Arthralgia, Diarrhea, Pain, Serious adverse reactions, Dyspnea, Pneumonia, Cellulitis, Peripheral edema, Chills, Pyrexia, Vomiting, Abdominal pain, Vitiligo, Metabolism and Nutrition Disorders, Pain in extremity, Myalgia, Back pain, Nervous System Disorders, Headache, Dizziness, Anemia, Psychiatric Disorders, Insomnia, Infections and Infestations, Upper respiratory tract infection, Sepsis, Hyperglycemia, Hyponatremia, Hypoalbuminemia, Hypertriglyceridemia, Increased Aspartate Aminotransferase, Hypocalcemia"
215,KEYTRUDA,warnings and precautions,"pneumonitis, colitis, hepatitis, hypophysitis, hyperthyroidism, hypothyroidism, Type 1 diabetes mellitus, nephritis, renal failure, immune-mediated nephritis, infusion-related reactions, embryofetal toxicity, exfoliative dermatitis, uveitis, arthritis, myositis, pancreatitis, hemolytic anemia, partial seizures, severe dermatitis, bullous pemphigoid, myasthenic syndrome, optic neuritis, rhabdomyolysis, rigors, chills, wheezing, pruritis, flushing, rash, hypotension, hypoxemia, fever, death"
216,MYALEPT,adverse reactions,"headache, hypoglycemia, decreased weight, abdominal pain, arthralgia, dizziness, ear infection, fatigue, nausea, ovarian cyst, upper respiratory tract infection, anemia, back pain, diarrhea, paresthesia, proteinuria, pyrexia, injection-site erythema, urticaria, pancreatitis, severe infections, worsening of metabolic control, increases in HbA1c, increases in triglycerides, death"
217,MYALEPT,boxed warnings,"anti-metreleptin antibodies with neutralizing activity, inhibition of endogenous leptin action, loss of MYALEPT efficacy, severe infection, worsening metabolic control, T-cell lymphoma, death"
218,MYALEPT,warnings and precautions,"anti-metreleptin antibodies with neutralizing activity, T-cell lymphoma, hypoglycemia, autoimmune disorder progression, hypersensitivity reactions, anaphylaxis, urticaria, generalized rash, Benzyl Alcohol Toxicity, severe infections, loss of efficacy, increases in HbA1c, increases in triglycerides, excessive weight gain, development of glucose intolerance, diabetes mellitus, peripheral T-cell lymphoma, anaplastic large cell lymphoma, leukopenia, neutropenia, bone marrow abnormalities, lymphadenopathy, autoimmune hepatitis, membranoproliferative glomerulonephritis, massive proteinuria, renal failure, death"
219,TRADJENTA,adverse reactions,"nasopharyngitis, hypoglycemia, diarrhea, cough, urinary tract infection, hypertriglyceridemia, hyperlipidemia, weight increased, constipation, back pain, arthralgia, upper respiratory tract infection, headache, pain in extremity, hypersensitivity, urticaria, angioedema, localized skin exfoliation, bronchial hyperreactivity, myalgia, pancreatitis, death, acute pancreatitis, anaphylaxis, exfoliative skin conditions, severe and disabling arthralgia, rash, mouth ulceration, stomatitis"
220,TRADJENTA,warnings and precautions,"acute pancreatitis, fatal pancreatitis, death, hypoglycemia, anaphylaxis, angioedema, exfoliative skin conditions, severe and disabling arthralgia, severe joint pain, <negated>macrovascular risk reduction"
221,BRINTELLIX,adverse reactions,"Hypersensitivity, Clinical Worsening, Suicide Risk, Serotonin Syndrome, Abnormal Bleeding, Activation of Mania/Hypomania, Hyponatremia, nausea, constipation, vomiting, diarrhea, dry mouth, flatulence, dizziness, abnormal dreams, pruritus, sexual dysfunction, headache, muscle tension, mood swings, sudden outbursts of anger, runny nose, vertigo, dyspepsia, dysgeusia, flushing"
222,BRINTELLIX,boxed warnings,"suicidal thoughts, suicidal behaviors, worsening of depression <negated>, emergence of suicidal thoughts, emergence of suicidal behaviors"
223,BRINTELLIX,warnings and precautions,"Serotonin Syndrome, abnormal bleeding, Activation of Mania/Hypomania, Angle Closure Glaucoma, Hyponatremia, Clinical Worsening, Suicide Risk, suicidality, suicidal ideation, suicidal behavior, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania, mental status changes, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms, nausea, vomiting, diarrhea, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death"
224,AUBAGIO,adverse reactions,"Hepatotoxicity, Bone Marrow Effects, Immunosuppression Potential, Infections, Peripheral Neuropathy, Skin Reactions, Increased Blood Pressure, Respiratory Effects, headache, diarrhea, nausea, alopecia, increase in ALT, Paresthesia, Arthralgia, Neutropenia, Hypertension, death, Acute Renal Failure, Hypophosphatemia"
225,AUBAGIO,boxed warnings,"hepatotoxicity, fatal liver failure, severe liver injury, major birth defects, death"
226,AUBAGIO,warnings and precautions,"decreased WBC, serious infection, peripheral neuropathy, Stevens-Johnson syndrome, toxic epidermal necrolysis, increased blood pressure, hepatotoxicity, fatal liver failure, liver dysfunction, elevated serum transaminases, ALT elevation, jaundice, serum transaminase increase, hepatic dysfunction, nausea <negated>, vomiting <negated>, abdominal pain <negated>, fatigue <negated>, anorexia <negated>, dark urine <negated>, teratogenic effects, fetal death, decrease in white blood cell count, neutrophil count decrease, lymphocyte count decrease, pancytopenia <negated>, agranulocytosis <negated>, thrombocytopenia <negated>, serious infection, klebsiella pneumonia sepsis, death, Pneumocystis jiroveci pneumonia <negated>, aspergillosis <negated>, cytomegalovirus hepatitis reactivation, tuberculosis, malignancy <negated>, lymphoproliferative disorders <negated>, polyneuropathy, mononeuropathy, carpal tunnel syndrome, hypertension, interstitial lung disease, cough <negated>, dyspnea <negated>, fever <negated>, hematologic toxicity <negated>."
227,POMALYST,adverse reactions,"Fetal Risk, Venous and Arterial Thromboembolism, Hematologic Toxicity, Hepatotoxicity, Hypersensitivity Reactions, Dizziness, Confusional State, Neuropathy, Risk of Second Primary Malignancies, Tumor Lysis Syndrome, fatigue, asthenia, neutropenia, anemia, constipation, nausea, diarrhea, dyspnea, upper-respiratory tract infections, back pain, pyrexia, leukopenia, febrile neutropenia, lymphopenia, edema peripheral, chills, vomiting, musculoskeletal chest pain, muscle spasms, arthralgia, muscular weakness, bone pain, musculoskeletal pain, pain in extremity, pneumonia, urinary tract infection, sepsis, decreased appetite, hypercalcemia, hypokalemia, hyperglycemia, hyponatremia, dehydration, hypocalcemia, cough, epistaxis, productive cough, oropharyngeal pain, peripheral neuropathy, headache, tremor, rash, pruritus, dry skin, hyperhidrosis, night sweats, blood creatinine increased, weight decreased, weight increased, anxiety, insomnia, renal failure, neutrophil count decreased, platelet count decreased, white blood cell count decreased, alanine aminotransferase increased, aspartate aminotransferase increased, lymphocyte count decreased, myocardial infarction, atrial fibrillation, angina pectoris, cardiac failure congestive, vertigo, abdominal pain, general physical health deterioration, non-cardiac chest pain, multi-organ failure, hyperbilirubinemia, Pneumocystis jiroveci pneumonia, respiratory syncytial virus infection, bacteremia, pneumonia respiratory syncytial viral, cellulitis, urosepsis, septic shock, Clostridium difficile colitis, pneumonia streptococcal, lobar pneumonia, viral infection, lung infection, hemoglobin decreased, fall, compression fracture, spinal compression fracture, hyperkalemia, failure to thrive, depressed level of consciousness, syncope, mental status change, urinary retention, interstitial lung disease, pulmonary embolism, respiratory failure, bronchospasm, hypotension, Pancytopenia, allergic reactions, angioedema, urticaria, elevated liver enzymes, hepatic failure, death"
228,POMALYST,boxed warnings,"Embryo-Fetal Toxicity, Venous Thromboembolism, Arterial Thromboembolism, Deep Venous Thrombosis (DVT), Pulmonary Embolism (PE), Myocardial Infarction, Stroke, Severe Birth Defects, Embryo-Fetal Death, Death"
229,POMALYST,warnings and precautions,"neutropenia, hematologic toxicity, hepatotoxicity, hepatic failure, death, angioedema, severe dermatologic reactions, tumor lysis syndrome, embryo-fetal toxicity, teratogen, embryo-fetal death, venous thromboembolic events, deep venous thrombosis, pulmonary embolism, arterial thromboembolic events, myocardial infarction, stroke, anemia, thrombocytopenia, febrile neutropenia, elevated levels of alanine aminotransferase, elevated levels of bilirubin, skin exfoliation, bullae, dizziness, confusional state, neuropathy, peripheral neuropathy, acute myelogenous leukemia <negated>, second primary malignancies <negated>"
230,SURFAXIN,adverse reactions,"endotracheal tube reflux, pallor, endotracheal tube obstruction, need for dose interruption, oxygen desaturation, bradycardia, apnea, intraventricular hemorrhage, periventricular leukomalacia, acquired sepsis, patent ductus arteriosus, retinopathy of prematurity, necrotizing enterocolitis, pulmonary air leak, pulmonary interstitial emphysema, pneumothorax, pulmonary hemorrhage, anemia, jaundice, metabolic acidosis, hyperglycemia, pneumonia, hyponatremia, hypotension, respiratory acidosis, death, multi-organ failure, sepsis, anoxic encephalopathy, renal failure, hypoxia/decreased oxygen saturation, pneumothorax, hypotension, pulmonary embolism"
231,SURFAXIN,warnings and precautions,"Acute Changes in Lung Compliance, bradycardia, oxygen desaturation, reflux of SURFAXIN into the endotracheal tube, airway/ETT obstruction, death, multi-organ failure, sepsis, anoxic encephalopathy, renal failure, hypoxia, pneumothorax, hypotension, pulmonary embolism"
232,ARZERRA,adverse reactions,"Infusion reactions, Hepatitis B Virus Reactivation, Hepatitis B Virus Infection, Progressive Multifocal Leukoencephalopathy, Tumor Lysis Syndrome, Cytopenias, neutropenia, pneumonia, pyrexia, cough, diarrhea, anemia, fatigue, dyspnea, rash, nausea, bronchitis, upper respiratory tract infections, infections, sepsis, Asthenia, Headache, Leukopenia, Herpes simplex, Lower respiratory tract infection, Arthralgia, Upper abdominal pain, pruritus, urticaria, neutropenic sepsis, agranulocytosis, prolonged neutropenia, late-onset neutropenia, Edema peripheral, Back pain, Chills, Nasopharyngitis, Urticaria, Insomnia, Herpes zoster, Hyperhidrosis, Hypertension, Hypotension, Muscle spasms, Sinusitis, Tachycardia, lung infection, lobar pneumonia, bronchopneumonia, rash macular, rash vesicular, bacteremia, septic shock, cardiac arrest, Stevens-Johnson syndrome, porphyria cutanea tarda, death"
233,ARZERRA,boxed warnings,"Hepatitis B Virus Reactivation, fulminant hepatitis, hepatic failure, death, Progressive Multifocal Leukoencephalopathy (PML)"
234,ARZERRA,warnings and precautions,"infusion reactions, bronchospasm, dyspnea, laryngeal edema, pulmonary edema, flushing, hypertension, hypotension, syncope, cardiac events, myocardial ischemia/infarction, acute coronary syndrome, arrhythmia, bradycardia, back pain, abdominal pain, pyrexia, rash, urticaria, angioedema, cytokine release syndrome, anaphylactoid reactions, anaphylactic reactions, Tumor Lysis Syndrome (TLS), neutropenia, anemia, thrombocytopenia, late-onset neutropenia, prolonged neutropenia, Hepatitis B Virus (HBV) reactivation, fulminant hepatitis, hepatic failure, death, hepatitis, Progressive Multifocal Leukoencephalopathy (PML), pancytopenia, agranulocytosis, neutropenic sepsis, Grade 3 or 4 cytopenias, Grade 3 or 4 late-onset neutropenia, prolonged neutropenia <negated> live viral vaccines"
235,ESBRIET,adverse reactions,"Liver Enzyme Elevations, Photosensitivity Reaction, Rash, Gastrointestinal Disorders, nausea, abdominal pain, upper respiratory tract infection, diarrhea, fatigue, headache, dyspepsia, dizziness, vomiting, anorexia, gastro-esophageal reflux disease, sinusitis, insomnia, weight decreased, arthralgia, decreased appetite, pruritus, asthenia, dysgeusia, non-cardiac chest pain, Agranulocytosis, Angioedema, Bilirubin increased."
236,ESBRIET,warnings and precautions,"Elevated liver enzymes, ALT elevations, AST elevations, bilirubin elevations, Photosensitivity, rash, Gastrointestinal disorders, Nausea, vomiting, diarrhea, dyspepsia, gastro-esophageal reflux disease, abdominal pain, Increases in ALT, Increases in AST, severe liver injury <negated>, liver transplant <negated>, death <negated>, photosensitivity reactions, gastrointestinal events"
237,ACTEMRA,all-concat,"upper respiratory tract infections, nasopharyngitis, headache, hypertension, increased ALT, injection site reactions, serious infections, pneumonia, urinary tract infection, cellulitis, herpes zoster, gastroenteritis, diverticulitis, sepsis, bacterial arthritis, opportunistic infections, gastrointestinal perforation, infusion reactions, anaphylaxis, neutropenia, thrombocytopenia, elevated liver enzymes, lipids, immunogenicity, malignancies, Stevens-Johnson Syndrome, death, tuberculosis, invasive fungal infections, candidiasis, aspergillosis, pneumocystis, bacterial infections, viral infections, other opportunistic pathogens, macrophage activation syndrome, hypersensitivity reactions, demyelinating disorders, active hepatic disease, hepatic impairment, live vaccine reactions, diarrhea, dizziness, bronchitis, rash, mouth ulceration, abdominal pain upper, gastritis, transaminase increased, edema peripheral, dyspnea, cough, conjunctivitis, nephrolithiasis, hypothyroidism, oral herpes simplex, stomatitis, gastric ulcer, weight increased, total bilirubin increased, leukopenia, injection site reactions (including erythema, pruritus, pain, and hematoma), angioedema, arthralgia, epigastric discomfort, urticaria, conjunctivitis, otitis media, varicella, gastroenteritis, LDL increased, HDL increased, LDL/HDL ratio increased, ApoB/ApoA1 ratio, anti-tocilizumab antibodies, neutralizing antibodies, ALT or AST elevations, total cholesterol elevations, triglycerides elevations, LDL cholesterol elevations, HDL cholesterol elevations, multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, live vaccine transmission."
238,ADEMPAS,all-concat,"Embryo-Fetal Toxicity, Hypotension, Bleeding, Headache, Dyspepsia, Gastritis, Dizziness, Nausea, Diarrhea, Vomiting, Anemia, Gastroesophageal Reflux Disease, Constipation, Palpitations, Nasal Congestion, Epistaxis, Dysphagia, Abdominal Distension, Peripheral Edema, Symptomatic Hypotension <negated>, Pulmonary Edema <negated>, Serious Hemoptysis, Vaginal Hemorrhage, Catheter Site Hemorrhage, Subdural Hematoma, Hematemesis, Intra-Abdominal Hemorrhage, death"
239,AKYNZEO,all-concat,"headache, asthenia, dyspepsia, fatigue, constipation, erythema, hypersensitivity reactions, anaphylaxis, serotonin syndrome, mental status changes, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, nausea, vomiting, diarrhea"
240,ANORO,all-concat,"asthma-related death, paradoxical bronchospasm, cardiovascular effects, worsening of narrow-angle glaucoma, worsening of urinary retention, pharyngitis, sinusitis, lower respiratory tract infection, constipation, diarrhea, pain in extremity, muscle spasms, neck pain, chest pain, productive cough, dry mouth, dyspepsia, abdominal pain, gastroesophageal reflux disease, vomiting, musculoskeletal chest pain, chest discomfort, asthenia, atrial fibrillation, ventricular extrasystoles, supraventricular extrasystoles, myocardial infarction, pruritus, rash, conjunctivitis, headache, back pain, cough, urinary tract infection, arthralgia, nausea, vertigo, pleuritic pain, viral respiratory tract infection, toothache, diabetes mellitus, death"
241,ARCALYST,all-concat,"Mycobacterium intracellulare infection, gastrointestinal bleeding, colitis, sinusitis, bronchitis, Streptococcus pneumoniae meningitis, death, injection-site reaction (ISR), upper respiratory infection, nausea, diarrhea, abdominal pain upper <negated>, cough, hypoesthesia, stomach discomfort, urinary tract infection, erythema, swelling, pruritis, mass, bruising, inflammation, pain, edema, dermatitis, discomfort, urticaria, vesicles, warmth, hemorrhage, transient neutropenia, hypersensitivity reactions, cholesterol increase, HDL cholesterol increase, LDL cholesterol increase, triglycerides increase"
242,ARZERRA,all-concat,"Infusion reactions, Hepatitis B Virus Reactivation, Hepatitis B Virus Infection, Progressive Multifocal Leukoencephalopathy, Tumor Lysis Syndrome, Cytopenias, neutropenia, pneumonia, pyrexia, cough, diarrhea, anemia, fatigue, dyspnea, rash, nausea, bronchitis, upper respiratory tract infections, infections, sepsis, Asthenia, Headache, Leukopenia, Herpes simplex, Lower respiratory tract infection, Arthralgia, Upper abdominal pain, Lymphopenia, Edema peripheral, Back pain, Chills, Nasopharyngitis, Urticaria, Insomnia, Herpes zoster, Hyperhidrosis, Hypertension, Hypotension, Muscle spasms, Sinusitis, Tachycardia, cardiac arrest, Stevens-Johnson syndrome, porphyria cutanea tarda, fulminant hepatitis, hepatic failure, death, bronchospasm, laryngeal edema, pulmonary edema, flushing, hypertension, hypotension, syncope, cardiac events, myocardial ischemia/infarction, acute coronary syndrome, arrhythmia, bradycardia, back pain, abdominal pain, cytokine release syndrome, anaphylactoid/anaphylactic reactions, neutropenic sepsis, agranulocytosis, prolonged neutropenia, late-onset neutropenia, Grade 3 or greater neutropenia, Grade 4 neutropenia, bacterial infections, viral infections, fungal infections, Grade 3 or greater infections, thrombocytopenia, pancytopenia, agranulocytosis, fatal neutropenic sepsis, Grade 3 or 4 late-onset neutropenia, prolonged neutropenia, myocardial ischemia/infarction, acute coronary syndrome, arrhythmia, bradycardia, cytokine release syndrome, anaphylactoid/anaphylactic reactions."
243,ASCLERA,all-concat,"mild local reactions at the site of injection, injection site haematoma, injection site irritation, injection site discoloration, injection site pain, injection site pruritus, injection site warmth, neovascularisation, injection site thrombosis, anaphylactic shock, angioedema, urticaria generalized, asthma, cerebrovascular accident, migraine, paresthesia (local), loss of consciousness, confusional state, dizziness, cardiac arrest, palpitations, deep vein thrombosis, pulmonary embolism, syncope vasovagal, circulatory collapse, vasculitis, dyspnea, skin hyperpigmentation, dermatitis allergic, hypertrichosis (in the area of sclerotherapy), injection site necrosis, pyrexia, hot flush, nerve injury, severe allergic reactions<negated>, tissue necrosis<negated>, anaphylaxis<negated>, severe necrosis<negated>, ischemia<negated>, gangrene<negated>, pain<negated>, death"
244,AUBAGIO,all-concat,"Hepatotoxicity, Bone Marrow Effects, Immunosuppression Potential, Infections, Peripheral Neuropathy, Skin Reactions, Increased Blood Pressure, Respiratory Effects, headache, diarrhea, nausea, alopecia, increase in ALT, Paresthesia, Arthralgia, Neutropenia, Hypertension, Cardiovascular deaths (death), Acute Renal Failure, Hypophosphatemia, Severe liver injury, fatal liver failure (death), Risk of Teratogenicity, White Blood Cell (WBC) count decrease, Risk of Infection, Tuberculosis Screening, Vaccination, Malignancy, Stevens-Johnson syndrome, toxic epidermal necrolysis, Interstitial lung disease, Concomitant Use with Immunosuppressive or Immunomodulating Therapies"
245,BANZEL,all-concat,"Suicidal Behavior and Ideation, Central Nervous System Reactions, QT Shortening, Multi-Organ Hypersensitivity/Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Leukopenia, headache, dizziness, fatigue, somnolence, nausea, vomiting, influenza, nasopharyngitis, decreased appetite, rash, ataxia, diplopia, bronchitis, sinusitis, psychomotor hyperactivity, upper abdominal pain, aggression, ear infection, disturbance in attention, pruritis, tremor, nystagmus, blurred vision, anxiety, constipation, dyspepsia, back pain, gait disturbance, vertigo, convulsion, Stevens-Johnson syndrome, depression <negated>, coordination abnormalities <negated>, gait disturbances <negated>, anemia, lymphadenopathy, neutropenia, iron deficiency anemia, thrombocytopenia, bundle branch block right, atrioventricular block first degree, increased appetite, pollakiuria, urinary incontinence, dysuria, hematuria, nephrolithiasis, polyuria, enuresis, nocturia, incontinence, pneumonia, decreased weight, gastroenteritis, nasal congestion, pneumonia aspiration."
246,BELSOMRA,all-concat,"CNS depressant effects, daytime impairment, abnormal thinking, behavioral changes, worsening of depression, suicidal ideation, sleep paralysis, hypnagogic/hypnopompic hallucinations, cataplexy-like symptoms, somnolence, diarrhea, dry mouth, upper respiratory tract infection, headache, dizziness, abnormal dreams, cough, daytime somnolence, ""sleep-driving"", compromised respiratory function"
247,BELVIQ,all-concat,"Serotonin Syndrome, NMS-like Reactions, Valvular Heart Disease, Cognitive Impairment, Psychiatric Disorders, Hypoglycemia, Heart Rate Decreases, Hematological Changes, Prolactin Elevation, headache, dizziness, fatigue, nausea, dry mouth, constipation, back pain, cough, diarrhea, vomiting, Upper respiratory tract infection, Nasopharyngitis, Urinary tract infection, Musculoskeletal pain, Oropharyngeal pain, Sinus congestion, Rash, Toothache, Peripheral edema, Seasonal allergy, Gastroenteritis, Worsening of diabetes mellitus, Decreased appetite, Muscle spasms, Anxiety, Insomnia, Stress, Depression, Hypertension, Euphoria, Lymphocyte and Neutrophil Counts, Hemoglobin, Eye disorders, blurred vision, dry eye, visual impairment, visual disorders, conjunctival infections, irritations, inflammations, ocular sensation disorders, cataract conditions, Priapism, Bradycardia, Leukopenia, Lymphopenia, Neutropenia, Anemia, Galactorrhea, Gynecomastia, Prolactinoma, Pulmonary Hypertension, Serotonin syndrome, Neuroleptic Malignant Syndrome, agitation, hallucinations, coma, autonomic instability, tachycardia, labile blood pressure, hyperthermia, neuromuscular aberrations, hyperreflexia, incoordination, gastrointestinal symptoms, vomiting, diarrhea, muscle rigidity, chills, tremor, confusional state, disorientation, hyperhidrosis, suicidal ideation, somnolence, euphoric mood, dissociation, hallucination, dyspnea, dependent edema, congestive heart failure, cardiac murmur, valvular regurgitation, aortic insufficiency, mitral insufficiency, leukopenia, decreased white cell count, decreases in hemoglobin, hematocrit, prolactin levels, galactorrhea, gynecomastia, prolactinoma, heart block"
248,BRILINTA,all-concat,"Bleeding, Dyspnea, Major bleeding, Fatal/Life-threatening bleeding, Fatal bleeding, Intracranial hemorrhage, Minor bleed, Major fatal/life-threatening bleeding, CABG-related bleeding, Dizziness, Nausea, Bradycardia, Syncope, Pre-syncope, Loss of consciousness, Serum Uric Acid increase, Gout, Serum Creatinine increase, Severe Hepatic Impairment, death"
249,BRINTELLIX,all-concat,"Hypersensitivity, Clinical Worsening, Suicide Risk, Serotonin Syndrome, Abnormal Bleeding, Activation of Mania/Hypomania, Hyponatremia, nausea, constipation, vomiting, diarrhea, dry mouth, flatulence, dizziness, abnormal dreams, pruritus, sexual dysfunction, headache, muscle tension, mood swings, sudden outbursts of anger, runny nose, laboratory test changes, weight changes, vital sign changes, vertigo, dyspepsia, dysgeusia, flushing, suicidal thoughts and behaviors <negated>, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania, Angle Closure Glaucoma, SIADH, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death"
250,CAPRELSA,all-concat,"QT Prolongation, Torsades de Pointes, Skin Reactions, Stevens-Johnson Syndrome, Interstitial Lung Disease, Ischemic Cerebrovascular Events, Hemorrhage, Heart Failure, Diarrhea, Hypothyroidism, Hypertension, Reversible Posterior Leukoencephalopathy Syndrome, Embryofetal Toxicity, death, diarrhea/colitis, rash, acneiform dermatitis, nausea, headache, upper respiratory tract infections, decreased appetite, abdominal pain, asthenia <negated>, fatigue, pyrexia, elevated creatinine, vomiting, dyspepsia, dry mouth, dermatitis acneiform, dry skin, photosensitivity reaction, pruritus, nail abnormalities, alopecia, hypertensive crisis, accelerated hypertension, dysgeusia, fatigue, upper respiratory tract infections, hypocalcemia, ECG QT Prolonged, corneal abnormalities, blurred vision, proteinuria, depression, muscle spasms, pancreatitis, hypokalemia <negated>, hypomagnesemia <negated>, long QT syndrome <negated>, bradyarrhythmias <negated>, uncompensated heart failure <negated>, ventricular arrhythmias <negated>, recent myocardial infarction <negated>, ALT increased, hypoglycemia, creatinine increased, hypomagnesemia, neutropenia, thrombocytopenia, hemoptysis <negated>, severe hemorrhage, severe ischemic cerebrovascular event, seizures, headache, visual disturbances, confusion, altered mental function, renal impairment, hepatic impairment, fetal harm, female fertility impairment, embryofetal development impairment, postnatal development impairment"
251,CYRAMZA,all-concat,"Hemorrhage, Arterial Thromboembolic Events, Hypertension, Infusion-Related Reactions, Gastrointestinal Perforation, Impaired Wound Healing, Reversible Posterior Leukoencephalopathy Syndrome, Proteinuria, Nephrotic Syndrome, Thyroid Dysfunction, Anemia, Intestinal Obstruction, Hyponatremia, Headache, Neutropenia, Epistaxis, Rash, Fatigue, Diarrhea, Stomatitis, Mucosal Inflammation, Decreased Appetite, Febrile Neutropenia, Granulocyte Colony-Stimulating Factors, Thrombocytopenia, Gastrointestinal Hemorrhage, Peripheral Edema, Hypoalbuminemia, Sepsis, Pulmonary Hemorrhage, Lacrimation Increased, Palmar-Plantar Erythrodysesthesia Syndrome, Hypothyroidism, Embryofetal Toxicity, death"
252,DALIRESP,all-concat,"Psychiatric Events Including Suicidality, Weight Decrease, Diarrhea, Nausea, Headache, Back Pain, Influenza, Insomnia, Dizziness, Decreased Appetite, Abdominal Pain, Dyspepsia, Gastritis, Vomiting, Rhinitis, Sinusitis, Urinary Tract Infection, Muscle Spasms, Tremor, Anxiety, Depression, Hypersensitivity Reactions, Angioedema, Urticaria, Rash, Atrial Fibrillation, Lung Cancer, Prostate Cancer, Acute Pancreatitis, Acute Renal Failure, <negated>Acute Bronchospasm, Suicidal Ideation, Suicide Attempts, Completed Suicide, Moderate Weight Loss, Severe Weight Loss, Death"
253,EDURANT,all-concat,"Skin and Hypersensitivity Reactions, Depressive Disorders, Hepatotoxicity, headache, insomnia, rash, abdominal pain, nausea, vomiting, fatigue, dizziness, abnormal dreams, diarrhea, abdominal discomfort, cholecystitis, cholelithiasis, decreased appetite, somnolence, sleep disorders, anxiety, glomerulonephritis membranous, glomerulonephritis mesangioproliferative, nephrolithiasis, nephrotic syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), redistribution/accumulation of body fat, immune reconstitution syndrome, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia, tuberculosis, Graves' disease, polymyositis, Guillain-Barre syndrome"
254,EFFIENT,all-concat,"Bleeding, life-threatening bleeding, fatal bleeding, death, Thrombotic thrombocytopenic purpura, epistaxis, gastrointestinal hemorrhage, hemoptysis, subcutaneous hematoma, post-procedural hemorrhage, retroperitoneal hemorrhage, pericardial effusion/hemorrhage/tamponade, retinal hemorrhage, malignancies, severe thrombocytopenia, anemia, abnormal hepatic function, allergic reactions, angioedema, Hypertension, Hypercholesterolemia/Hyperlipidemia, Headache, Back pain, Dyspnea, Nausea, Dizziness, Cough, Hypotension, Fatigue, Non-cardiac chest pain, Atrial fibrillation, Bradycardia, Leukopenia, Rash, Pyrexia, Peripheral edema, Pain in extremity, Diarrhea, Thrombocytopenia, Hypersensitivity reactions, anaphylaxis, Symptomatic intracranial hemorrhage (ICH), Requiring inotropes, Requiring surgical intervention, Requiring transfusion (>=4 units), Intracranial hemorrhage, Reoperation, Transfusion of >=5 units, CABG-related bleeding, CABG-related TIMI Major or Minor bleeding, TIMI Major bleeding, TIMI Minor bleeding."
255,EGRIFTA,all-concat,"hypersensitivity, rash, urticaria, arthralgia, extremity pain, peripheral edema, hyperglycemia, carpal tunnel syndrome, injection site reactions, injection site erythema, pruritus, pain, irritation, swelling, hemorrhage, myalgia, musculoskeletal pain, musculoskeletal stiffness, joint stiffness, muscle spasms, joint swelling, edema, injection site pain, injection site irritation, chest pain, injection site rash, paresthesia, hypoesthesia, nausea, vomiting, dyspepsia, abdominal pain upper, palpitations, depression, night sweats, hypertension, muscle strain, blood creatine phosphokinase increased, neuropathy peripheral, insomnia, hot flush, fluid retention, glucose intolerance, injection site bruising, acute critical illness, death"
256,ELELYSO,all-concat,"pruritus, flushing, headache, arthralgia, pain in extremity, abdominal pain, vomiting, fatigue, back pain, dizziness, nausea, rash, urticaria, hypersensitivity reactions, severe vomiting, gastrointestinal inflammation, throat irritation, chest discomfort, anaphylaxis, angioedema, erythema, cough, chest tightness, Type III immune-mediated fixed drug eruption, death"
257,ELLA,all-concat,"headache, abdominal pain, nausea, dysmenorrhea, fatigue, dizziness, acne, intermenstrual bleeding, <negated> termination of an existing pregnancy, <negated> ectopic pregnancy, <negated> alteration of menstrual cycle, <negated> protection against STI/HIV"
258,ENTYVIO,all-concat,"Infusion-Related Reactions, Hypersensitivity Reactions, Infections, Progressive Multifocal Leukoencephalopathy, Liver Injury, nasopharyngitis, headache, arthralgia, nausea, pyrexia, upper respiratory tract infection, fatigue, cough, bronchitis, influenza, back pain, rash, pruritus, sinusitis, oropharyngeal pain, pain in extremities, anaphylaxis, dyspnea, bronchospasm, urticaria, flushing, increased blood pressure, increased heart rate, vomiting, dizziness, infusion-related reaction, anal abscess, sepsis, tuberculosis, salmonella sepsis, Listeria meningitis, giardiasis, cytomegaloviral colitis, hepatitis, malignancies, colon cancer, transitional cell carcinoma, breast cancer, carcinoid tumor of the appendix, squamous cell carcinoma, B-cell lymphoma, malignant hepatic neoplasm, malignant lung neoplasm, malignant melanoma, lung cancer of primary neuroendocrine carcinoma, renal cancer, death"
259,ERIVEDGE,all-concat,"muscle spasms, alopecia, dysgeusia, weight loss, fatigue, nausea, diarrhea, decreased appetite, constipation, arthralgias, vomiting, ageusia, amenorrhea, hyponatremia, hypokalemia, azotemia, embryo-fetal death <negated>, severe birth defects <negated>, embryotoxic <negated>, fetotoxic <negated>, teratogenic <negated>, severe midline defects <negated>, missing digits <negated>, irreversible malformations <negated>, death"
260,ESBRIET,all-concat,"Liver Enzyme Elevations, Photosensitivity Reaction, Rash, Gastrointestinal Disorders, nausea, abdominal pain, upper respiratory tract infection, diarrhea, fatigue, headache, dyspepsia, dizziness, vomiting, anorexia, gastro-esophageal reflux disease, sinusitis, insomnia, weight decreased, arthralgia, decreased appetite, pruritus, asthenia, dysgeusia, non-cardiac chest pain, Agranulocytosis, Angioedema, Bilirubin increased, ALT elevations, AST elevations, photosensitivity reactions, death"
261,FOLOTYN,all-concat,"Bone Marrow Suppression, Mucositis, Dermatologic Reactions, Tumor Lysis Syndrome, Hepatic Toxicity, Thrombocytopenia, Nausea, Fatigue, Pyrexia, Sepsis, Febrile Neutropenia, Dehydration, Dyspnea, Anemia, Constipation, Edema, Cough, Epistaxis, Vomiting, Neutropenia, Diarrhea, Anorexia, Hypokalemia, Rash, Pruritus, Pharyngolaryngeal pain, Liver function test abnormal, Abdominal pain, Pain in extremity, Back pain, Leukopenia, Night sweats, Asthenia, Tachycardia, Upper respiratory tract infection, Toxic epidermal necrolysis, death"
262,FYCOMPA,all-concat,"Serious Psychiatric and Behavioral Reactions, Suicidal Behavior and Ideation, Dizziness, Gait Disturbance, Somnolence, Fatigue, Falls, Nausea, Weight Gain, Vertigo, Ataxia, Headache, Vomiting, Contusion, Abdominal Pain, Anxiety, Aggression, Anger, Blurred Vision, Irritability, Dysarthria, Back Pain, Cough, Upper Respiratory Tract Infection, Hypersomnia, Balance Disorder, Diplopia, Head Injury, Hypoaesthesia, Pain in Extremity, Constipation, Myalgia, Coordination Abnormal, Euphoric Mood, Confusional State, Hyponatremia, Limb Injury, Mood Altered, Arthralgia, Asthenia, Memory Impairment, Musculoskeletal Pain, Oropharyngeal Pain, Paraesthesia, Peripheral Edema, Skin Laceration, Ligament Sprain, Rash, Urinary Tract Infection, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Hostility, Belligerence, Affect Lability, Agitation, Physical Assault, Homicidal Ideation and Threats <negated>, Paranoia, Mental Status Changes, Disorientation, Confusional State, Delusion, Depression, Suicidal Thoughts or Behavior, Mood or Behavior Changes, Thoughts about Self-Harm, Lethargy, Alcohol-related Mood and Anger Changes <negated>."
263,GATTEX,all-concat,"abdominal pain, injection site reactions, nausea, headaches, abdominal distension, upper respiratory tract infection, vomiting, fluid overload, flatulence, hypersensitivity, appetite disorders, sleep disturbances, cough, skin hemorrhage, gastrointestinal stoma complication, malignancy, colorectal polyps, gastrointestinal obstruction, gallbladder disease, biliary disease, pancreatic disease, cholecystitis, gallbladder perforation, cholecystectomy, cholelithiasis, cholestasis, pancreatic pseudocyst, chronic pancreatitis, acute pancreatitis, congestive heart failure, cognition and attention disturbances, coma, immunogenicity, anti-GATTEX antibody, neutralizing antibodies, neoplastic growth, intestinal obstruction <negated>, biliary tract disease, cholangitis, pancreatitis, congestive heart failure, altered mental status, death"
264,GAZYVA,all-concat,"Hepatitis B reactivation, Progressive multifocal leukoencephalopathy, Infusion reactions, Tumor lysis syndrome, Infections, Neutropenia, Thrombocytopenia, Anemia, Pyrexia, Cough, Nausea, Diarrhea, Urinary tract infection, Back pain, Nasopharyngitis, Constipation, Lymphopenia, Leukopenia, Hypocalcemia, Hyperkalemia, Hyponatremia, AST (SGOT increased), Creatinine increased, ALT (SGPT increased), Hypoalbuminemia, Alkaline phosphatase increased, Hypokalemia, Musculoskeletal disorders, Liver enzyme elevations, Worsening of Pre-existing Cardiac Conditions, death."
265,HARVONI,all-concat,"fatigue, headache, nausea, diarrhea, insomnia, bilirubin elevations, lipase elevations, creatine kinase elevations, serious symptomatic bradycardia, cardiac arrest <negated>, pacemaker intervention <negated>, bradycardia, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pains, confusion, memory problems, death"
266,HETLIOZ,all-concat,"headache, increased alanine aminotransferase, nightmares, unusual dreams, upper respiratory tract infection, urinary tract infection, somnolence"
267,ICLUSIG,all-concat,"Vascular Occlusion, Heart Failure, Hepatotoxicity, Hypertension, Pancreatitis, Neuropathy, Ocular Toxicity, Hemorrhage, Fluid Retention, Cardiac Arrhythmias, Myelosuppression, Arterial ischemia, Cardiac Failure, Gastrointestinal disorders, Abdominal pain, Constipation, Nausea, Diarrhea, Vomiting, Oral mucositis, GI hemorrhage, Blood and lymphatic system disorders, Febrile neutropenia, Infections and infestations, Sepsis, Pneumonia, Urinary tract infection, Upper respiratory tract infection, Nasopharyngitis, Cellulitis, Nervous system disorders, Headache, Peripheral neuropathy, Dizziness, Respiratory, thoracic, and mediastinal disorders, Pleural effusion, Cough, Dyspnea, Skin and subcutaneous tissue disorders, Rash and related conditions, Dry skin, Musculoskeletal and connective tissue disorders, Arthralgia, Myalgia, Pain in extremity, Back pain, Muscle spasms, Bone pain, General disorders and administration site conditions, Fatigue or asthenia, Pyrexia, Edema, peripheral, Pain, Chills, Metabolism and nutrition disorders, Decreased appetite, Investigations, Weight decreased, Psychiatric disorders, Insomnia, Cardiovascular disorders, Arterial ischemic event, Cardiovascular, Cerebrovascular, Peripheral vascular, CNS hemorrhage, Gastrointestinal hemorrhage, Cardiac failure, Effusions, Atrial fibrillation, Venous thromboembolism, Hypertension, Gastrointestinal disorders, Pancreatitis, Abdominal pain, Blood and lymphatic system disorders, Febrile neutropenia, Thrombocytopenia, Anemia, Infections, Pneumonia, Sepsis, General, Pyrexia, Laboratory Abnormalities, Thrombocytopenia, Neutropenia, Leukopenia, Anemia, Lymphopenia, Liver function tests, ALT increased, AST increased, Alkaline phosphatase increased, Albumin decreased, Bilirubin increased, Pancreatic enzymes, Lipase increased, Amylase increased, Chemistry, Glucose increased, Phosphorus decreased, Calcium decreased, Sodium decreased, Glucose decreased, Potassium decreased, Potassium increased, Sodium increased, Bicarbonate decreased, Creatinine increased, Calcium increased, Triglycerides increased, Venous Thromboembolism, Tumor Lysis Syndrome, Compromised Wound Healing, Gastrointestinal Perforation, Embryo-Fetal Toxicity, death"
268,IMPAVIDO,all-concat,"nausea, vomiting, diarrhea, headache, decreased appetite, dizziness, abdominal pain, pruritus, somnolence, elevated transaminases, elevated creatinine, death, Stevens-Johnson syndrome, melena, thrombocytopenia, arthritis, skin rash, CTCAE Grade 4 diarrhea, CTCAE Grade 4 hyperbilirubinemia, asthenia, motion sickness, malaise, pyrexia, lymphangitis, agranulocytosis, generalized edema, peripheral edema, jaundice, seizure, scrotal pain, decreased ejaculate volume, absent ejaculation, epistaxis, anemia, lymphadenopathy, abdominal distension, constipation, dysphagia, flatulence, fatigue, abscess, cellulitis, ecthyma, paresthesia, testicular pain, testicular swelling, urticaria, rash, pyoderma"
269,ISTODAX,all-concat,"Myelosuppression, Infection, Electrocardiographic Changes, Tumor Lysis Syndrome, Neutropenia, Lymphopenia, Thrombocytopenia, Nausea, Fatigue, Vomiting, Anorexia, Anemia, ECG T-wave changes, Asthenia, Hypomagnesemia, Diarrhea, Pyrexia, Dysgeusia, Constipation, Hypotension, Pruritus, Hypokalemia, Dermatitis, Exfoliative dermatitis, Hypocalcemia, Leukopenia, Alanine aminotransferase increased, Aspartate aminotransferase increased, Hypoalbuminemia, Electrocardiogram ST-T wave changes, Hyperglycemia, Hyponatremia, Hypermagnesemia, Hypophosphatemia, Hyperuricemia, Sepsis, Supraventricular arrhythmia, Central line infection, Edema, Ventricular arrhythmia, QT prolongation, Gastrointestinal disorders, Abdominal pain, Stomatitis, General disorders and administration site conditions, Chills, Edema peripheral, Blood and lymphatic system disorders, Metabolism and nutrition disorders, Nervous system disorders, Headache, Respiratory, thoracic and mediastinal disorders, Cough, Investigations, Weight decreased, Cardiac disorders, Tachycardia, Hepatitis B virus infection, Epstein Barr virus reactivation, Multi-organ failure, Septic shock, Candida sepsis, Cardiogenic shock, Pneumonia, Cellulitis, Deep vein thrombosis, Febrile neutropenia, Chest pain, Pulmonary embolism, Dehydration, Hyperbilirubinemia, Hypoxia, Packed red blood cell transfusion, Platelet transfusion, Hypersensitivity, Pneumonitis, Syncope, death."
270,JAKAFI,all-concat,"thrombocytopenia, anemia, neutropenia, risk of infection, symptom exacerbation following interruption or discontinuation of treatment, non-melanoma skin cancer, bruising, dizziness, headache, urinary tract infections, weight gain, flatulence, herpes zoster, post-herpetic neuralgia, abdominal pain, diarrhea, fatigue, pruritus, dyspnea, muscle spasms, nasopharyngitis, constipation, cough, edema, arthralgia, asthenia, epistaxis, nausea, hypertension, hypercholesterolemia, elevated ALT, elevated AST, hypertriglyceridemia, tuberculosis, progressive multifocal leukoencephalopathy (PML)"
271,JETREA,all-concat,"Decreased Vision, Intravitreal Injection Procedure Associated Effects, Potential for Lens Subluxation, Retinal Breaks, vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, retinal edema, macular edema, increased intraocular pressure, anterior chamber cell, photophobia, vitreous detachment, ocular discomfort, iritis, cataract, dry eye, metamorphopsia, conjunctival hyperemia, retinal degeneration, Dyschromatopsia, intraocular inflammation, intraocular infection, intraocular hemorrhage, lens subluxation, retinal detachment, retinal tear, yellowish vision, electroretinographic changes, a-wave amplitude decrease, b-wave amplitude decrease"
272,JUXTAPID,all-concat,"hepatotoxicity, reduced absorption of fat-soluble vitamins, serum fatty acids, gastrointestinal adverse reactions, diarrhea, nausea, vomiting, dyspepsia, abdominal pain, abdominal discomfort, abdominal distension, constipation, flatulence, increased ALT, chest pain, influenza, nasopharyngitis, fatigue, decreased weight, fever, back pain, headache, dizziness, pharyngolaryngeal pain, nasal congestion, angina pectoris, palpitations, gastroenteritis, gastroesophageal reflux disease, defecation urgency, rectal tenesmus, transaminase elevations, hepatic steatosis, embryo-fetal toxicity, myopathy, rhabdomyolysis, supratherapeutic anticoagulation, subtherapeutic anticoagulation, malabsorption, difficulty controlling INR on warfarin <negated>, death"
273,KADCYLA,all-concat,"Hepatotoxicity, Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Pulmonary Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions, Hemorrhage, Thrombocytopenia, Neurotoxicity, Neutropenia, Anemia, Lacrimation increased, Dry eye, Vision blurred, Conjunctivitis, Dyspepsia, Stomatitis, Dry Mouth, Abdominal pain, Vomiting, Diarrhea, Constipation, Nausea, Peripheral edema, Chills, Pyrexia, Asthenia, Fatigue, Nodular regenerative hyperplasia, Portal hypertension, Drug hypersensitivity, Urinary tract infection, Blood alkaline phosphatase increased, Increased transaminases, Hypokalemia, Myalgia, Arthralgia, Musculoskeletal pain, Dysgeusia, Dizziness, Peripheral neuropathy, Headache, Insomnia, Pneumonitis, Dyspnea, Cough, Epistaxis, Pruritus, Rash, Hemorrhage, Hypertension, Increased bilirubin, Increased AST, Increased ALT, Decreased platelet count, Decreased hemoglobin, Decreased neutrophils, Decreased potassium, Hepatic failure, death"
274,KERYDIN,all-concat,"application site exfoliation, ingrown toenail, application site erythema, application site dermatitis, skin irritation, <negated>contact sensitization"
275,KEYTRUDA,all-concat,"immune-mediated pneumonitis, immune-mediated colitis, immune-mediated hepatitis, immune-mediated endocrinopathies, renal failure, immune-mediated nephritis, infusion-related reactions, fatigue, cough, nausea, pruritus, rash, decreased appetite, constipation, arthralgia, diarrhea, peripheral edema, chills, pyrexia, vomiting, abdominal pain, dyspnea, pneumonia, cellulitis, vitiligo, decreased appetite, pain in extremity, myalgia, back pain, headache, dizziness, anemia, insomnia, upper respiratory tract infection, sepsis, hyperglycemia, hyponatremia, hypoalbuminemia, hypertriglyceridemia, increased aspartate aminotransferase, hypocalcemia, hypophysitis, thyroid disorders, hyperthyroidism, hypothyroidism, type 1 diabetes mellitus, exfoliative dermatitis, uveitis, arthritis, myositis, pancreatitis, hemolytic anemia, partial seizures, severe dermatitis, bullous pemphigoid, myasthenic syndrome, optic neuritis, rhabdomyolysis, rigors, wheezing, pruritis, flushing, rash, hypotension, hypoxemia, fever, embryofetal toxicity, death"
276,KIT,all-concat,"injection site irritation, pain, hypersensitivity reactions, cancer, death"
277,KRYSTEXXA,all-concat,"anaphylaxis, infusion reactions, gout flares, nausea, contusion, ecchymosis, nasopharyngitis, constipation, chest pain, vomiting, congestive heart failure exacerbation, urticaria, dyspnea, erythema, pruritus, anti-pegloticase antibodies development, anti-PEG antibodies detection, wheezing, peri-oral edema, lingual edema, hemodynamic instability, rash, delayed-type hypersensitivity reactions, death"
278,KYNAMRO,all-concat,"hepatotoxicity, injection site reactions, flu-like symptoms, nausea, headache, elevations in serum transaminases, ALT increased, injection site reactions, alanine aminotransferase increased, flu-like symptoms, aspartate aminotransferase increased, liver function test abnormal, angina pectoris, palpitations, vomiting, abdominal pain, fatigue, influenza like illness, pyrexia, chills, edema peripheral, hepatic steatosis, alanine aminotransferase increased, aspartate aminotransferase increased, liver function test abnormal, hepatic enzyme increased, pain in extremity, musculoskeletal pain, headache, insomnia, hypertension, proteinuria, hypersensitivity reaction with angioedema, glomerular nephritis, thrombocytopenia, erythema, pain, hematoma, pruritus, swelling, discoloration, myalgia, arthralgia, malaise, immunogenicity, anti-KYNAMRO antibodies, idiopathic thrombocytopenic purpura, death (due to fatal events mentioned), hepatotoxicity <negated>, steatohepatitis <negated>, cirrhosis <negated>"
279,LASTACAFT,all-concat,"eye irritation, burning and/or stinging on instillation, eye redness, eye pruritus, nasopharyngitis, headache, eye discharge, eye swelling, erythema of eyelid, eyelid edema, hypersensitivity, somnolence, <negated>contact lens-related irritation"
280,LATUDA,all-concat,"Increased Mortality in Elderly Patients with Dementia-Related Psychosis, Suicidal Thoughts and Behaviors, Cerebrovascular Adverse Reactions (including stroke), Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes (Hyperglycemia, Diabetes Mellitus, Dyslipidemia, Weight Gain), Hyperprolactinemia, Leukopenia, Neutropenia, Agranulocytosis, Orthostatic Hypotension, Syncope, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Dysregulation, Suicide, Activation of Mania/Hypomania, Dysphagia, Neurological Adverse Reactions in Patients with Parkinson's Disease or Dementia with Lewy Bodies, somnolence, akathisia, extrapyramidal symptoms, nausea, vomiting, diarrhea, anxiety, back pain, dizziness, insomnia, agitation, restlessness, salivary hypersecretion, dry mouth, nasopharyngitis, influenza, urinary tract infection, fatigue, increased appetite, weight increased, anemia, tachycardia, AV block 1st degree, angina pectoris, bradycardia, vertigo, blurred vision, abdominal pain, gastritis, sudden death <negated>, CPK increased, decreased appetite, rhabdomyolysis <negated>, cerebrovascular accident, dysarthria, abnormal dreams, panic attack, sleep disorder, dysuria, renal failure <negated>, amenorrhea, dysmenorrhea, breast enlargement, breast pain, galactorrhea, erectile dysfunction, rash, pruritus, angioedema <negated>, hypertension, death."
281,LEXISCAN,all-concat,"Myocardial Ischemia, Sinoatrial Nodal Block, Atrioventricular Nodal Block, Atrial Fibrillation, Atrial Flutter, Hypersensitivity, Anaphylaxis, Hypotension, Hypertension, Bronchoconstriction, Seizure, Cerebrovascular Accident, Stroke, dyspnea, headache, flushing, chest discomfort, dizziness, angina pectoris, chest pain, nausea, abdominal discomfort, dysgeusia, feeling hot, rhythm abnormalities, PACs, PVCs, first-degree AV block, second-degree AV block, AV conduction abnormalities, ventricular conduction abnormalities, wheezing, FEV1 reduction, myocardial infarction, cardiac arrest, ventricular arrhythmias, supraventricular tachyarrhythmias, heart block, asystole, marked hypertension, symptomatic hypotension, transient ischemic attack, QTc prolongation, tremor, transient ischemic attack, cerebrovascular accident, intracranial hemorrhage, abdominal pain, diarrhea, fecal incontinence, angioedema, cardiac arrest, respiratory arrest, respiratory distress, decreased oxygen saturation, throat tightness, urticaria, rashes, musculoskeletal pain, respiratory arrest, death."
282,LINZESS,all-concat,"diarrhea, abdominal pain, flatulence, abdominal distension, viral gastroenteritis, headache, gastroesophageal reflux disease, vomiting, fatigue, upper respiratory tract infection, sinusitis, dyspepsia, fecal incontinence, rectal hemorrhage, hematochezia, melena, allergic reactions, urticaria, hives, dehydration, death"
283,LIVALO,all-concat,"rhabdomyolysis, myoglobinuria, acute renal failure, myopathy, myositis, liver enzyme abnormalities, myalgia, back pain, diarrhea, constipation, pain in extremity, arthralgia, headache, influenza, nasopharyngitis, elevated creatine phosphokinase, transaminases, alkaline phosphatase, bilirubin, glucose, hypersensitivity reactions, rash, pruritus, urticaria, abdominal discomfort, abdominal pain, dyspepsia, nausea, asthenia, fatigue, malaise, hepatitis, jaundice, hepatic failure, dizziness, hypoesthesia, insomnia, depression, interstitial lung disease, erectile dysfunction, muscle spasms, cognitive impairment, memory loss, forgetfulness, amnesia, memory impairment, confusion, immune-mediated necrotizing myopathy (IMNM), death"
284,LUMASON,all-concat,"severe cardiopulmonary reactions, hypersensitivity reactions, headache, nausea, hypersensitivity-type rash, near syncope symptoms, anaphylactic shock, dysgeusia, injection site pain, chest discomfort, feeling hot, chest pain, injection site warmth, fatalities <negated>, arrhythmias, hypertensive episodes, fatal cardiac or respiratory arrest, shock, syncope, symptomatic arrhythmias, atrial fibrillation, tachycardia, bradycardia, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia, hypertension, hypotension, dyspnea, hypoxia, respiratory distress, stridor, wheezing, loss of consciousness, convulsions, skin erythema, rash, urticaria, flushing, throat tightness, anaphylactic shock, systemic embolization, tissue ischemia, ventricular arrhythmias, death"
285,LUZU,all-concat,"application site reactions, contact dermatitis, cellulitis, death"
286,LYNPARZA,all-concat,"Myelodysplastic syndrome, Acute Myeloid Leukemia, Pneumonitis, Anemia, Nausea, Fatigue, Asthenia, Vomiting, Diarrhea, Dysgeusia, Dyspepsia, Headache, Decreased appetite, Nasopharyngitis, Pharyngitis, URI, Cough, Arthralgia, Musculoskeletal pain, Myalgia, Back pain, Dermatitis, Rash, Abdominal pain, Discomfort, Increase in creatinine, Mean corpuscular volume elevation, Decrease in hemoglobin, Decrease in lymphocytes, Decrease in absolute neutrophil count, Decrease in platelets, Constipation, Peripheral edema, Dizziness, Urinary tract infection, Dyspnea, Leukopenia, Stomatitis, Peripheral neuropathy, Pyrexia, Hypomagnesemia, Hyperglycemia, Anxiety, Depression, Insomnia, Dysuria, Urinary incontinence, Vulvovaginal disorder, Dry skin, Eczema, Pruritis, Hypertension, Venous thrombosis, Pulmonary embolism <negated>, Hot flush, COPD <negated>, Cerebrovascular accident <negated>, Intestinal perforation <negated>, Sepsis <negated>, Suture rupture <negated>, Lethargy, Embryo-Fetal toxicity <negated>, Wheezing <negated>, Death."
287,MEKINIST,all-concat,"New Primary Malignancies, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Interstitial Lung Disease, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, rash, diarrhea, lymphedema, pyrexia, chills, fatigue, nausea, vomiting, abdominal pain, peripheral edema, cough, headache, arthralgia, night sweats, decreased appetite, constipation, myalgia, stomatitis, dry skin, pruritus, paronychia, hypertension, dermatitis acneiform, stomatitis, mouth ulceration, mucosal inflammation, abdominal pain lower, abdominal pain upper, abdominal tenderness, edema, epistaxis, gingival bleeding, hematochezia, rectal hemorrhage, melena, vaginal hemorrhage, hemorrhoidal hemorrhage, hematuria, conjunctival hemorrhage, Bradycardia, Xerostomia, Folliculitis, rash pustular, cellulitis, Rhabdomyolysis, Dizziness, dysgeusia, Vision blurred, dry eye, increased aspartate aminotransferase (AST), increased alanine aminotransferase (ALT), hypoalbuminemia, anemia, increased alkaline phosphatase, pyrexia, edema peripheral, rash, dry skin, actinic keratosis, erythema, nausea, vomiting, diarrhea, abdominal pain, constipation, dry mouth, headache, dizziness, cough, oropharyngeal pain, arthralgia, myalgia, back pain, muscle spasms, pain in extremity, decreased appetite, dehydration, insomnia, hemorrhage, urinary tract infection, renal failure, leukopenia, lymphopenia, neutropenia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, hyperglycemia, increased gamma-glutamyltransferase (GGT), hyponatremia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QTcF prolongation, tumor promotion, hemolytic anemia, basal cell carcinoma, cutaneous squamous cell carcinomas (SCC), keratoacanthoma, new primary melanoma, pancreatic adenocarcinoma, colorectal carcinoma, head and neck carcinoma, glioblastoma, brain stem hemorrhage, cerebral hemorrhage, gastric hemorrhage, eye hemorrhage, vitreous hemorrhage, renal failure acute, transient blindness, pancreatitis, asthenia, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperkeratosis, hyperhidrosis, hypertension, vision blurred, retinal pigment epithelial detachment (RPED), uveitis, iritis, embryotoxicity, abortifacient, death."
288,MOVANTIK,all-concat,"Gastrointestinal perforation, Opioid withdrawal, abdominal pain, diarrhea, nausea, flatulence, vomiting, headache, hyperhidrosis, chills, anxiety, irritability, yawning, death"
289,MYALEPT,all-concat,"headache, hypoglycemia, decreased weight, abdominal pain, arthralgia, dizziness, ear infection, fatigue, nausea, ovarian cyst, upper respiratory tract infection, anemia, back pain, diarrhea, paresthesia, proteinuria, pyrexia, injection-site erythema, urticaria, pancreatitis, severe infections, worsening metabolic control, increases in HbA1c, increases in triglycerides, excessive weight gain, development of glucose intolerance, diabetes mellitus, peripheral T-cell lymphoma, anaplastic large cell lymphoma, autoimmune hepatitis, membranoproliferative glomerulonephritis, massive proteinuria, renal failure, anaphylaxis, generalized rash, benzyl alcohol toxicity, death"
290,MYRBETRIQ,all-concat,"hypertension, nasopharyngitis, urinary tract infection, headache, nausea, diarrhea, constipation, dizziness, tachycardia, atrial fibrillation, prostate cancer, constipation, upper respiratory tract infection, arthralgia, abdominal pain, fatigue, palpitations, blood pressure increased, glaucoma, dyspepsia, gastritis, abdominal distension, sinusitis, rhinitis, GGT increased, AST increased, ALT increased, LDH increased, nephrolithiasis, bladder pain, vulvovaginal pruritus, vaginal infection, urticaria, leukocytoclastic vasculitis, rash, pruritus, purpura, lip edema, back pain, dry mouth, sinusitis, influenza, cystitis, dry eyes, vision blurred, cerebrovascular accident, osteoarthritis, neoplasm, breast cancer, lung neoplasm malignant, Stevens-Johnson syndrome, angioedema, urinary retention, death"
291,NATROBA,all-concat,"application site erythema, ocular erythema, application site irritation, application site dryness, application site exfoliation, alopecia, dry skin, benzyl alcohol toxicity, death"
292,NPLATE,all-concat,"arthralgia, dizziness, insomnia, myalgia, pain in extremity, abdominal pain, shoulder pain, dyspepsia, paresthesia, headache, bone marrow reticulin deposition, worsened thrombocytopenia after Nplate discontinuation, erythromelalgia, hypersensitivity, angioedema, increased blast cell counts, progression to acute myelogenous leukemia, thrombotic/thromboembolic complications, portal vein thrombosis, bone marrow fibrosis, death"
293,NUCYNTA,all-concat,"Respiratory Depression, Interaction with Alcohol, Chronic Pulmonary Disease, Hypotensive Effects, Interactions with Other CNS Depressants, Drug abuse, addiction, and dependence, Gastrointestinal Effects, Seizures, Serotonin Syndrome, nausea, dizziness, vomiting, somnolence, headache, Constipation, Dry mouth, Dyspepsia, Fatigue, Feeling hot, Nasopharyngitis, Upper respiratory tract infection, Urinary tract infection, Decreased appetite, Tremor, Lethargy, Insomnia, Confusional state, Abnormal dreams, Anxiety, Pruritus, Hyperhidrosis, Pruritus generalized, Rash, Hot flush, heart rate increased, heart rate decreased, visual disturbance, abdominal discomfort, impaired gastric emptying, irritability, edema, drug withdrawal syndrome, feeling drunk, hypersensitivity, gamma-glutamyltransferase increased, alanine aminotransferase increased, aspartate aminotransferase increased, involuntary muscle contractions, sensation of heaviness, hypoesthesia, paresthesia, disturbance in attention, sedation, dysarthria, depressed level of consciousness, memory impairment, ataxia, presyncope, syncope, coordination abnormal, seizure, euphoric mood, disorientation, restlessness, agitation, nervousness, thinking abnormal, urinary hesitation, pollakiuria, oxygen saturation decreased, cough, dyspnea, respiratory depression, urticaria, blood pressure decreased, diarrhea, headache, hallucination, suicidal ideation, panic attack, palpitations, death"
294,OFEV,all-concat,"Liver Enzyme and Bilirubin Elevations, Gastrointestinal Disorders, Embryofetal Toxicity, Arterial Thromboembolic Events, Risk of Bleeding, Gastrointestinal Perforation, diarrhea, nausea, abdominal pain, vomiting, liver enzyme elevation, decreased appetite, headache, weight decreased, hypertension, bronchitis, myocardial infarction, pneumonia, lung neoplasm malignant, hypothyroidism, ALT elevations, AST elevations, ALKP elevations, GGT elevations, bilirubin elevations, bleeding events, gastrointestinal perforation, death"
295,OLYSIO,all-concat,"Serious Symptomatic Bradycardia, Hepatic Decompensation, Hepatic Failure, Photosensitivity, Rash, Pruritus, Nausea, Myalgia, Dyspnea, Alkaline phosphatase elevation, Hyperbilirubinemia, Fatigue, Headache, Insomnia, Dizziness, Diarrhea, Cardiac Disorders, Hepatobiliary Disorders, Serious photosensitivity reactions, Severe rash, Sulfa Allergy, Adverse Reactions or Reduced Therapeutic Effect Due to Drug Interactions, death"
296,ONGLYZA,all-concat,"upper respiratory tract infection, urinary tract infection, headache, peripheral edema, lymphopenia, rash, blood creatinine increased, blood creatine phosphokinase increased, sinusitis, abdominal pain, gastroenteritis, vomiting, fractures, thrombocytopenia, hypoglycemia, hypersensitivity reactions, urticaria, facial edema, infections, tuberculosis, salmonella sepsis, death, lymphocyte count decreased, anaphylaxis, angioedema, exfoliative skin conditions, acute pancreatitis, arthralgia"
297,OPDIVO,all-concat,"Immune-Mediated Pneumonitis, Immune-Mediated Colitis, Immune-Mediated Hepatitis, Immune-Mediated Nephritis and Renal Dysfunction, Immune-Mediated Hypothyroidism, Immune-Mediated Hyperthyroidism, Other Immune-Mediated Adverse Reactions, rash, fatigue, dyspnea, musculoskeletal pain, decreased appetite, cough, nausea, constipation, abdominal pain, hyponatremia, increased aspartate aminotransferase, increased lipase, pruritus, upper respiratory tract infection, peripheral edema, ventricular arrhythmia, iridocyclitis, infusion-related reactions, increased amylase, dizziness, peripheral and sensory neuropathy, exfoliative dermatitis, erythema multiforme, vitiligo, psoriasis, increased AST, increased alkaline phosphatase, hyperkalemia, increased ALT, asthenia, edema, pyrexia, chest pain, pain, arthralgia, vomiting, diarrhea, rash, decreased weight, pneumonia, stomatitis, peripheral neuropathy, bronchitis, upper respiratory tract infection, hyponatremia, increased creatinine, hypercalcemia, hypokalemia, hypomagnesemia, hypocalcemia, lymphopenia, anemia, thrombocytopenia, adrenal insufficiency, uveitis, pancreatitis, facial and abducens nerve paresis, demyelination, autoimmune neuropathy, motor dysfunction, vasculitis, hypophysitis, diabetic ketoacidosis, hypopituitarism, Guillain-Barre syndrome, myasthenic syndrome, death"
298,OPSUMIT,all-concat,"Embryo-fetal toxicity, Hepatotoxicity, Decrease in Hemoglobin, Anemia, Nasopharyngitis, Pharyngitis, Bronchitis, Headache, Influenza, Urinary tract infection, Hypersensitivity reactions, Angioedema, Pruritus, Rash, Nasal congestion, Pulmonary edema, Decreased sperm counts, Elevated aminotransferases, Hepatic injury, Nausea, Vomiting, Right upper quadrant pain, Fatigue, Anorexia, Jaundice, Dark urine, Fever, Itching, Hemoglobin decrease, Pulmonary Veno-occlusive Disease (PVOD)"
299,ORBACTIV,all-concat,"Hypersensitivity Reactions, Infusion related reactions, Clostridium difficile-associated diarrhea, Osteomyelitis, headache, nausea, vomiting, limb and subcutaneous abscesses, diarrhea, cellulitis, Infusion site phlebitis, Infusion site reaction, Abscess (limb and subcutaneous), Alanine aminotransferase increased, Aspartate aminotransferase increased, Tachycardia, Dizziness, anemia, eosinophilia, infusion site erythema, extravasation, induration, pruritis, rash, edema peripheral, hypersensitivity <negated>, osteomyelitis <negated>, total bilirubin increased, hyperuricemia, hypoglycemia, tenosynovitis, myalgia, bronchospasm, wheezing, urticaria, angioedema, erythema multiforme, leucocytoclastic vasculitis, bleeding (associated with warfarin use), Clostridium difficile-associated colitis, death (implied by fatal colitis)."
300,OSPHENA,all-concat,"hot flush, vaginal discharge, muscle spasms, genital discharge, hyperhidrosis, thromboembolic stroke, hemorrhagic stroke, deep vein thrombosis (DVT), allergic conditions, hypersensitivity, angioedema, rash, rash erythematous, rash generalized, pruritus, urticaria, endometrial cancer, stroke, coronary heart disease, myocardial infarction (MI), venous thromboembolism, pulmonary embolism (PE), endometrial hyperplasia, uterine polyps, breast cancer <negated>, severe hepatic impairment"
301,PERJETA,all-concat,"Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions, Anaphylaxis, Diarrhea, Alopecia, Neutropenia, Nausea, Fatigue, Rash, Peripheral Neuropathy, Febrile Neutropenia, Leukopenia, Asthenia, Edema Peripheral, Mucosal Inflammation, Pyrexia, Nail Disorder, Pruritus, Dry Skin, Vomiting, Constipation, Stomatitis, Anemia, Thrombocytopenia, Headache, Dysgeusia, Dizziness, Myalgia, Arthralgia, Upper Respiratory Tract Infection, Nasopharyngitis, Dyspnea, Decreased Appetite, Lacrimation Increased, Insomnia, Paronychia, Pleural Effusion, Cardiac Disorders, Immune System Disorders, Nervous System Disorders, Infections and Infestations, Respiratory, Thoracic and Mediastinal Disorders, Metabolism and Nutrition Disorders, Eye Disorders, Psychiatric Disorders, Investigations, Cough, Epistaxis, Oropharyngeal Pain, ALT Increased, Palmar-Plantar Erythrodysaesthesia Syndrome, Dyspepsia, Hypokalemia, <negated>death."
302,PLEGRIDY,all-concat,"Hepatic Injury, Depression, Suicide, Seizures, Anaphylaxis, Allergic Reactions, Injection Site Reactions, Congestive Heart Failure, Decreased Peripheral Blood Counts, Autoimmune Disorders, injection site erythema, influenza-like illness, pyrexia, headache, myalgia, chills, injection site pain, asthenia, injection site pruritus, arthralgia, Nausea, Vomiting, Hyperthermia, Pain, Injection site edema, Injection site warmth, Injection site hematoma, Injection site rash, Body temperature increased, Alanine aminotransferase increased, Aspartate aminotransferase increased, Gamma-glutamyl-transferase increased, Pruritus, flu-like symptoms, hepatic injury, hepatitis, autoimmune hepatitis, hepatic failure, elevation of hepatic transaminases, suicidal ideation, serious allergic reaction, angioedema, urticaria, injection site necrosis, cardiomyopathy, pancytopenia, severe thrombocytopenia, idiopathic thrombocytopenia, hyperthyroidism, hypothyroidism, autoimmune hepatitis"
303,POMALYST,all-concat,"fetal risk, venous thromboembolism, arterial thromboembolism, hematologic toxicity, hepatotoxicity, hypersensitivity reactions, dizziness, confusional state, neuropathy, second primary malignancies, tumor lysis syndrome, fatigue, asthenia, neutropenia, anemia, constipation, nausea, diarrhea, dyspnea, upper respiratory tract infections, back pain, pyrexia, leukopenia, febrile neutropenia, lymphopenia, edema peripheral, chills, vomiting, musculoskeletal chest pain, muscle spasms, arthralgia, muscular weakness, bone pain, musculoskeletal pain, pain in extremity, pneumonia, urinary tract infection, sepsis, decreased appetite, hypercalcemia, hypokalemia, hyperglycemia, hyponatremia, dehydration, hypocalcemia, cough, epistaxis, productive cough, oropharyngeal pain, peripheral neuropathy, headache, tremor, rash, pruritus, dry skin, hyperhidrosis, night sweats, blood creatinine increased, weight decreased, weight increased, anxiety, insomnia, renal failure, myocardial infarction, atrial fibrillation, angina pectoris, cardiac failure congestive, vertigo, abdominal pain, general physical health deterioration, non-cardiac chest pain, multi-organ failure, hyperbilirubinemia, pneumocystis jiroveci pneumonia, respiratory syncytial virus infection, bacteremia, pneumonia respiratory syncytial viral, cellulitis, urosepsis, septic shock, clostridium difficile colitis, pneumonia streptococcal, lobar pneumonia, viral infection, lung infection, hemoglobin decreased, fall, compression fracture, spinal compression fracture, hyperkalemia, failure to thrive, depressed level of consciousness, syncope, mental status change, urinary retention, interstitial lung disease, pulmonary embolism, respiratory failure, bronchospasm, hypotension, pancytopenia, allergic reactions, angioedema, urticaria, elevated liver enzymes, hepatic failure, death"
304,PREPOPIK,all-concat,"nausea, headache, vomiting, abdominal bloating <negated>, distension <negated>, pain/cramping <negated>, watery diarrhea <negated>, electrolyte abnormalities, potassium (low), sodium (low), chloride (low), magnesium (high), calcium (low), creatinine (high), eGFR (low), allergic reactions, rash, urticaria, purpura, hypokalemia, hyponatremia, hypermagnesemia, abdominal pain, diarrhea, fecal incontinence, proctalgia, aphthoid ileal ulcers, ischemic colitis, generalized tonic-clonic seizures, fluid and electrolyte abnormalities, cardiac arrhythmias, renal impairment, orthostatic changes, seizures, mucosal ulcerations, aspiration"
305,RAPIVAB,all-concat,"Serious skin reactions, hypersensitivity reactions, Stevens-Johnson Syndrome, erythema multiforme, neuropsychiatric events, hallucinations, delirium, abnormal behavior, diarrhea, Alanine Aminotransferase increased, Serum Glucose increased, Creatine Phosphokinase increased, Neutrophils decreased, constipation, insomnia, AST increased, hypertension, exfoliative dermatitis, rash, death"
306,RAXIBACUMAB,all-concat,"rash, pain in extremity, pruritus, somnolence, urticaria, clonus, dyspnea, anemia, leukopenia, lymphadenopathy, palpitations, vertigo, fatigue, infusion site pain, peripheral edema, blood amylase increased, blood creatine phosphokinase increased, prothrombin time prolonged, back pain, muscle spasms, syncope vasovagal, insomnia, flushing, hypertension"
307,RELISTOR,all-concat,"Gastrointestinal perforation, Severe or persistent diarrhea, Opioid withdrawal, Abdominal pain, Nausea, Diarrhea, Hyperhidrosis, Hot flush, Tremor, Chills, Flatulence, Dizziness, Vomiting, Feeling of body temperature change, Piloerection, Myocardial infarctions, Stroke, Cardiac arrest, Sudden death, Cramping, Diaphoresis, Flushing, Malaise, Pain, <negated> Severe or persistent diarrhea, <negated> Opioid withdrawal, death"
308,SABRIL,all-concat,"Vision Loss, Magnetic Resonance Imaging (MRI) Abnormalities in Infants, Neurotoxicity, Suicidal Behavior and Ideation, Withdrawal of Antiepileptic Drugs (AEDs), Anemia, Somnolence and Fatigue, Peripheral Neuropathy, Weight Gain, Edema, permanent vision loss, fatigue, somnolence, nystagmus, tremor, vision blurred, memory impairment, arthralgia, abnormal coordination, confusional state, increased weight, upper respiratory tract infection, aggression, diplopia, bronchitis, ear infection, otitis media acute, headache, dizziness, convulsion, nasopharyngitis, visual field defect, depression, nausea, diarrhea, insomnia, irritability, coordination abnormal, vomiting, influenza, pyrexia, rash, tinnitus, vertigo, asthenopia, eye pain, diarrhoea, constipation, abdominal pain upper, dyspepsia, stomach discomfort, abdominal pain, toothache, abdominal distension, gait disturbance, asthenia, oedema peripheral, fever, chest pain, thirst, malaise, urinary tract infection, contusion, joint sprain, muscle strain, wound secretion, increased appetite, back pain, pain in extremity, myalgia, muscle twitching, muscle spasms, disturbance in attention, sensory disturbance, hyporeflexia, paraesthesia, lethargy, hyperreflexia, hypoaesthesia, sedation, status epilepticus, dysarthria, postictal state, sensory loss, irritability, anxiety, depressed mood, thinking abnormal, abnormal behaviour, expressive language disorder, nervousness, abnormal dreams, dysmenorrhoea, erectile dysfunction, pharyngolaryngeal pain, cough, pulmonary congestion, sinus headache, acne, psychomotor hyperactivity, disorientation, strabismus, conjunctivitis, viral infection, pneumonia, candidiasis, gastroenteritis viral, sinusitis, croup infectious, decreased appetite, sedation, nasal congestion, congenital cardiac defects, congenital external ear anomaly, congenital hemangioma, congenital hydronephrosis, congenital male genital malformation, congenital oral malformation, congenital vesicoureteric reflux, dentofacial anomaly, dysmorphism, fetal anticonvulsant syndrome, hamartomas, hip dysplasia, limb malformation, limb reduction defect, low set ears, renal aplasia, retinitis pigmentosa, supernumerary nipple, talipes, deafness, delayed puberty, gastrointestinal hemorrhage, esophagitis, developmental delay, facial edema, malignant hyperthermia, multi-organ failure, cholestasis, dystonia, encephalopathy, hypertonia, muscle spasticity, myoclonus, optic neuritis, dyskinesia, acute psychosis, apathy, delirium, hypomania, neonatal agitation, psychotic disorder, laryngeal edema, pulmonary embolism, respiratory failure, stridor, angioedema, maculo-papular rash, pruritus, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), death."
309,SAMSCA,all-concat,"thirst, dry mouth, asthenia, constipation, pollakiuria, polyuria, hyperglycemia, death, pyrexia, anorexia, nausea, gastrointestinal bleeding, disseminated intravascular coagulation, intracardiac thrombus, ventricular fibrillation, prothrombin time prolonged, ischemic colitis, diabetic ketoacidosis, rhabdomyolysis, cerebrovascular accident, urethral hemorrhage, vaginal hemorrhage, pulmonary embolism, respiratory failure, deep vein thrombosis, osmotic demyelination syndrome, hypernatremia, hypersensitivity reactions, anaphylactic shock, rash generalized, dehydration, hypovolemia, liver injury, hyperkalemia"
310,SAVELLA,all-concat,"nausea, headache, constipation, dizziness, insomnia, hot flush, hyperhidrosis, vomiting, palpitations, heart rate increased, dry mouth, hypertension, tachycardia, vision blurred, abdominal pain, chest pain, chills, chest discomfort, upper respiratory tract infection, blood pressure increased, decreased appetite, migraine, paresthesia, tremor, hypoesthesia, tension headache, anxiety, dyspnea, rash, pruritus, flushing, weight loss, weight gain, dysuria, ejaculation disorder, erectile dysfunction, ejaculation failure, libido decreased, prostatitis, scrotal pain, testicular pain, testicular swelling, urinary hesitation, urinary retention, urethral pain, urine flow decreased, diarrhea, dyspepsia, gastroesophageal reflux disease, flatulence, abdominal distension, fatigue, peripheral edema, irritability, pyrexia, urinary tract infection, cystitis, contusion, fall, hypercholesterolemia, somnolence, dysgeusia, depression, stress, night sweats, leukopenia, neutropenia, thrombocytopenia, supraventricular tachycardia, accommodation disorder, hyperprolactinemia, hepatitis, anorexia, hyponatremia, rhabdomyolysis, convulsions, loss of consciousness, Parkinsonism, aggression, anger, delirium, hallucination, homicidal ideation, acute renal failure, galactorrhea, erythema multiforme, Stevens Johnson syndrome, hypertensive crisis, suicidality <negated>, serotonin syndrome <negated>, seizures <negated>, hepatotoxicity <negated>, abnormal bleeding <negated>, mania <negated>, angle closure glaucoma <negated>, death"
311,SIGNIFOR,all-concat,"Hypocortisolism, Hyperglycemia, Diabetes, Bradycardia, QT prolongation, Liver Test Elevations, Cholelithiasis, Pituitary Hormone Deficiency, Diarrhea, Nausea, Hyperglycemia, Cholelithiasis, Headache, Abdominal pain, Fatigue, Diabetes mellitus, Injection site reactions, Nasopharyngitis, Alopecia, Asthenia, Glycosylated hemoglobin increased, Alanine aminotransferase increased, Gamma-glutamyl transferase increased, Edema peripheral, Abdominal pain upper, Decreased appetite, Hypercholesterolemia, Hypertension, Dizziness, Hypoglycemia, Type 2 diabetes mellitus, Anxiety, Influenza, Insomnia, Myalgia, Arthralgia, Pruritus, Lipase increased, Constipation, Hypotension, Vomiting, Back pain, Dry skin, Electrocardiogram QT prolonged, Hypokalemia, Pain in extremity, Sinus bradycardia, Vertigo, Abdominal distension, Adrenal insufficiency, Aspartate aminotransferase increased, Blood glucose increased, Anemia <negated>, Blood amylase increased <negated>, Prothrombin time prolonged <negated>, Gastrointestinal Disorders, Hyperglycemia and Diabetes, Elevated Liver Tests, Hypocortisolism, Injection Site Reactions, Thyroid Function, Other Abnormal Laboratory Findings, Hypothyroidism, Pancreatitis <negated>, Hemoglobin levels decreased <negated>, PT and PTT elevations <negated>."
312,SIVEXTRO,all-concat,"nausea, headache, diarrhea, vomiting, dizziness, anemia, palpitations, tachycardia, asthenopia, vision blurred, visual impairment, vitreous floaters, infusion-related reactions, drug hypersensitivity, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, white blood cell count decreased, hypoesthesia, paresthesia, VIIth nerve paralysis, insomnia, pruritus, urticaria, dermatitis, flushing, hypertension, myelosuppression, peripheral neuropathy, optic nerve disorders, Clostridium difficile-associated diarrhea <negated>, death"
313,SOVALDI,all-concat,"Serious Symptomatic Bradycardia, fatigue, headache, nausea, insomnia, anemia, pruritus, asthenia, rash, decreased appetite, chills, influenza like illness, pyrexia, diarrhea, neutropenia, myalgia, irritability, pancytopenia, severe depression, suicidal ideation, suicide, hematologic effects, laboratory abnormalities, bilirubin elevations, creatine kinase elevations, lipase elevations, cardiac disorders, symptomatic bradycardia, cardiac arrest <negated>, death"
314,STELARA,all-concat,"Infections, Malignancies, Reversible Posterior Leukoencephalopathy Syndrome, Nasopharyngitis, Upper respiratory tract infection, Headache, Fatigue, Diarrhea, Back pain, Dizziness, Pharyngolaryngeal pain, Pruritus, Injection site erythema, Myalgia, Depression, Cellulitis, Herpes zoster, Diverticulitis, Injection site reactions (pain, swelling, pruritus, induration, hemorrhage, bruising, irritation), Serious hypersensitivity reactions (including anaphylaxis and angioedema), Other hypersensitivity reactions (including rash and urticaria), Pustular psoriasis, Erythrodermic psoriasis, Arthralgia, Nausea, Dental infections, Serious bacterial infections, Fungal infections, Viral infections, Diverticulitis, Cellulitis, Pneumonia, Appendicitis, Cholecystitis, Sepsis, Osteomyelitis, Gastroenteritis, Urinary tract infections, Tuberculosis (TB), Malignancy, Non-melanoma skin cancer, Prostate cancer, Melanoma, Colorectal cancer, Breast cancer, Squamous cell carcinomas, Reversible Posterior Leukoencephalopathy Syndrome (RPLS) <negated>, Serious infections from mycobacteria, salmonella and Bacillus Calmette-Guerin (BCG) vaccinations <negated>, Death (associated with fatal outcomes reported in the context of RPLS and particular infections)."
315,STIVARGA,all-concat,"hepatotoxicity, hemorrhage, dermatological toxicity, hypertension, cardiac ischemia, infarction, reversible posterior leukoencephalopathy syndrome (RPLS), gastrointestinal perforation, fistula, asthenia/fatigue, hand-foot skin reaction (HFSR), diarrhea, decreased appetite/food intake, mucositis, dysphonia, infection, pain (not otherwise specified), decreased weight, gastrointestinal and abdominal pain, rash, fever, nausea, hypersensitivity reaction, death, anemia, thrombocytopenia, neutropenia, lymphopenia, hypocalcemia, hypokalemia, hyponatremia, hypophosphatemia, hyperbilirubinemia, increased AST, increased ALT, proteinuria, increased INR, increased lipase, increased amylase, alopecia, headache, musculoskeletal stiffness, hypothyroidism, wound healing complications, embryofetal toxicity"
316,STRIVERDI,all-concat,"asthma-related death, nasopharyngitis, upper respiratory tract infection, bronchitis, urinary tract infection, cough, dizziness, rash, diarrhea, back pain, arthralgia, pneumonia, constipation, pyrexia, lung cancer, worsening COPD, COPD exacerbation, atrial fibrillation, paradoxical bronchospasm, cardiovascular effects, ECG changes, hypokalemia, hyperglycemia, angioedema, death"
317,SURFAXIN,all-concat,"endotracheal tube reflux, pallor, endotracheal tube obstruction, need for dose interruption, oxygen desaturation, bradycardia, apnea, intraventricular hemorrhage, periventricular leukomalacia, acquired sepsis, patent ductus arteriosus, retinopathy of prematurity, necrotizing enterocolitis, pulmonary air leak, pulmonary interstitial emphysema, pneumothorax, pulmonary hemorrhage, death, multi-organ failure, sepsis, anoxic encephalopathy, renal failure, hypoxia, hypotension, pulmonary embolism, anemia, jaundice, metabolic acidosis, hyperglycemia, pneumonia, hyponatremia, respiratory acidosis"
318,SYLVANT,all-concat,"severe infections, infusion-related reactions, hypersensitivity, pruritus, increased weight, rash, hyperuricemia, upper respiratory tract infection, rash generalized, rash maculo-papular, rash popular, rash pruritic, skin hyperpigmentation, eczema, psoriasis, dry skin, lower respiratory tract infection, thrombocytopenia, edema, constipation, hypertriglyceridemia, hypercholesterolemia, oropharyngeal pain, renal impairment, headache, weight increased, hypotension, abdominal pain, abdominal distension, decreased appetite, dehydration, peripheral edema, anaphylaxis, back pain, chest pain, nausea, vomiting, flushing, erythema, palpitations, diarrhea, pain in extremities, arthralgia, fatigue, gastrointestinal perforation <negated>"
319,SYNRIBO,all-concat,"myelosuppression, bleeding, hyperglycemia, thrombocytopenia, anemia, neutropenia, diarrhea, nausea, fatigue, asthenia, injection site reaction, pyrexia, infection, lymphopenia, pancytopenia, increased alanine aminotransferase, bone marrow failure, febrile neutropenia, constipation, abdominal pain, upper abdominal pain, vomiting, edema peripheral, leukocytosis, arthralgia, pain in extremity, back pain, myalgia, headache, insomnia, cough, epistaxis, alopecia, rash, anorexia, dyspnea, chills, tachycardia, palpitations, acute coronary syndrome, angina pectoris, arrhythmia, bradycardia, ventricular extrasystoles, ear pain, ear hemorrhage, tinnitus, cataract, vision blurred, conjunctival hemorrhage, dry eye, lacrimation increased, conjunctivitis, diplopia, eye pain, eyelid edema, stomatitis, mouth ulceration, abdominal distension, dyspepsia, gastroesophageal reflux disease, gingival bleeding, aphthous stomatitis, dry mouth, hemorrhoids, gastritis, gastrointestinal hemorrhage, melena, mouth hemorrhage, oral pain, anal fissure, dysphagia, gingival pain, gingivitis, mucosal inflammation, pain, chest pain, hyperthermia, influenza-like illness, catheter site pain, general edema, malaise, hypersensitivity, contusion, transfusion reaction, decreased appetite, diabetes mellitus, gout, dehydration, bone pain, muscular weakness, muscle spasms, musculoskeletal chest pain, musculoskeletal pain, musculoskeletal stiffness, musculoskeletal discomfort, dizziness, cerebral hemorrhage, paresthesia, convulsion, hypoesthesia, lethargy, sciatica, burning sensation, dysgeusia, tremor, anxiety, depression, agitation, confusional state, mental status change, dysuria, pharyngolaryngeal pain, nasal congestion, dysphonia, productive cough, rales, rhinorrhea, hemoptysis, sinus congestion, erythema, pruritus, dry skin, petechiae, hyperhidrosis, night sweats, ecchymosis, purpura, skin lesion, skin ulcer, rash erythematous, rash papular, skin exfoliation, skin hyperpigmentation, hematoma, hypertension, hot flush, hypotension, death, cerebral hemorrhage <negated>, multi-organ failure <negated>, progression of disease <negated>, unknown causes <negated>, leukocytosis <negated>, embryo-fetal toxicity <negated>, glucose intolerance <negated>, hyperosmolar non-ketotic hyperglycemia <negated>, elevated transaminases <negated>, hemoglobin decreased <negated>, leukocytes decreased <negated>, neutrophils decreased <negated>, platelets decreased <negated>, alanine aminotransferase (ALT) increased <negated>, bilirubin increased <negated>, creatinine increased <negated>, glucose increased <negated>, uric acid increased <negated>, glucose decreased <negated>."
320,TRADJENTA,all-concat,"nasopharyngitis, hypoglycemia, diarrhea, cough, urinary tract infection, hypertriglyceridemia, hyperlipidemia, weight increased, constipation, back pain, arthralgia, upper respiratory tract infection, headache, pain in extremity, hypersensitivity, urticaria, angioedema, localized skin exfoliation, bronchial hyperreactivity, myalgia, pancreatitis, acute pancreatitis, death, anaphylaxis, exfoliative skin conditions, rash, mouth ulceration, stomatitis, severe and disabling arthralgia, severe hypoglycemia <negated>, asymptomatic hypoglycemia <negated>, confirmed symptomatic hypoglycemia <negated>, increases in uric acid <negated>."
321,VIBATIV,all-concat,"Nephrotoxicity, Infusion-related reactions, Clostridium difficile-associated diarrhea, Diarrhea, Taste disturbance, Nausea, Vomiting, Foamy urine, Rigors, Decreased appetite, Renal System, Renal Failure Acute, Nephrotoxicity, Renal impairment, Renal insufficiency, Renal failure, Increased serum creatinine, Serious hypersensitivity reactions, Anaphylactic reactions, Hypersensitivity reactions, QTc prolongation, Death"
322,VICTOZA,all-concat,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Renal Impairment, Hypersensitivity Reactions, Headache, Nausea, Diarrhea, Anti-liraglutide antibody formation, Immunogenicity-related events, Urticaria, Withdrawals due to gastrointestinal adverse reactions, Vomiting, Dyspepsia, Constipation, Injection site reactions, Papillary thyroid carcinoma, Increased serum creatinine, Acute renal failure, Worsening of chronic renal failure, Angioedema, Anaphylactic reactions, Rash, Pruritus, Acute pancreatitis, Hemorrhagic pancreatitis, Necrotizing pancreatitis, death <negated>, Medullary thyroid carcinoma, Dehydration, Allergic reactions, Serious Hypoglycemia, Macrovascular Outcomes <negated>, Bilirubin elevation <negated>, Vital signs changes <negated>."
323,VIEKIRA,all-concat,"fatigue, nausea, pruritus, other skin reactions, insomnia, asthenia, serious adverse event (SAE), rash, erythema, eczema, rash maculo-papular, rash macular, dermatitis, rash papular, skin exfoliation, rash pruritic, rash erythematous, rash generalized, dermatitis allergic, dermatitis contact, exfoliative rash, photosensitivity reaction, psoriasis, skin reaction, ulcer, urticaria, dyspnea, serum ALT elevations, serum bilirubin elevations, anemia/decreased hemoglobin, headache, cough, irritability, ocular icterus, muscle spasms, hypersensitivity reactions, angioedema, Stevens Johnson Syndrome (SJS) <negated>, toxic epidermal necrolysis (TEN) <negated>, erythema multiforme (EM) <negated>, drug rash with eosinophilia and systemic symptoms (DRESS) <negated>, diarrhea, jaundice, hyperbilirubinemia, AIDS-related opportunistic infection <negated>"
324,VIIBRYD,all-concat,"Suicidal Thoughts and Behaviors, Serotonin Syndrome, Increased Risk of Bleeding, Activation of Mania or Hypomania, Discontinuation Syndrome, Seizures, Angle-Closure Glaucoma, Hyponatremia, diarrhea, nausea, vomiting, insomnia, dry mouth, abdominal pain, dyspepsia, flatulence, gastroenteritis, abdominal distension, headache, dizziness, somnolence, paresthesia, abnormal dreams, restlessness, fatigue, palpitations, increased appetite, arthralgia, increased weight, abnormal orgasm, anorgasmia, erectile dysfunction, libido decreased, ejaculation disorder, ventricular extrasystoles, dry eye, vision blurred, cataracts, sedation, tremor, migraine, panic attack, hyperhidrosis, night sweats, irritability, hallucinations, suicide attempt, suicidal ideation, rash, generalized rash, urticaria, drug eruption, death"
325,VIMPAT,all-concat,"Suicidal Behavior and Ideation, Dizziness, Ataxia, Cardiac Rhythm and Conduction Abnormalities, Syncope, Multiorgan Hypersensitivity Reactions, diplopia, headache, nausea, insomnia, somnolence, fatigue, vomiting, blurred vision, vertigo, diarrhea, gait disturbance, asthenia, contusion, skin laceration, tremor, nystagmus, balance disorder, memory impairment, depression, pruritus, neutropenia, anemia, palpitations, tinnitus, constipation, dyspepsia, dry mouth, oral hypoaesthesia, irritability, pyrexia, feeling drunk, fall, muscle spasms, paresthesia, cognitive disorder, hypoaesthesia, dysarthria, disturbance in attention, cerebellar syndrome, confusional state, mood altered, depressed mood, injection site pain, injection site discomfort, injection site irritation, injection site erythema, bradycardia, chest pain, abnormal coordination, hyperhidrosis, agranulocytosis, aggression, agitation, hallucination, psychotic disorder, angioedema, rash, urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis, hepatitis, nephritis, myocarditis, death"
326,VOTRIENT,all-concat,"diarrhea, hypertension, hair color changes, depigmentation, nausea, anorexia, vomiting, fatigue, decreased weight, decreased appetite, tumor pain, dysgeusia, headache, musculoskeletal pain, myalgia, gastrointestinal pain, dyspnea, hepatotoxicity, QT prolongation, torsades de pointes, cardiac dysfunction, hemorrhagic events, arterial thromboembolic events, venous thromboembolic events, thrombotic microangiopathy, gastrointestinal perforation, fistula, interstitial lung disease, pneumonitis, reversible posterior leukoencephalopathy syndrome, infection, increased toxicity with other cancer therapies, renal cell carcinoma, soft tissue sarcoma, asthenia, abdominal pain, alopecia, chest pain, dysphonia, facial edema, palmar-plantar erythrodysesthesia, hand-foot syndrome, proteinuria, rash, skin depigmentation, weight decreased, arthralgia, muscle spasms, leukopenia, neutropenia, thrombocytopenia, lymphocytopenia, ALT increased, AST increased, glucose increased, total bilirubin increased, phosphorus decreased, sodium decreased, magnesium decreased, glucose decreased, exfoliative rash, cough, peripheral edema, mucositis, dizziness, skin disorder, skin hypopigmentation, stomatitis, insomnia, hypothyroidism, epistaxis, left ventricular dysfunction, dry skin, chills, vision blurred, nail disorder, lipase elevations, pancreatitis, pneumothorax, bradycardia, retinal detachment/tear, severe and fatal hepatotoxicity, serum transaminase levels increase, bilirubin increase, congestive heart failure, decreased left ventricular ejection fraction, myocardial dysfunction, hematuria, epistaxis, hemoptysis, rectal hemorrhage, cerebral/intracranial hemorrhage, myocardial infarction, ischemia, cerebrovascular accident, transient ischemic attack, pulmonary embolus, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, wound healing impairment, nephrotic syndrome, hypertensive crisis, fetal harm, death"
327,VPRIV,all-concat,"hypersensitivity reactions, headache, dizziness, abdominal pain, nausea, back pain, joint pain, prolonged activated PTT, fatigue/asthenia, pyrexia, bone pain, tachycardia, rash, urticaria, flushing, hypertension, hypotension, chest discomfort, dyspnea, pruritus, death"
328,XARELTO,all-concat,"Increased risk of stroke, Bleeding risk, Spinal/epidural hematoma, Bleeding, Hemorrhage, Major bleeding, Bleeding into a critical organ, Fatal bleeding <death>, Gastrointestinal bleeding, Intracranial bleeding, Non-fatal critical organ bleeding, Retroperitoneal bleeding, Intraocular bleeding, Intra-articular bleeding, Non-fatal non-critical organ bleeding, Decrease in Hb >= 2g/dL, Transfusion of >=2 units of whole blood or packed red blood cells, Clinically relevant non-major bleeding, Any bleeding, Menorrhagia, Prophylaxis of Deep Vein Thrombosis, Major bleeding event, Extra-surgical site bleeding requiring transfusion of >2 units of whole blood or packed cells, Any bleeding event, Wound secretion, Pain in extremity, Muscle spasm, Syncope, Pruritus, Blister, Pulmonary hemorrhage, Pulmonary hemorrhage with bronchiectasis, Agranulocytosis, Thrombocytopenia, Retroperitoneal hemorrhage, Jaundice, Cholestasis, Hepatitis, Hepatocellular injury, Hypersensitivity, Anaphylactic reaction, Anaphylactic shock, Angioedema, Cerebral hemorrhage, Subdural hematoma, Epidural hematoma, Hemiparesis, Stevens-Johnson syndrome, Abdominal pain upper, Dyspepsia, Toothache, Fatigue, Sinusitis, Urinary tract infection, Back pain, Osteoarthritis, Oropharyngeal pain"
329,XELJANZ,all-concat,"upper respiratory tract infections, headache, diarrhea, nasopharyngitis, serious infections, infections, urinary tract infections, pneumonia, cellulitis, herpes zoster, tuberculosis <negated>, opportunistic infections <negated>, malignancies, malignancy, lymphoma, lung cancer, breast cancer, gastric cancer, colorectal cancer, renal cell cancer, prostate cancer, malignant melanoma, lymphopenia, neutropenia, liver enzyme elevations, liver injury, lipid elevations, serum creatinine elevations, anemia, diverticulitis, dehydration, insomnia, paresthesia, dyspnea, cough, sinus congestion, abdominal pain, dyspepsia, vomiting, gastritis, nausea, hepatic steatosis, rash, erythema, pruritus, musculoskeletal pain, arthralgia, tendonitis, joint swelling, non-melanoma skin cancers, pyrexia, fatigue, peripheral edema, gastrointestinal perforations, death"
330,XENAZINE,all-concat,"Depression, suicidality, akathisia, restlessness, agitation, parkinsonism, dysphagia, sedation, somnolence, fatigue, insomnia, anxiety, nausea, irritability, decreased appetite, obsessive reaction, balance difficulty, bradykinesia, dizziness, dysarthria, unsteady gait, headache, vomiting, fall, laceration (head), ecchymosis, upper respiratory tract infection, shortness of breath, bronchitis, dysuria, tremor, confusion, worsening aggression, pneumonia, hyperhidrosis, skin rash, neuroleptic malignant syndrome (NMS), QTc prolongation, hypotension, orthostatic hypotension, hyperprolactinemia, tardive dyskinesia, death"
331,XOFIGO,all-concat,"Bone Marrow Suppression, nausea, diarrhea, vomiting, peripheral edema, anemia, lymphocytopenia, leukopenia, thrombocytopenia, neutropenia, Pancytopenia, Renal failure and impairment, dehydration, erythema, pain, edema at the injection site, Secondary Malignant Neoplasms, osteosarcoma, Bone Marrow Suppression <negated>, bone marrow failure, vascular hemorrhage, myelosuppression, serious infections, febrile neutropenia, death"
332,ZALTRAP,all-concat,"Hemorrhage, Gastrointestinal Perforation, Compromised Wound Healing, Fistula Formation, Hypertension, Arterial Thromboembolic Events, Proteinuria, Neutropenia, Neutropenic Complications, Diarrhea, Dehydration, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), leukopenia, AST increased, stomatitis, fatigue, thrombocytopenia, ALT increased, weight decreased, decreased appetite, epistaxis, abdominal pain, dysphonia, serum creatinine increased, headache, Urinary Tract Infection, Blood and lymphatic system disorders, Metabolism and nutrition disorders, Nervous system disorders, Vascular disorders, Respiratory, thoracic and mediastinal disorders, Dyspnea, Oropharyngeal Pain, Rhinorrhea, Gastrointestinal disorders, Abdominal Pain Upper, Hemorrhoids, Rectal Hemorrhage, Proctalgia, Skin and subcutaneous tissue disorders, Palmar-Plantar Erythrodysesthesia Syndrome, Skin Hyperpigmentation, Renal and urinary disorders, General disorders and administration site conditions, Asthenia, Investigations, Infections, severe hypersensitivity reactions, venous thromboembolic events (VTE), deep venous thrombosis, pulmonary embolism, Immunogenicity, anti-product antibody (APA), neutralizing antibodies, death"
333,ZELBORAF,all-concat,"New Primary Malignancies, Hypersensitivity Reactions, Dermatologic Reactions, QT Prolongation, Hepatotoxicity, Photosensitivity, Ophthalmologic Reactions, Radiation Sensitization, Radiation Recall, arthralgia, rash, alopecia, fatigue, photosensitivity reaction, nausea, pruritus, skin papilloma, cuSCC, Rash maculo-papular, Actinic keratosis, Dry skin, Rash papular, Erythema, Myalgia, Pain in extremity, Musculoskeletal pain, Back pain, Edema peripheral, Pyrexia, Asthenia, Diarrhea, Vomiting, Constipation, Headache, Dysgeusia, Skin papilloma, Cutaneous SCC, Seborrheic keratosis, Gamma-glutamyltransferase increased, Decreased appetite, Cough, Sunburn, palmar-plantar erythrodysesthesia syndrome, keratosis pilaris, panniculitis, erythema nodosum, Stevens-Johnson syndrome, toxic epidermal necrolysis, arthritis, neuropathy peripheral, VIIth nerve paralysis, basal cell carcinoma, oropharyngeal squamous cell carcinoma, folliculitis, retinal vein occlusion, vasculitis, atrial fibrillation, GGT, AST, ALT, Alkaline phosphatase, Bilirubin, Neutropenia, Pancreatitis, Cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, Non-Cutaneous Squamous Cell Carcinoma, Other Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Serious Hypersensitivity Reactions, anaphylaxis, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome), Severe Dermatologic Reactions, QT prolongation, Liver injury, Photosensitivity, Uveitis, blurry vision, photophobia, Embryo-Fetal Toxicity, Radiation sensitization, Radiation recall"
334,ZIOPTAN,all-concat,"conjunctival hyperemia, ocular stinging/irritation, ocular pruritus, allergic conjunctivitis, cataract, dry eye, ocular pain, eyelash darkening, growth of eyelashes, vision blurred, headache, common cold, cough, urinary tract infection, exacerbation of asthma, dyspnea, iritis/uveitis, deepening of the eyelid sulcus, pigmentation of the iris, pigmentation of the periorbital tissue, pigmentation of the eyelashes, increased length of eyelashes, increased thickness of eyelashes, increased number of eyelashes, intraocular inflammation <negated>, macular edema <negated>"
335,ZONTIVITY,all-concat,"Bleeding, life-threatening bleeding, fatal bleeding, death, GUSTO severe bleeding, intracranial bleeding, bleeding with hemodynamic compromise requiring intervention, GUSTO moderate bleeding, bleeding requiring transfusion, GUSTO Bleeding Categories, Severe bleeding, Moderate or Severe bleeding, Any GUSTO Bleeding (Severe/Moderate/Mild), Fatal Bleeding <negated>, Intracranial Hemorrhage (ICH), Clinically Significant Bleeding, Gastrointestinal Bleeding, Anemia, Depression, Rashes, Eruptions, Exanthemas, iron deficiency <negated>, retinopathy or retinal disorder <negated>, diplopia/oculomotor disturbances, active pathological bleeding <negated>"
